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Abstract 
 
Title: 
A preliminary investigation into the association between chronic obstructive 
pulmonary disease (COPD) and oropharyngeal dysphagia, and its impact on 
health. 
 
Background:  
Prevalence of oropharyngeal dysphagia in patients with COPD is under 
researched; with its contribution to exacerbations of the disease and impact 
on quality of life remaining elusive.  
 
Aim of Study: 
To investigate the extent and nature of oropharyngeal dysphagia by phase of 
COPD, and its impact on health. 
 
Objectives of the study: 
Three objectives investigated were 
 subject perception of symptoms and swallowing related quality of life 
between normal controls and COPD (stable and exacerbation phase)  
 prevalence of biomechanical dysphagia by phase of COPD (stable 
and exacerbation) 
 prevalence of altered respiratory-swallow pattern by phase of COPD 
(stable and exacerbation)  
 
Study Design: 
Prospective, repeated measures observational study design with a cross 
sectional control arm. Feasibility Testing was conducted for the three key 
components of the assessment process. 
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Methods for Prospective Study: 
Normal controls (n=36) completed a validated questionnaire (SWAL-QOL). 
COPD subjects completed the SWAL-QOL, videofluoroscopy and respiratory 
assessment simultaneously during exacerbation phase of COPD (n=14); 
followed up during stable phase (n=10). 
 
Results: 
Descriptive and non parametric analysis revealed COPD subjects were more 
likely to: 
 perceive their swallowing ability lower than controls (p<0.01) with 
further deterioration during exacerbations (p=0.012)  
 perceive their quality of life lower than controls (p<0.01) with further 
deterioration in two domains during exacerbation phase (Duration 
p=0.021, Fear p=0.043).  
 exhibit dysphagic characteristics significantly more for food (p=0.046) 
and drink trials (p=0.035); with increased penetration (p=0.031) and 
spontaneous manoeuvres (p=0.044) during exacerbation phase of 
COPD.  
 use inhalation post swallow for either phase of COPD more than 
normative data within the literature. 
 
Conclusions: 
This study showed the presence of oropharyngeal dysphagia in patients with 
COPD; with symptoms increasing during exacerbation phase. This finding 
was significantly altered from the 'normal swallowing pattern' from controls 
within this study and from normative data found within the literature.  
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Chapter One: Introduction to Study 
1.1 Introduction 
Chronic Obstructive Pulmonary Disease (COPD) is a respiratory disease 
with progressive decline in lung function, often punctuated by acute 
exacerbations when respiratory function temporarily deteriorates above and 
beyond the usual impairment (Donaldson & Wedzicha, 2006). Factors 
affecting the severity and frequency of these exacerbations, or the 
associated impact on quality of life are largely unknown. Furthermore, there 
has been increased suspicion that oropharyngeal dysphagia (swallowing 
difficulties) contributes to the onset, severity or frequency of acute 
exacerbations and subsequent decline in patients with COPD; however this 
has yielded little research interest to date. 
The study presented in this thesis aims to investigate prevalence, define 
relevant factors contributing to oropharyngeal dysphagia in COPD and 
explores swallowing related quality of life by phase (stable or exacerbation) 
of the condition. This was achieved by reviewing previous literature, building 
on current knowledge of oropharyngeal dysphagia and the respiratory-
swallow pattern to design an innovative research methodology.   
Chapter one introduces the two key elements of this thesis, with an in-depth 
review of oropharyngeal dysphagia continuing in chapter two. Finally, this 
chapter summarises the study design and plan of the thesis.  
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1.2  Contribution to Body of Knowledge 
This thesis provides a unique contribution to the currently limited body of 
knowledge in the area of oropharyngeal dysphagia and COPD, which is 
discussed in detail in chapters two and three. The innovative study design 
presented in this thesis addresses past methodological weaknesses within 
the literature and extends research objectives to include: 
 visual analysis of oropharyngeal dysphagia simultaneously with 
respiratory-swallow pattern analysis by phase of COPD in a British 
population 
 
 self-rated perception of swallowing skills and swallow related quality of 
life by phase of COPD 
 
 
Additionally, there is no known research exploring true prevalence and 
nature of oropharyngeal dysphagia in patients with COPD in the United 
Kingdom, nor is there any known study to integrate information gathered 
from the three concurrent measures (self perception of swallowing skills and 
related quality of life, oropharyngeal swallow assessment and respiratory-
swallow pattern assessment, discussed in chapter four) in patients with 
COPD internationally. This holistic approach aims to provide clinically 
relevant information on the overall swallowing function, and considers the 
wider implications of swallowing aberrations in patients with COPD such as 
phase of disease and impact on quality of life; relevant to both the 
professional and COPD patient/carer.  
A summary of the contributions this thesis offers to the body of knowledge is 
summarised in table 1. 
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Table 1 Summary of contribution of thesis to the current body of knowledge. 
Contribution to Body of Knowledge 
 
 Consolidates and integrates current evidence regarding 
oropharyngeal dysphagia and respiratory-swallow pattern within 
COPD population. 
 
 Provides new information on extent and nature of oropharyngeal 
dysphagia by phase of COPD. 
 
 The first research known internationally and within the U.K. to 
measure self rated perception of swallowing skills and related 
quality of life concurrently with visual oropharyngeal and 
respiratory-swallow pattern assessment. 
 
 Highly replicable innovative study design. 
 
1.3  Clinical Driver  
I started work in Sheffield in 2002 as a Highly Specialist Speech and 
Language Therapist. My role was to develop a speech and language therapy 
service (swallowing and communication assessment and intervention) within 
the newly formed team called Assessment and Integrated Care Scheme 
(AICS). The AICS team’s remit was to provide safe, prompt discharge from 
hospital with initial community support for people over the age of 65 years. 
As part of the team, I would assess admissions into the emergency units at 
the two major teaching hospitals in Sheffield (Royal Hallamshire Hospital and 
Northern General Hospital) for potential candidates who would benefit from 
the AICS service.  
During this time I noticed a high readmission rate for people presenting with 
purulent sputum and shortness of breath, and subsequently diagnosed with 
an exacerbation of their pre-existing COPD. Furthermore, these patients had 
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a history of recurrent chest infection; some with low body mass index (BMI) 
and dehydration, acknowledged as a complication of their disease (National 
Collaborating Centre for Acute and Chronic Conditions., 2010). Even though 
these symptoms mirror symptoms of recurrent aspiration pneumonia caused 
by oropharyngeal dysphagia (Perlman & Schulze-Delrieu, 2003), referral to 
Speech and Language Therapy for dysphagia assessment occurred only if 
their past medical history included a disease/disorder well known to cause 
dysphagia (such as stroke). It became apparent that the pathway for a 
patient presenting with an exacerbation of their COPD in Sheffield followed 
national guidelines for managing acute exacerbations (National Collaborating 
Centre for Acute and Chronic Conditions., 2010), alongside local pathways 
(NHS Sheffield, accessed online 2007) which were streamlined in treating 
exacerbations in a timely and efficient manner. As the empirical therapy 
(usually including antibiotics and steroids in hospitalised cases) is 
acknowledged to be effective, other potential differential diagnoses (such as 
chest infections/ pneumonia caused by oropharyngeal dysphagia) were not 
routinely investigated. If a percentage of admissions presenting with acute 
exacerbation of COPD also included potentially undiagnosed oropharyngeal 
dysphagia (swallowing problems), the already prescribed antibiotic 
intervention would treat the acute infection, but would not treat the underlying 
cause of the oropharyngeal dysphagia and allow recurrent chest infections to 
continue. However, the underlying association was not clear at a clinical level 
and the potential association between exacerbations of COPD and 
oropharyngeal dysphagia could not be explained fully within the literature.  
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This initiated the question:  
Does oropharyngeal dysphagia cause (some) exacerbations of 
COPD, or could acute exacerbations of COPD induce episodes of 
oropharyngeal dysphagia? 
Clinical suspicion was increased during my videofluoroscopy clinics at 
Sheffield Teaching Hospitals. In 2006, approximately 30% of people referred 
(mostly by Speech and Language Therapists) to videofluoroscopy clinics for 
a swallowing assessment (as described in chapter four) had a primary or 
secondary diagnosis of COPD. A case history noted most of those referred 
reported ‘not eating and/or drinking for (up to) eight days’ during an 
exacerbation as they were ‘scared of choking’, ‘coughing on food/drink’, ‘not 
being able to catch their breath during eating/drinking’, or ‘too tired to eat’. 
From videofluoroscopy assessment, approximately 80% were diagnosed 
with some level of dysphagia, with approximately half considered as ‘silent 
aspirators’ (described in chapter two) as shown in figure 1. 
Figure 1 Arrow pointing to aspiration as seen during videofluoroscopy. 
 
Thus, these individuals reported symptoms of, and were clinically diagnosed 
with oropharyngeal dysphagia. However, as the videofluoroscopy took place 
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in a general clinic, it was difficult to ascertain if the oropharyngeal dysphagia 
could be attributed solely to COPD, or as a result of co-morbidities. A review 
of the literature revealed oropharyngeal dysphagia in COPD has had limited 
research attention in the past (as discussed in the theoretical chapters two 
and three), and further research was required to ascertain whether COPD as 
a primary diagnosis was a relevant client group for identification as an ‘at 
risk’ group, which would then warrant dysphagia screening and intervention. 
 
1.4  Background to the Study 
1.4.1 Oropharyngeal Dysphagia 
‘Dysphagia’ is derived from the Greek root meaning ‘disordered or difficulty 
eating’, also known as deglutitive disorders (Murry & Carrau, 2006). The 
Health and Social Care Information Centre (accessed online 2009)1 reported 
dysphagia was considered the primary reason for 20,528 hospital 
admissions in England during 2005/6, resulting in a total of 63,204 bed days. 
Sheffield recorded 360 admissions for this problem resulting in 1,268 bed 
days for the same period. However a true estimate of hospital admissions 
due to oropharyngeal dysphagia is difficult to achieve due to possible mis-
diagnosis, under-diagnosis, coding variations or over generalisation of 
diagnosis. World Health Organisation (WHO, accessed online 2009) 
classifies oropharyngeal dysphagia and oesophageal dysphagia within the 
same ICD category (R13). Also, oropharyngeal dysphagia may be coded 
under other headings such as pneumonitis due to food and vomit (J690), 
                                            
1
 Copyright © 2010 Re-used with the permission of The Health and Social Care Information Centre. All 
rights reserved. 
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bacterial pneumonia not elsewhere classified (J15). Accounting for these 
potential coding variations, oropharyngeal dysphagia related admissions may 
be as high as 35,000; resulting in approximately 3,268,000 bed days in 
England during 2005/6. Furthermore, the figures quoted are from acute 
hospital records, therefore do not show figures or related health care costs 
within the community setting. 
In 2008, the Royal College of Physicians produced guidelines stating a 
patient who shows clinical features of oropharyngeal dysphagia should be 
referred for a full clinical assessment by a trained specialist. Whilst 
multidisciplinary management is crucial, Speech and Language Therapists 
are internationally recognised as the lead profession in the assessment and 
management of oropharyngeal dysphagia, with the profession receiving 
increasing referrals (Enderby & Petheram, 2002).  Relevant professional 
bodies have produced clinical guidelines and procedures detailing 
competencies required for oropharyngeal dysphagia assessment and 
management (Speech Pathology Australia [SPA], 2004; Royal College of 
Speech and Language Therapists [RCSLT], 2006; Royal College of 
Physicians, 2008; American Speech-Language Hearing Association [ASHA], 
2010).  
Oropharyngeal dysphagia has been found to contribute to pneumonia, 
malnutrition, poor wound healing, reduced tolerance to medical treatments 
and lower quality of life (Langmore, Terpinning & Schork et al., 1998; 
Gaziano, 2002; Murry & Carrau, 2006; Cabre, Serra-Prat, Palomera, & 
Almirall, et al., 2010). Furthermore, a dramatic reduction in pneumonia has 
been reported when systematic diagnosis and treatment of oropharyngeal 
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dysphagia is implemented (Langmore, 1991). The most common signs and 
symptoms of pneumonia caused by oropharyngeal dysphagia (or aspiration 
pneumonia) are frequent coughing, purulent sputum, increased shortness of 
breath, high fever and chest infection (Langmore, Terpinning, & Schork, et 
al., et al., 1998). Observational assessment of aspiration pneumonia 
presents similar signs and symptoms to an acute exacerbation COPD (see 
section 1.4.2vi), yet differential diagnosis is not yet routinely investigated. 
A number of aetiologies have been attributed to oropharyngeal dysphagia in 
neurological and non neurological populations (Kidd, Lawson, Nesbitt, & 
MacMahon, 1995; Shaker, Milbrath, Ren, & Campbell, et al., 1995; 
Logemann, 1998). However COPD does not conform with typical 
neurological aetiologies; such as acute insult to the brain (e.g. stroke), nor 
does it conform with typical non-neurological aetiologies such as 
surgical/intervention induced changes (e.g. head and neck cancer, 
tracheostomy patients). Therefore it is difficult to generalise any of these 
findings in the literature to the COPD aetiology. Furthermore, the influence of 
respiratory status on swallowing has received little attention in non 
tracheostomy aetiologies. Until the evidence based is clearly established, the 
extent of oropharyngeal dysphagia in patients with COPD may continue to be 
under-diagnosed. The study detailed in this thesis aims to address this issue. 
 
1.4.2 COPD 
Chronic Obstructive Pulmonary Disease (COPD) or Chronic Obstructive 
Airways Disease (COAD) is the preferred term for emphysema, bronchiolitis 
and chronic bronchitis. It is defined by the airflow obstruction that is ‘not fully 
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reversible and does not change markedly over several months’ (National 
Clinical Guideline Centre, 2010, p. 54). COPD develops as the lungs become 
damaged over a long period of time. An abnormal inflammatory response to 
tobacco smoke and other irritants result in alveolar destruction, loss of 
parenchymal elasticity and bronchial inflammation; with the latter resulting in 
increased mucus production by the lungs which compromises their defence 
system.  The combination of damage impedes airflow out of the lungs and 
impairs gas exchange, producing increasing symptoms of breathlessness.  
 
COPD is most commonly caused by smoking, with an estimated 10% to 30% 
of smokers developing COPD (Voelkel, 2000).  Another strong (inverse) 
relationship with COPD is socioeconomic status; with poor housing 
conditions and childhood respiratory illnesses influencing respiratory 
diseases later in life (Pauwels, 2000).  Less common causes include genetic 
predisposition; such as alpha one antitrypsin deficiency (Stockley, Rennard, 
Rabe, & Celli, 2007), and occupational and atmospheric exposure such as 
welding or working within the steel industry (Meldrum, Rawbone, Curran, & 
Fishwick, 2005).  
 
1.4 .2i) Guidelines 
The rising prevalence of COPD and increasing burden on health resources 
(as discussed later) has led to guidelines for COPD diagnosis and 
management to become a high priority for government health initiatives.  For 
the purposes of this thesis, U.K. guidelines and professional bodies will be 
 11 
 
used as the main source for this study, and international guidelines 
referenced where appropriate. 
International  consensus based guidelines for COPD have been published 
since the 1990s; with the American Thoracic Society (ATS) (1995), European 
Respiratory Society (ERS) (1995), and Global Initiative for Chronic 
Obstructive Pulmonary Disease (GOLD) (2001) aiming to improve diagnosis 
and management of COPD on a global scale. Within the United Kingdom 
(U.K.), the British Thoracic Society (BTS) published guidelines for COPD in 
1997 (Haplin, 2004), however the Department of Health also included 
management recommendations for patients with COPD within the generic 
National Standard Frameworks (NSF) under the NHS Plan (Department of 
Health, 2000); such as the NSF for Long Term Conditions (Department of 
Health, 2005a) and NSF for Older People (Department of Health, 2002) and 
strategies such as Chronic Disease Management (Department of Health, 
2004). The Department of Health also instructed the National Institute for 
Health and Clinical Excellence to develop COPD guidelines for England and 
Wales, which were published in 2004 (National Collaborating Centre for 
Acute and Chronic Conditions., 2004). This aimed to provide guidelines for 
consistent service delivery across England and Wales, reduce overall 
prevalence and improve quality of life. Since the original work presented here 
was undertaken, a revised version has also been published (National 
Collaborating Centre for Acute and Chronic Conditions., 2010). Furthermore, 
a National Service Strategy for COPD is currently in consultation phase, due 
to be implemented in 2011 (Department of Health, 2010a). Therefore from 
2004, the United Kingdom government policies have identified COPD as a 
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national priority and have encouraged Strategic Health Authorities and 
Primary Care Trusts to address COPD diagnosis and management at a local 
level. 
 
Local Context 
In 2005, the diagnosis and management of patients with COPD in Sheffield 
was considered a priority due to the higher than national average incidence 
of the disease (Sheffield Health Authority and Sheffield Primary Care 
Groups, 2002), with Sheffield Respiratory services incorporating the COPD 
NICE guidelines into local practice (National Collaborating Centre for Acute 
and Chronic Conditions., 2004). Guidelines emphasised that management 
should be delivered by a multidisciplinary team, and innovative ways to 
reduce hospital admission rates should be explored. As such, local strategies 
including specialist oxygen assessment services, pulmonary rehabilitation 
and the Supported Early Discharge Scheme were initiated to address the 
increase use of health resources locally (NHS Sheffield, accessed online 
2007).   
Although a multidisciplinary team approach is recommended in all guidelines, 
limited evidence for oropharyngeal dysphagia in patients with COPD has 
resulted in the lack of oropharyngeal dysphagia assessments to be routinely 
included within care pathways. 
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1.4 .2ii) Prevalence 
The NICE Clinical Guideline 101 (National Collaborating Centre for Acute 
and Chronic Conditions., 2010) suggests overall prevalence of COPD in the 
United Kingdom is estimated between 2- 4% in England and Wales.  
However prevalence varies depending on age and socio-economic factors, 
and NICE suggest current prevalence in U.K. adults over the age of 45 years 
increases between 9% and11%; showing yearly increases more so in 
women. The ‘Lung Report III’ in 2003 (British Lung Foundation, 2003) 
suggest early symptoms go largely undetected, or are wrongly associated 
with signs of ageing (for example increased breathlessness), and is therefore 
significantly under-diagnosed in the primary care setting. Sheffield has a 
higher than national overall prevalence in pockets of lower socioeconomic 
regions; recording 7% prevalence (Sheffield Health Authority and Sheffield 
Primary Care Groups, 2002). 
 
1.4.2iii) Morbidity  
COPD is a significant drain on health care resources. In 1990 COPD was 
estimated to be the twelfth greatest burden of disease globally, and predicted 
to rise to fifth place by 2020 (Murray & Lopez, 1996). In the United Kingdom, 
people diagnosed with COPD tended to access NHS services more than the 
non COPD population in 2000, with 80% of the COPD population accessing 
GP services (compared to 55% of non COPD population) (Sheffield Health 
Authority and Sheffield Primary Care Groups, 2002). The British Thoracic 
Society (2006) reported patients with COPD attended approximately 1.4 
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million general practice consultations with 62 million prescriptions used in the 
prevention and treatment of respiratory disease (with COPD as a major 
contributor) in 2004. Additionally, a high socio-economic burden is attributed 
to COPD, with an estimated 24 million working days per year lost due to the 
disease, at an estimated cost of £2.7billion in lost productivity (Department of 
Health, 2005b). 
Patients with COPD also use a significant proportion of acute services in 
England and Wales. Acute hospital admission rates were 64% (compared to 
43% of non COPD population) for 1996/7- 2000/01 (Sheffield Health 
Authority and Sheffield Primary Care Groups, 2002). In 2000, one in eight 
emergency medical hospital admissions in England were due to COPD, and 
the British Thoracic Society (2006) reported COPD accounted for one million 
inpatient bed days and a mean length of stay of 9 days in 2003. Studies also 
report high readmission rates for acute exacerbation, with 22% of patients 
with COPD being readmitted within two weeks (Adams, Melo, Luther, & 
Anzueto, 2000) and 40% within six months (Connors, Dawson, Thomas, & 
Harrell, et al., 1996).  
COPD has been reported as among the most costly diseases for inpatient 
NHS care. The Department of Health (2005b) estimated COPD accounted 
for a total of £1.7 billion in morbidity costs, of which more than £800 million is 
used in direct NHS healthcare costs each year. Within Sheffield, COPD also 
rated as the second highest ranking emergency medical admission to 
Sheffield Hospitals with the highest length of hospital stay per patient group 
(Sheffield Health Authority and Sheffield Primary Care Groups, 2002). 
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1.4.2iv) Quality of Life 
Previous research on the impact of COPD on quality of life found in the 
literature can be broadly categorised within medical or psychosocial models. 
The tendency within early research was to investigate quality of life in 
patients with COPD in order to predict increased use of resources 
(Seemungal, Donaldson, Paul, & Bestall, et al., 1998). Such studies found 
poor quality of life predicted the increased use of health resources and 
increased hospital admissions (Osman, Godden, Friend, & Legge, et al., 
1997; Traver, 1998). Seemungal and Donaldson et al (1998) found quality of 
life was also significantly related to exacerbations, where frequent 
exacerbators scored lower in quality of life questionnaires. The studies 
mentioned used a medical model approach measuring declining lung 
function to account for progressive deterioration in quality of life. This may 
not accurately reflect or measure the impact COPD had on wellbeing; such 
that significant distress or deterioration in mental health or quality of life may 
occur during exacerbations of the condition, independent of clinical 
deterioration of lung function. Although not a direct aim, studies such as 
Ferrer and Alonso et al (1997), and Burge and Caverley et al (2000) 
highlighted that perceived quality of life did not always correlate with severity 
of COPD (or decline in lung function); a patient with mild COPD may show 
substantially reduced quality of life. Thus measuring lung function decline in 
isolation to design management protocols was no longer considered 
appropriate, as severity of COPD was shown to be a poor indicator of quality 
of life (Jones, 1995). Since the study by Burge and Caverley et al (2000), the 
importance of incorporating psychosocial aspects of health and wellbeing to 
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identify, treat and engage patients with COPD has received greater priority in 
national agendas  (Department of Health, 2004). Therefore studies have also 
aimed to investigate the impact of COPD on aspects of quality of life. Such 
studies found patients with COPD exhibit significantly higher levels of mental 
health issues such as depression and anxiety which have a negative impact 
on quality of life than normal controls (Felker, Katon, Hedrick & Rasmussen 
et al., 2001; Arnold, Ranchor, DeJongste, & Koeter, 2005; Cully, Graham, 
Stanley & Ferguson, et al., 2006). Furthermore, severity of COPD and 
frequency of exacerbations was found to relate to perceived decline in 
physical functioning, vitality and psychological functioning. Arnold and 
Ranchor et al (2005) suggested severity of COPD related to self reports of 
deteriorating physical functioning and reduced quality of life. However, 
perceived quality of life and wellbeing has also been shown to be mediated 
by levels of personal control or self efficacy, independent of severity of 
COPD (Kohler, Fish, & Greene, 2002). Some studies have suggested that 
levels of self efficacy influenced health promoting behaviours, such as 
adherence to smoking cessation programs, medication regimes, and 
exercise programs; which in turn increased perceived quality of life (Lox & 
Freehill, 1999; Gifford, Bormann, Shivey, & Wright, et al., 2000; Gebhardt, 
van der Doef, & Paul, 2001). These findings reiterate the importance of 
pulmonary rehabilitation and education programs on improving quality of life 
and wellbeing, which are discussed later in chapters two and seven.  
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1.4.2v) Mortality 
COPD has a high mortality, killing more women than breast cancer, and 
more men than prostate cancer (Haplin, 2004). The World Health 
Organisation (WHO) estimated 5% of all deaths worldwide were due to 
COPD in 2005. This makes COPD the sixth leading cause of death globally 
(Department of Health, 2005b), and predicted to be the third leading cause of 
death worldwide by 2020 (WHO, accessed online 2007).  
In 2000, COPD was recorded as the fifth most common cause of death and 
disability in England and Wales. This accounts for approximately 30 000 
deaths per year, costing the NHS £1.9 billion (Department of Health, 2005b). 
However these numbers may underestimate the true mortality rates, as 
studies have shown difficulties in estimating death attributable to COPD due 
to coding differences of death certificates, changes in criteria for diagnosis 
and where COPD may not have been the primary cause of death (Mannino, 
Gagnon, Petty, & Lydick, 2000; Hansell, Hollowell, McNiece, & Nichols, et 
al., 2003; Hansell, Walk, & Soriano, 2003). McGarvey and Matthias et al 
(2007) reported on mortality rates within the TORCH (Towards Revolution in 
COPD Health) study; a large multisite clinical trial (n=6145) conducted 
between 2000 and 2003. Of the 911 deaths recorded, 40% were considered 
related to COPD, with the most common causes of death being acute-on-
chronic respiratory failure (35%), cardiovascular events (27%), and lung 
cancer (21%). Other studies also suggest cause of death in COPD can be 
attributed to pulmonary infection or pulmonary embolism (Zielinski, MacNee, 
Wedzicha & Ambrosino et al., 1997). Soler- Cataluna and Martinez-Garcia et 
al (2005) reported that mortality is strongly associated with the frequency of 
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severe exacerbations requiring hospitalisation. In 2003, an average of 15% 
of COPD patients died within 90 days of admission into an acute hospital for 
exacerbation (Department of Health [DoH], 2005b). Furthermore, the DoH 
also reported survival rates can be as low as 50%, yet can increase as high 
as 95% if a highly specialist multidisciplinary team in an acute care facility is 
available.  
 
1.4 .2vi) Diagnosis 
As there is no single test to diagnose COPD, diagnosis relies on spirometry 
assessment in conjunction with ‘multi-dimensional’ tools that also assess 
clinical features and physical examination (National Clinical Guideline 
Centre, 2010). Spirometry measures airflow obstruction, and is defined by 
forced expiratory volume in one second (FEV1 or the amount of air you can 
blow out of the lungs in one second) and reduced FEV1/FVC ratio (where 
FVC is forced vital capacity or the total amount of air blown out of the lungs 
in one breath). COPD is indicated if spirometry shows post bronchodilator 
FEV1 of less than 80% predicted (from predicted normal for age, height and 
sex) and there is airflow obstruction as shown by decreased FEV1/FVC ratio 
of less than 70% in an appropriate clinical context. As discussed earlier, 
definitions of severity was used from the COPD NICE Clinical Guideline 12 
(National Collaborating Centre for Acute and Chronic Conditions., 2004) 
(highlighted in table 2) was used within the study detailed in this thesis as 
this was the most up-to-date guideline at the time of the recruitment phase. 
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However, the clinical guidelines have since been revised, and therefore 
relevant information is discussed in section 7.4. 
Table 2 COPD severity ratings (adapted from NICE Clinical Guideline 101, 2010: p16) 
  
NICE clinical 
guideline 12 
(2004) 
GOLD 
2008 
NICE clinical guideline 
101 (2010) 
Post bronchodilator 
FEV1/FVC 
FEV1 % 
predicted 
Severity of airflow obstruction 
 
  
Post bronchodilator 
< 0.7 ≥ 80%  Stage 1-  
Mild 
Stage 1-  
Mild* 
< 0.7 50–79% MILD Stage 2- 
Moderate 
Stage 2-Moderate 
< 0.7 30–49% MODERATE Stage 3- Severe Stage 3- Severe 
< 0.7 < 30% SEVERE Stage 4-  
Very Severe** 
Stage 4-  
Very Severe** 
*Symptoms should be present to diagnose COPD in people with mild airflow obstruction  
**Or FEV1 < 50% with respiratory failure. 
Using spirometry alone has the potential of underestimating, or 
overestimating the impact of the disease on the patient, and is unable to 
confidently predict quality of life and level of disability (Jones, 2001). 
Therefore a comprehensive severity assessment should also include tools 
that cover airflow obstruction in combination with level of impact on health 
status and perceived disability and burden for the individual. National Clinical 
Guideline Centre (2010) states COPD should be generally considered if: 
 Over 35 years of age 
 Current or ex smoker 
 Have any of the following symptoms: 
- Exertion breathlessness 
- Chronic cough 
- Regular sputum production 
- Frequent winter bronchitis 
- Wheeze 
- No clinical features of asthma 
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As COPD progresses, the pattern of symptomatology will change. They may 
include diverse conditions such as peripheral muscle weakness, changes in 
sleep, mood and cognition (Hung, Wisnivesky, Siu, & Ross, 2009) in addition 
to direct respiratory symptoms of breathlessness; as can be measured by 
Dyspnoea Visual Analogue Scales (Wewers & Lowe, 1990) and Modified 
Borg Scale (Burdon, Jumiper, Killian, Hargrave, & Campbell, 1982) and 
cough as well as being effected by co-morbidities. Thus, COPD diagnosis 
and ongoing assessment should be holistic throughout the disease process 
as this will guide the intervention pathway to suit the individual’s needs.   
 
1.4.2vii) Exacerbations 
An exacerbation of COPD is defined as a ‘sustained worsening of patient’s 
symptoms from his or her usual state that is beyond normal day-to-day 
variations, and is acute in onset.’ (National Clinical Guideline Centre, 2010, 
p. 351). However Donaldson and Wedzicha (2006) suggest a precise 
definition of an acute exacerbation is difficult to specify due to the 
heterogeneity and natural progression of the disease. Historically 
exacerbations were believed to be random events in the natural progression 
of the disease process; however more recently they are understood to 
‘cluster’ together in time. Therefore patients are more likely to experience a 
second exacerbation soon after the first (Hurst, Donaldson, Quint, & 
Goldring, et al., 2009), with studies showing up to 30% of patients admitted 
to hospital presenting with an exacerbation are readmitted within eight weeks 
(Skwarska, Cohen, Skwarska, & Lamb, et al., 2000; Sethi & File, 2004). 
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Known potential causes of exacerbations are air pollution, allergic responses 
or non compliance with medication regimes and viral infections (Wedzicha & 
Seemungal, 2007; Wilson, 2007), but bacterial infections are most important 
accounting for over half of all exacerbations (Murphy, Sethi, & Neiderman, 
2000; Diamantea, Nakou, Drakopanagiotakis, & Milioni, et al., 2007; Nazir & 
Erbland, 2009; Cosio & Agusti, 2010). Additionally, Donaldson and Wedzicha 
(2006) reported that the expected number of exacerbations per year was 
directly related to severity of COPD; with severe COPD averaging 3.43 per 
year compared with moderate COPD averaging 2.68 per year. Additionally, 
Bhowmik and Seemungal et al (2000) documented that frequent 
exacerbations occurred in patients who were shown to have bacteria already 
present in the lower airway when stable, suggesting these patients were 
more susceptible to exacerbations due to reduced pulmonary defences 
during stable phase. Furthermore, pulmonary bacterial infections in patients 
with COPD were associated with longer hospital admissions, faster decline in 
lung function, poorer mobility and reduced quality of life than in patients 
without bacterial infection (Bhowmik, Seemungal, Sapsford, & Wedzicha, 
2000; Donaldson & Wedzicha, 2006). 
The role and impact of bacterial infections contributing to exacerbations and 
the decline in COPD is controversial (Hirschmann, 2000; Hurst & Wedzicha, 
2007). However the literature generally acknowledges the strains of bacteria 
most strongly associated with exacerbations in COPD; and interestingly also 
associated with aspiration pneumonia (discussed in section 2.7.1) are H. 
influenza, Strep. Pneumonae, Staph. Aureus, P.aeruginosa, and 
K.pneumoniae also playing a role (Murphy, Sethi, & Neiderman, 2000; 
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Diamantea, Nakou, Drakopanagiotakis & Millioni, et al., 2007). Yet the 
mechanism by which bacterial infections lead to exacerbations is largely 
under researched and consequently not routinely investigated. Furthermore, 
acute exacerbations treated within the community setting do not routinely 
include chest x-ray to confirm diagnosis of an acute exacerbation, or 
alternatively used to exclude pneumonia. In a study by Lieberman and 
Liebermann et al (2002), pneumonic (PNAE) verses non pneumonic (NPAE) 
acute exacerbations of COPD were investigated by comparing acute and 
stable phase chest x-rays. They found 10% (23/240) of subjects were 
classified with PNAE; of which more than 50% (13/23) were further 
diagnosed as right sided (as seen in aspiration pneumonia discussed in 
section 2.7.1). However the cause of the pneumonia was not reported. As a 
specific cause of exacerbations are currently not identified in approximately 
30% of cases (Wedzicha & Seemungal, 2007), undiagnosed recurrent 
aspiration as a result of oropharyngeal dysphagia may play an important role 
as this may increase the bacterial load, and/or alter the type or location of 
bacteria (Singh, 2011); whereby causing or further complicating 
exacerbations in some cases. Therefore oropharyngeal dysphagia as a 
potential contributing factor to exacerbations warrants further investigation. 
 
1.4.2viii) Current Intervention 
The most common intervention strategies currently focus on alleviating 
airflow obstruction, however it is acknowledged that other therapies may 
positively impact on quality of life, disability and symptom relief without 
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addressing airflow obstruction (National Collaborating Centre for Acute and 
Chronic Conditions., 2010). An exacerbation of COPD may require 
intervention in either primary or secondary care, with more severe 
exacerbations resulting in emergency admission into hospital, and eventually 
lead to death (Donaldson & Wedzicha, 2006). Intervention strategies 
recommended by National Clinical Guideline Centre (2010) and relevant to 
this study are the use of antimicrobials (in severe cases), nutritional 
evaluation and patient education, which are now discussed. 
 
Antimicrobials 
The use of antibacterials in the treatment of patients with exacerbation of 
COPD is controversial and currently not routinely recommended in every 
case. This may be due to the literature being equivocal on benefit (Sharma & 
Gupta, 2004; Nazir & Erbland, 2009); most likely as a consequence of the 
debate surrounding the importance of the bacterial load found in both stable 
and exacerbative phases of COPD as discussed earlier. Nevertheless, 
eleven randomised controlled trials have shown positive outcomes in the use 
of antibiotics in patients with COPD (McCrory, Brown, Gelfand, & Bach, 
2001). Studies have found that daily administration of an antibiotic for up to 
12 months, or for up to a week during an acute exacerbation reduce the 
frequency and duration of exacerbations (Adams, Melo, Luther, & Anzueto, 
2000; Wilson, 2005; Seemungal, Wilkinson, Hurst, & Perara, et al., 2008), 
decreased mortality, use of mechanical ventilation, and length of hospital 
stay (Nouira, Marghli, Belghith, & Besbes, et al., 2001; El Moussaoui, Roede, 
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Speelman, & Bresser, et al., 2008). Not all studies have found improvements 
and this may be as a consequence of differing study inclusion criteria, types 
of antibiotics or clinical endpoints assessed. However, studies such as the 
MOSAIC trial highlight that when more stringent inclusion criteria and 
baseline assessment by which to measure improvement is instigated, 
findings suggest the use of antibiotics (moxifloxacin was used for five days in 
the study mentioned) allow mucosal inflammation to recover, improving 
pulmonary defence mechanisms and thereby increasing the duration 
between exacerbations (Wilson, Allegra, Huchon & Izquierdo, et al., 2004).  
The effectiveness of both long and short term antibiotic therapy is not 
surprising if one potential contributing factor of an exacerbation is due to 
oropharyngeal dysphagia, as discussed previously. Dependent on the type of 
antibiotic prescribed, long term use would mask any recurrent aspiration, 
whilst short term antibiotic use would clear evidence of an acute infection, 
enabling the patient to feel well enough to eat and drink normally again. This 
cycle would continue as antibiotic therapy treats the symptoms, not the 
cause; suggesting a plausible theory for the occurrence of ‘clusters’ of 
exacerbations as described previously. 
 
Nutritional evaluation 
An association between COPD and malnutrition has been well documented 
within the literature (Schols, Slangen, Volovic, & Wouters, 1998; Landbo, 
Prescott, Lange, & Vestbo, et al., 1999; Prescott, Almdal, Mikkelsen, & 
Tofteng, et al., 2002), with the degree of malnutrition correlating with the 
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severity of the disease (Openbrier, Irwin, Rogers, & Gottlieb, et al., 1983). 
Known causes of weight loss and malnutrition acknowledged in the literature 
are decreased food intake secondary to breathlessness; increased resting 
metabolism due to increased energy requirements for breathing, and altered 
absorption of essential nutrients due to hypoxia (Schols & Wouters, 2000). A 
study by Schols and Slangen et al (1998) found a history of weight loss was 
significantly related to mortality (p<0.005), with survival decreasing in 
underweight (severe COPD) and normal weight subjects when compared to 
overweight and obese patients (p<0.0001). This inverse relationship was 
confirmed in later studies (Prescott, Almdal, Mikkelsen, & Tofteng, et al., 
2002); where Landbo and Prescott et al (1999) found this was also 
dependent on stage of COPD. Conversely, the relationship between weight 
gain and mortality rates had mixed findings; with Schols and Slangen et al 
(1998) reporting increased weight significantly reduced mortality risk, 
however Prescott and Almdal et al (2002) found no changes in mortality risk 
with increasing weight. 
One possible cause of weight loss and malnutrition not considered in COPD 
guidelines is oropharyngeal dysphagia (discussed in more detail in chapter 
two). Some known complications of oropharyngeal dysphagia are 
malnutrition, dehydration, reduced appetite, and shortness of breath 
(Langmore, 1991; Logemann, 1998; Leslie, Carding, & Wilson, 2003), all 
symptoms exhibited in COPD, particularly during exacerbations.  
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Patient education 
A multidisciplinary team approach to intervention is acknowledged to 
encompass physical as well as quality of life issues the patient may 
encounter (National Clinical Guideline Centre, 2010). Professions considered 
essential in the management of COPD are Doctor, Nurse (including COPD 
Specialist Nurse), Physiotherapist, Occupational Therapist and Pharmacist. 
When COPD increases in severity, professionals added to the team are 
Dietitian, Social Work, Mental Health Worker, Psychologist/Psychiatrist and 
Behavioural Nurse/Therapist. 
The aim of this multidisciplinary team is to monitor progression and 
exacerbations, provide treatment and care as required and educate on self 
management and exercise advice. All this aims to avoid emergency 
admissions and maintain quality of life. One multidisciplinary intervention 
strategy is the provision of pulmonary rehabilitation (Nazir & Erbland, 2009). 
Although recommended by the National Clinical Guidance Centre (2010) as 
an important tool in maintaining health and independence, availability is 
variable within the United Kingdom. Yet the guidelines acknowledge such 
intervention strategies increase quality of life, exercise tolerance; and reduce 
hospital admissions and length of stay. The basic framework for pulmonary 
rehabilitation sessions tends to focus on exercise tolerance and strength, 
disease education, psychosocial support and nutritional advice. These 
sessions are usually operated by physiotherapy with invited sessions from 
dietetics and psychology. Oropharyngeal assessment and intervention is not 
routinely included into multidisciplinary intervention strategies for COPD, 
most likely due to the lack of professional awareness, robust evidence in the 
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literature and omission within national guidelines. However two recent 
studies have found the effectiveness of including oropharyngeal dysphagia 
assessment and education within existing pulmonary rehabilitation sessions 
(McKinstry, Tranter, & Sweeney, 2009; Ilsley, 2011), and are discussed in 
more detail in chapter two. 
 
1.4.2ix) Prognosis 
COPD is not a curable condition and death is most commonly due to 
respiratory failure, lung cancer or cardiac disease (McGarvey, Matthias, 
Anderson, & Zvarich, et al., 2007). The disease is progressive but the course 
may be punctuated by exacerbations. Although exacerbations in general 
recover, recovery may not be complete, hence the accelerating decline in 
lung function. Furthermore quality of life may deteriorate alongside 
exacerbations with or without measurable decline in lung function.  
The long term effects of COPD are increased breathlessness, sleep 
disturbances, restricted mobility, decreased independence, anxiety, 
depression and malnutrition. Most people continue to have a slowly 
deteriorating level of function, with unpredictable exacerbations worsening 
their condition.  
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1.5  Aim and Objectives  
Aim of the Study: 
To investigate the nature and extent of oropharyngeal dysphagia in patients 
with COPD; during stable and exacerbative phases of the disease, and its 
impact on health. 
Objectives of the Study: 
1. Compare perception of dysphagia symptoms and impact on 
swallowing related quality of life between Normal Controls and by 
phase of COPD (stable or exacerbation). 
 
2. Investigate prevalence of oropharyngeal biomechanical dysphagia by 
phase of COPD. 
a. Explore the nature of the oropharyngeal dysphagia by phase of 
COPD. 
b. Compare the perception of dysphagia symptoms with the 
biomechanical analysis by phase of COPD. 
 
3. Investigate the nature of the respiratory-swallow pattern by phase of 
COPD. 
a. Compare the respiratory-swallow pattern with the 
biomechanical analysis by phase of COPD. 
 
1.6  Study Design 
This original study used a prospective repeated measures observational 
study design, with a cross sectional control stage; discussed in chapters four 
and five.  
1.7 Plan of thesis 
This thesis is presented in seven chapters. Chapters two and three provide 
the theoretical background and critique previous oropharyngeal and 
respiratory literature relevant to this study. These two chapters define normal 
swallowing and respiratory-swallow patterns, comparing against known 
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dysphagic populations, along with previously published COPD swallowing 
ability and respiratory-swallow patterns.  Information gathered from the 
literature shaped the research questions and informed the methodology of 
the research conducted in this thesis. As the study presented in this thesis 
was conducted in 2007/8, studies pertinent to COPD and oropharyngeal 
dysphagia published in the literature after 2007 were included in the 
theoretical chapters for completeness; however were not available to 
influence this study’s methodology. However all relevant studies are 
subsequently reviewed in light of this study’s findings within chapter seven.   
Chapter four describes the methodology of the research; using the MRC 
2010 guidelines, evidence based modelling and triangulation methodology as 
a framework. This chapter also justifies the assessment measures used to 
meet the aim and objectives of this study. 
Chapter five details the relevant methods employed in the study detailed in 
this thesis, and chapter six uses descriptive and quantitative analysis to 
report findings for each objective of the study. 
Chapter seven discusses the findings from this study; comparing clinical and 
statistical relevance with findings in the literature. This chapter also reports 
the limitations of the study detailed in this thesis, and highlights further 
research required in the future. 
 
1.8 Concluding Thoughts 
COPD places a significant burden on health care resources, accessing NHS 
services more than the non-COPD population (Department of Health, 2004). 
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This is commonly due to exacerbations in the condition requiring lengthy 
acute inpatient care. The most predominate cause of exacerbations is 
bacterial infection, yet oropharyngeal dysphagia as a potential mechanism 
contributing to the progression of COPD has yet to be thoroughly 
investigated.  As acute exacerbations of COPD and consequences of 
oropharyngeal dysphagia exhibit similar medical presentations, the potential 
for oropharyngeal dysphagia contributing to exacerbations and/or developing 
as a result of exacerbations in COPD warrants further investigation. 
Historically, measures identifying oropharyngeal dysphagia have been 
predominately led by the medical profession’s desire to associate 
physiological cause or changes in quality of life measures with severity of 
disease in order to improve rates of mortality and hospital admission 
(Seemungal, Donaldson, Paul, & Bestall, et al., 1998). Even though these 
clinical outcomes are important to clinicians and patients, the final success of 
any intervention strategy is decided by the patient themselves. Thus a key 
element crucial in the investigation of associations of oropharyngeal 
dysphagia in patients with COPD must include patient perception of their 
swallowing difficulty and how this impacts on their quality of life. Whereby 
quality of life measures can be utilised to influence future management 
strategies. Therefore the study presented in this thesis aimed to explore the 
clinician’s and patient’s perspective of the association between 
oropharyngeal dysphagia and COPD; including health related quality of life 
by phase of the condition by enlisting a triangulation methodological study 
design. 
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Chapter Two 
 
Pre-Clinical Theory Part I: 
 
The Oropharyngeal Swallow and 
COPD 
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Chapter Two: The Oropharyngeal Swallow and COPD 
2.1  Introduction  
Swallowing saliva, food or drink is a subconscious act that is usually taken 
for granted; yet it occurs up to 600 times a day and involves more than 30 
cranial nerves and muscles (Perlman & Schulze-Delrieu, 2003).  Classifying 
a swallow pattern as ‘impaired’ or ‘dysphagic’ occurs when eating and 
drinking becomes unsafe and/or laboured and unfit for purpose;negatively 
impacting health and quality of life. The identification of dysphagic 
characteristics is most frequently associated by risk factors, such as 
neurological disease or head and neck oncology. However there is a paucity 
of research associating COPD as a risk factor for oropharyngeal dysphagia. 
To appreciate the potentially devastating effects COPD may have on 
swallowing, it is important to first understand what is considered ‘normal’. 
The first aim of this chapter is to summarise current knowledge to clearly 
establish what is considered ‘a normal swallow pattern’ across an adult 
lifespan. Secondly, definitions of dysphagia are discussed against the normal 
swallow benchmark, including identification of the potential consequences to 
health and quality of life. Thirdly, studies investigating oropharyngeal 
dysphagia specifically in COPD are critically reviewed; against normative 
data discussed in points one and two, and for methodological design and 
outcome.  The ten studies published before protocol development and data 
collection completed for the study in this thesis, combined with knowledge of 
the normal swallow and oropharyngeal dysphagia informed the methodology 
enlisted in this study (see chapter four).  
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2.2 Search Strategy 
A literature search was conducted to identify current knowledge and was 
replicated by an allied health librarian (MLEO) for accuracy. I initiated the 
literature search in 2006 and performed a review every three to six months 
throughout the research period to ensure information was up to date. Hand 
searches of specific journals, such as Chest and Dysphagia, and relevant 
websites such as the Cochrane Collaboration and NICE guidelines were also 
recruited. Reference lists from relevant journal articles were examined and 
journal articles important to this study were obtained. Keyword and Mesh 
searches included Anglicised and American spelling and terminology.  
Oesophageal dysphagia was not included within the search strategy as it 
was not the focus of the study detailed in this thesis. The following terms are 
examples of key words used to source relevant articles: 
Chronic Obstructive 
Pulmonary Disease (COPD) 
Normal swallow Respiratory/breathing 
swallow pattern 
Chronic Bronchitis Normal aged swallow Aspiration/Penetration 
Chronic Obstructive Airway 
Disease (COAD) 
Dysphagia /Swallowing 
Disorder 
Aspiration/bacterial 
pneumonia 
 
The following databases were accessed via Athens: 
Pub Med Cochrane Databases 
CINAHL Medline 
Ovid DataStar 
Proquest EMBASE 
 
Studies published prior to protocol development and the initiation of data 
collection phase (2007) were used to inform the research design of this 
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study, however relevant articles have been published since this date and are 
therefore included in the critical review and in the discussion chapter for 
completeness. 
 
2.3 The Normal and Normal ‘Age Related’ Swallow 
The normal biomechanical swallowing pattern has been studied for over fifty 
years (Martin-Harris, Brodsky, Michel, & Lee, et al., 2007; Leslie, 2010). It is 
most commonly described as having three main stages; oral preparatory, 
oral and pharyngeal (Logemann, 1988). More recently, Martin-Harris and 
Brodsky et al (2003) described the swallowing pattern as having 12 events, 
rather than three distinct (and interlinked) stages (oral bolus transport, 
apnoea onset, bolus position at ramus of mandible, hyoid excursion, 
laryngeal elevation, maximum laryngeal closure, pharyngoesophageal [PES] 
segment opening, maximum hyoid excursion, last PES opening, first 
laryngeal opening, apnoea offset, hyoid return to rest). Although this 
describes the fluidity and overlapping nature of the stages of the swallow; 
and the influence each event has on each other more effectively, most 
textbooks and published studies describe results using the three stage 
pattern. Therefore the swallowing pattern will be discussed as stages of the 
swallowing throughout this thesis, and is summarised in table 3.  
Functional variability within the normal swallowing pattern has been 
demonstrated to occur within and between age groups as a result of 
increasing evidence based research and increased use of technology 
(Martin-Harris, Brodsky, Michel, & Lee, et al., 2007; Butler, Stuart, & Kemp, 
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2009). This evidence has shown age related changes to the swallow; as a 
variation and not an aberration from the norm. Ageing in swallowing is 
generally investigated in three broad age ranges; young adult (>20 years), 
older (60-80 years), and elderly (80+ years) (Logemann, 1990), and the term 
‘normal age related swallow’ is most frequently indicated from 60 years of 
age (Leslie, Drinnan, Ford, & Wilson, 2005). Logemann (1990) describes 
three types of effects on the ageing swallow:  
 primary effects which are age related changes by itself  
 secondary effects which are caused by a disease process in an older 
swallow  
 tertiary effects which are changes in the older swallow due to 
psychosocial and environmental variables.  
 
The following sections discuss the current knowledge base for the normal 
and normal aged related stages of the swallow relative to the three types of 
effects seen with increasing age. Figure 2 shows a) drawing and b) 
videofluoroscopy image of the anatomy of the swallow that will be discussed 
in the following sections. 
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Figure 2: Labelled a) Drawing and b) Videofluoroscopy image of lateral view of oral cavity and 
pharynx. 
a)  b) 
Drawing reproduced with permission by Prof. P. Enderby (2010) 
 
2.3.1 The Oral Preparatory and Oral Stage 
The oral preparatory stage triggers the senses, stimulating the brain to 
prepare for the routine of a mealtime. The olfactory nerve initiates saliva flow 
in the oral cavity, making manipulation of the bolus easier. The motor and 
sensory control of lifting food or drink to the mouth triggers the motor cortex 
that food or drink is approaching the mouth. As the bolus (food or drink) 
enters the oral cavity, muscles and cranial nerves (V and VII) stimulate the 
lips, tongue, teeth and cheeks to work together to break up the food, mix it 
with saliva, and form it into a cohesive bolus in readiness to be transported to 
the posterior section of the oral cavity. Depending on the consistency of the 
bolus, duration of this stage may vary between two and 120 seconds (Love & 
Webb, 1996; Logemann, 1988).  
 
 
Hyoid 
Vocal 
Folds 
Oral 
Cavity 
Hyoid 
Epiglottis 
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The oral stage is initiated when the cohesive bolus has been prepared and 
the tongue begins to push the bolus to the posterior section of the oral cavity. 
The tip and blade of the tongue push the bolus against the hard palate past 
the pillars of fauces using a backward humping and stripping action (cranial 
nerve XII). The bolus is propelled using negative pressure built up in the oral 
cavity by increased tension of the buccal muscles and channelling of the 
bolus by the tongue.  
The oral and oral preparatory stage are considered to be in voluntary control, 
where the bolus can be removed from the oral cavity or begin movement to 
the posterior section of the oral cavity in preparation of the pharyngeal stage 
of the swallow. Normative data show most people use one or two swallows 
to clear a 10ml bolus, irrespective of age (Leslie, Drinnan, Ford, & Wilson, 
2005; Perlman & He, 2006). Respiration continues normally at this stage. 
Where the duration of the oral preparatory stage is dependent on the 
consistency of the bolus, the oral stage should not exceed one second 
(Logemann, 2008).  
 
2.3.1i)  Age related changes 
Anatomical and physiological changes have been documented within the oral 
stage of swallowing with increasing age. A study by Logemann (1990) found 
an increase of fat to muscle ratio and connective tissue of the tongue with 
increasing age, resulting in reduced tongue pressure. Changes in taste and 
reduction of salivary flow have been shown to reduce bolus control (Tracy, 
Logemann, Kahliras, & Jacob, et al., 1989; Logemann, 1990; Robbins, 
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Levine, Wood, & Roecker, et al., 1995). The reduced natural dentition with or 
without the use of dentures is more prevalent in the older populations 
resulting in reduced control of food in the mouth and increased chewing 
durations (Logemann, 1990; Robbins, Levine, Wood, & Roecker, et al., 
1995). Logemann and Rademaker et al (1998) showed a small but 
significantly longer oral transit time in older adults (60-80 years) of 0.5-0.6 
seconds. This has been confirmed in more recent studies (Fucile, Wright, 
Chan, & Yee, 1998; Leslie, Drinnan, Ford, & Wilson, 2005; Perlman & He, 
2006). However, some studies report no change (Robbins, Hamilton, & Lof, 
1992; Logemann, Pauloski, Rademaker, & Kahrilas, 2002) and one reported 
decreased oral transit times in an older population (McCullough, Rosenbek, 
Wertz, & Suiter, et al., 2007). These changes have been found to increase 
the length of mealtimes, and older adults tending to self modify their intake; 
such as choosing soft-moist foods to compensate for documented oral stage 
changes.  
 
2.3.2 The Pharyngeal Stage 
The pharyngeal stage occurs when cranial nerve sensory receptors are 
stimulated on the faucal arches, tonsils, soft palate, base of tongue and 
posterior pharyngeal wall (Murry & Carrau, 2006; Logemann, 2008); initiated 
when the head of the bolus reaches the anterior faucal arches, or at the level 
of the ramus of the mandible. After stimulation, afferent fibres converge on 
the nucleus solitarius (sensory branch), located in the ‘swallow’ central 
pattern generator (CPG) of the medulla. The ‘motor’ swallow is then initiated 
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when the afferent information is passed to the nucleus ambiguous, also 
within the CPG. This causes the pillars of fauces to constrict, the soft palate 
to elevate and contraction of the superior pharyngeal constrictors. The base 
of tongue moves posteriorly to the pharyngeal wall to increase the pressure 
on the bolus to aid downward movement. Pharyngeal pressure continues 
with the addition of superior pharyngeal contraction, whilst the larynx 
elevates and tilts anteriorly (cranial nerve IX and X).   
The airway is closed off and protected by superior and anterior movement of 
the hyoid (cranial nerve V, with VII and XII). The airway is further protected 
by early arytenoid to epiglottic closure (Logemann, Kahrilas, Cheng & 
Pauloski, et al., 1992; Gross, 2010). The epiglottis passively inverts to 
facilitate bolus flow laterally down around the closed airway and through the 
cricopharyngeal sphincter (Gross, Atwood Jnr, Grayhack, & Shaiman, 2003). 
The cricopharyngeal sphincter is opened by the relaxation of the 
cricopharyngeus muscle and elevation of the larynx, allowing the bolus to 
continue into the oesophagus.  
The pharyngeal stage is in involuntary control and averages 750msec (Love 
& Webb, 1996). During this time breathing is paused due to the protective 
mechanisms of the pharyngeal stage; with the urge to swallow dominating 
the urge to breathe, adding an extra layer to the airway protection during 
swallow apnoea (Perlman & Schulze-Delrieu, 2003). This pause in breathing 
during swallowing (or swallow apnoea) is usually shorter in duration than the 
pharyngeal stage, and is discussed in more detail in chapter three. 
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2.3.2i)  Age related changes 
Studies of age related changes to the pharyngeal stage of the swallow have 
mostly focused on timing of the swallow initiation, laryngeal excursion and 
closure and cricopharyngeal opening; which are now discussed. The 
prevalence of penetration and aspiration in normal and age related swallows 
is discussed in sections 2.3.3 and 2.4.3 respectively. 
Consensus in the literature suggests that the onset of the swallow occurs 
later with increasing age, initiating more frequently at the level of the 
valleculae from 60 years of age (Tracy, Logemann, Kahrilas, & Jacob, et al., 
1989; Logemann, 1990; Robbins, Hamilton, & Lof, 1992; Jaradeh, 1994; 
Murry & Carrau, 2006; Martin-Harris, Brodsky, Michel, & Lee, et al., 2007).  
The study by Martin-Harris and Brodsky et al (2007) quantifies this normal 
‘delay’ to be approximately 220 milliseconds longer than the normal younger 
onset of pharyngeal swallow, and Aviv and Martin et al (1994) specified this 
delay to occur during the onset of supraglottic closure with increasing age. 
Conversely, Murry and Carrau (2006) found no difference in the onset of 
swallow between younger and older subjects. Differences found in the 
literature may be accounted for in study methodology; such as the use of 
differing bolus sizes, as Aviv and Martin et al (1994) found larger volumes 
were required to initiate laryngeal closure in older adults.  Logemann (2008) 
summised that a delayed or slow laryngeal closure has implications for 
timing coordination for airway protection; the longer the airway remains open 
during the swallow, the higher the risk of penetration and or aspiration. 
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Further studies by Logemann and Pauloski et al (2000) and again later in 
2002 investigated changes to the timing of laryngeal excursion and closure 
further in older healthy volunteers using videofluoroscopy. The two studies 
compared healthy older male swallows (80-94 years) with healthy younger 
males (21-29 years) (Logemann, Pauloski, Rademaker, & Colangelo, et al., 
2000); and healthy older females (80-93 years) with healthy younger females 
(21-29 years) (Logemann, Pauloski, Rademaker, & Kahrilas, 2002) and 
confirmed findings within an earlier study by DeJaeger and Pelemans et al 
(1994). Findings suggested significant age and gender differences with 
laryngeal position and hyolaryngeal movement. Logemann and Pauloski et al 
(2000) reported a lower laryngeal resting position in older males, and 
reduced laryngeal elevation and closure; even though there was a shorter 
cervical 2 (C2) to C4 distance in older males compared to the younger male 
group. In the female study (Logemann, Pauloski, Rademaker, & Kahrilas, 
2002), C2 to C4 distances were also found to be shorter in older females 
(when compared with younger females), however laryngeal resting position 
was not altered by age, nor was laryngeal elevation. Interestingly, this study 
found older females increased their range of motion, relative to the younger 
female and the older male group. Combined results from the two studies 
suggested older females have a greater ‘muscle reserve’ than older males, 
allowing them to compensate for age related changes by using a longer 
pharyngeal stage and cricopharyngeal sphincter opening duration; not seen 
in the older male group. Most importantly, all young and older groups did not 
show any obvious penetration or aspiration, so whilst there were anatomical 
and physiological differences in the swallowing between groups, they were 
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all found to have functional swallows whilst medically stable. However 
Logemann and Pauloski et al (2002) predicted that the lack of muscle 
reserve, combined with reduced laryngeal elevation (of up to half a 
centimetre) and reduced cricopharyngeal opening, places older males more 
at risk of dysphagia (with or without aspiration). Furthermore, they predicted 
that the risk increased when older males were medically unstable. Although 
the two studies by Logemann and colleagues provide clinically important 
information, the findings must be viewed with caution as both studies used 
small samples; with eight adults in each group. Furthermore, information was 
not gathered between the ages of 30-79 years, nor swallowing pattern for a 
solid bolus or sequential liquid swallows.  
The literature remains equivocal regarding the presence of pharyngeal 
residue post swallow as a result of increasing age. Some studies suggest 
trace pharyngeal residue is present regardless of age (Robbins, Hamilton, & 
Lof, 1992; DeJaeger, Pelemans, Bibau, & Ponette, 1994; Logemann, 
Pauloski, Rademaker, & Kahrilas, 2002; McCullough, Rosenbek, Wertz, & 
Suiter, et al., 2007), with Daggett and Logemann et al (2006) revealing an 
increasing frequency and amount of pharyngeal residue occurring with 
increasing age. However both viewpoints agree the pharyngeal residue is of 
trace or mild levels as per The Penetration-Aspiration Scale by Rosenbek 
and Robbins et al (1996). Variability in my opinion may be due to type of 
barium used, bolus type and size, and differing definitions of ‘older’ age 
groups.  
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Table 3: Summary of activities by stage of the swallowing pattern. 
Stage of 
Swallow 
Activity (Normal swallow) Duration 
 
Oral 
Preparatory 
 
 Voluntary action; 
 Bolus enters the oral cavity;  
 Preparation of bolus, ready to transport to posterior oral 
cavity; 
2-120 sec. 
(Love & 
Webb, 1996; 
Logemann, 
1988) 
 
Oral 
 
 Voluntary action; 
 Tongue pushes bolus toward posterior oral cavity, against 
hard palate and pillars of fauces. 
 1 sec 
(Logemann, 
2008) 
 
 
Pharyngeal 
 Involuntary action; 
 Initiation triggered when bolus stimulates sensory nerve 
receptors at pillar of fauces or ramus of mandible (Murry & 
Carrau, 2006; Logemann, 2008) or at level of valleculae 
 Hyoid elevates and tilts; larynx elevates; cricopharyngeus 
relaxes and opens 
 Airway closed off by 3 protective mechanisms (Logemann, 
et al., 1992; Gross, et al 2003; Gross, 2010). 
 Oral pressure and pharyngeal constrictors push bolus 
through pharynx 
 Once bolus passes through cricopharyngeus, larynx lowers 
and breathing resumes 
750msec 
(Love & 
Webb, 1996; 
Perlman & 
Schulze-
Delrieu, 2003) 
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2.3.3  Does Penetration Occur During Normal and Normal Age 
Swallows? 
If the swallow is inefficient or wrongly timed, the bolus may penetrate into 
laryngeal vestibule, up to and including the level of the true vocal cords; 
before, during or after the swallow.  The bolus then tends to be squeezed out 
of the laryngeal vestibule during laryngeal elevation and closure of the 
laryngeal vestibule, re- entering the pharynx to then enter the oesophagus.  
Most recent studies concur that penetration is seen in normal swallows 
regardless of age; however there is still debate regarding whether the 
frequency of penetration increases with increasing age. Differences in 
opinion may be due to sample size and differing type, volume, or delivery of 
the bolus, or definition of penetration used as highlighted in the following 
studies. Robbins and Hamilton et al (1992) and Logemann and Pauloski et al 
(2002) found adults in both young and older age groups penetrated boluses 
to the level of the vocal cords with similar frequency; however conclusions 
were drawn from one small liquid swallow trial.  Other studies using an 
increased number bolus trials (more representative of a normal drink) 
showed the older adults penetrated more frequently than younger adults 
(Daniels, Corey, & Hadskey, 2004; McCullough, Rosenbek, Wertz, & Suiter, 
et al., 2007; Allen, White, Leonard, & Belafsky, 2010), with liquids (Allen, 
White, Leonard, & Belafsky, 2010), with increased volume or in the ‘older old’ 
(>80 years) groups (McCullough, Rosenbek, Wertz, & Suiter, et al., 2007).  
Studies in the literature also conflict regarding whether a reflexive cough is 
elicited during this event in normal and normal age swallows (Langmore, 
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Terpenning, Schork, & Chen, et al., 1998; Gross, 2010) or not (Logemann, 
2008). Producing a  reflexive cough from penetration of a bolus in normal 
and normal age is most likely; as it is elicted from sensory fibres within the 
pharynx, upper trachea and bronchi (Ebihara, Sekizawa, Nakazawa, & 
Sasaki, 1993; Morice, 2005; Teramoto, Ishii, Yamamoto, & Yamaguchi et al., 
2005). Failure to produce a reflexive cough would therefore seem to result 
from altered sensation in this area. 
In my opinion, the literature provides strong evidence to support the 
presence of penetration in older adults; potentially increasing with increased 
bolus size. Additionally, the literature does not provide strong evidence to 
support the theory that the reflexive cough is absent  during episodes of 
penetration in normal and normal age related swallows. Therefore the 
interpretation of results of the study detailed in this thesis (chapter seven) 
reflect the evidence to support the presence of penetration of bolus, coupled 
with a reflexive cough as considered within the realm of normal and normal 
age related swallowing. Furthermore, quanitfying the amount or depth of 
penetration has not yet been satisfactorily determined within the literature 
and therefore will be addressed with the study detailed in this thesis as an 
assessment measure during biomechanical analysis (see chapter five).  
 
2.3.4 Swallowing Related Quality Of Life 
Definitions of quality of life (QOL) are continuing to evolve, however it can be 
broadly described as ‘human experiences related to overall wellbeing and 
satisfaction’ (Burckhardt & Anderson, 2003). Quality of life is considered to 
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be multidimensional, encompassing psychosocial aspects of daily living. By 
its very nature, quality of life reports are subjective and idiosyncratic to the 
individual, and their unique situation or experience. This definition highlights 
that perceived quality of life is as equally important as traditional health 
status outcomes. This is confirmed indirectly in studies that compared QOL 
measures against objective measures to reveal the degree of impact on 
quality of life cannot be predicted using objective measures in isolation 
(Skinner, Gillespie, Brodsky, & Day, et al., 2004; McHorney, Martin-Harris, 
Robbins, & Rosenbek, 2006; Ding & Logemann, 2008). Similarly, this notion 
can be confirmed directly, such as in a study by Ekberg and Hamdy et al 
(2002), where subjects who were interviewed reported that they felt their 
psychosocial needs were as important as their swallow safety. This is also 
followed-up with the Department of Health and Human Services report which 
states quality of life is equally important as length of life (Department of 
Health, 2010b).  
There is limited literature investigating swallowing related QOL in normal 
healthy adults using a dysphagia specific QOL tool, as most studies 
investigate known dysphagic populations, or use general health related 
questionnaires. As will be discussed in later in chapter four, general health 
questionnaires tend to focus on physical wellbeing; with only one to two 
questions on eating or drinking. Therefore only studies that used swallowing 
specific QOL tools will now be discussed. 
A person, regardless of age, should not perceive any difficulties in their 
swallow, or attribute any biopsychosocial difficulties to their swallowing ability 
without the presence of one or two major disease processes (for example, 
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stroke) influencing their swallow; as suggested by Logemann in 2008. A 
study by Tibbling and Gustafsson (1991) aimed to study the effect of 
oropharyngeal (and oesophageal dysphagia) on quality of life in a general 
older Swedish population (median age 67 years) using a mail out 
questionnaire. Their study reports of the 0.01% (n=796) responders who 
reported ‘hypopharyngeal dysphagic’ symptoms, all felt anxious  and feared 
choking during mealtimes, and preferred not to eat alone. However the 
‘hypopharyngeal dysphagia’ subgroup did not differ from the oesophageal 
dysphagia group in terms of levels of reflux, and the questionnaire used 
presented difficulties in separating oesophageal symptoms from true 
oropharyngeal dysphagic symptoms; as only one of the 16 questions could 
be classified as specifically questioning oropharyngeal dysphagic symptoms: 
‘do you get food or drink going the wrong way?’ ; whereas neither of the two 
quality of life questions could be easily differentiated: ‘Do you sometimes feel 
anxious when you have swallowing difficulties at mealtimes? or ‘Does food 
sometimes stick in your throat?’ (Tibbling & Gustafsson, 1991, p. 201). 
Inclusion criteria, such as past medical history was not described in this 
study and therefore the research group may have recruited known 
dysphagics and/or ‘at risk’ groups.  
In contrast to the Tibbling and Gustafsson (1991) findings, studies by 
McHorney and Robbins et al (2002) and Leow and Huckabee et al (2010) 
found no significant changes to QOL in older healthy adults.  During the 
development of the Swallowing Quality Of Life (SWAL-QOL), McHorney and 
Robbins et al (2002) investigated the clinical validity of the tool by comparing 
age matched known dysphagics with non dysphagics (mean age= 66 years), 
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and found a significant difference in QOL; with known dysphagics scoring 
lower (therefore reduced QOL) compared with the normal healthy age group. 
Leow and Huckabee et al (2010) also used the SWAL-QOL and compared 
healthy younger adults (mean age= 25 years) with healthy older adults 
(mean age=72 years) excluding conditions that may affect swallowing. Leow 
and Huckabee et al (2010) confirmed findings in the earlier study by 
McHorney and Robbins et al (2002) revealing that age did not significantly 
influence QOL outcomes between the two age groups. It appears using a 
swallowing specific QOL tool and clearly defining inclusion/exclusion criteria 
predicts that normal age related changes to swallowing does not negatively 
impact on quality of life. 
 
2.4  Oropharyngeal Dysphagia 
Difficulties in swallowing can occur at any stage of the swallowing process, 
and is termed ‘dysphagia’ (Perlman & Schulze-Delrieu, 2003). Dysphagia 
can be divided into two categories, oropharyngeal dysphagia and 
oesophageal dysphagia. For the purposes of this thesis, oropharyngeal 
dysphagia will be explored further as this was the focus of the study in this 
thesis. Henceforth the terms ‘oropharyngeal dysphagia’ and ‘dysphagia’ will 
be used interchangeably.   
From an understanding of what is expected from a normal swallow and age 
related changes as discussed previously, it becomes easier to identify and 
classify dysphagic signs and symptoms, as summarised in table 4. It is 
usually a combination of characteristics, clinical signs and symptoms that 
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lead to a diagnosis of dysphagia (Daniels, McAdam, Brailey, & Foundas, 
1997), and are now discussed by stages of the swallow pattern.  
2.4.1 Oral Preparatory and Oral Stage Dysphagia 
The oral preparatory and oral stages of swallowing may be compromised 
due to a number of factors, and dependent on the person’s diagnosis, pre- 
morbid ability and prognosis. Reduced alertness level and cognitive state 
may also result in increased risk of dysphagic characteristics, along with poor 
postural control (Love & Webb, 1996; Langmore, Skarupski, Park, & Fries, 
2002; Hansen & Jakobsen, 2010). Unilateral or bilateral facial weakness 
with/without reduced sensation can cause difficulties with the oral 
preparatory and oral stage of swallowing (Kidd, Lawson, Nesbitt, & 
MacMahon, 1995; Love & Webb, 1996; Logemann, 1998). This may include 
decreased awareness of food/drink in the mouth, reduced strength or range 
of motion of lips, cheeks and tongue (Logemann, 1988; Huckabee, 2009), 
resulting in difficulty coordinating, chewing the bolus, and transporting it to 
the back of the mouth in readiness for the oral stage. Reduced lip seal will 
lead to the bolus falling anteriorly from the mouth (Logemann, 1998) or 
residue pocketing in the oral cavity sulci post swallow. Altered saliva 
production may result in drooling, or conversely not enough salvia and poor 
dentition will interfere with bolus preparation and transport to the posterior 
oral cavity (Fucile, Wright, Chan, & Yee, 1998). Additionally, reduced 
posterior tongue strength will lead to the bolus tipping into the pharynx pre 
swallow initiation (Huckabee, 2009). 
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2.4.2  Pharyngeal Stage Dysphagia 
The flow of the bolus through the pharynx may be disrupted by one or 
multiple complications. The swallow may be delayed, allowing the bolus to 
pass the level of the valleculae before ‘triggering’ the swallow 
(Logemann,1998). This may lead to penetration or aspiration before the 
swallow. The swallow may ‘trigger’ in a timely fashion, however the laryngeal 
elevation may be slow or not completely closed off the laryngeal vestibule, 
thus reducing airway protection (Perlman & Schulze-Delrieu, 2003; Gross, 
2010). This may lead to penetration or aspiration of the bolus during the 
swallow. If laryngeal elevation is incomplete, and/or pharyngeal constrictors 
are weakened, bolus residue may occur in the pharynx, leading to a 
sensation of ‘something stuck in the throat’; and risk of penetration or 
aspiration after the swallow (Huckabee, 2009). 
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Table 4: Summary of signs and symptoms characteristic of oropharyngeal dysphagia by stage 
of swallow. 
 
ORAL  PREPARATORY 
AND ORAL STAGE 
 
Poor sitting balance and posture 
Reduced taste, smell 
Difficulties self feeding 
Altered cognition  
Reduced alertness 
 
Drooling 
Dry mouth 
Reduced lip seal 
Facial weakness (uni/bilateral) 
Impaired chewing 
Reduced/poor dentition 
Reduced tongue strength (uni/bilateral) 
Reduced oral sensation 
 
 
PHARYNGEAL STAGE 
 
Problems ‘triggering swallow 
Reduced velopharyngeal closure 
Pharyngeal weakness (uni/bilateral) 
Reduced sensation 
Slow laryngeal elevation 
Reduced laryngeal closure 
Reduced cricopharyngeal opening 
Reduced pharyngeal constriction 
 
Laryngeal penetration 
Laryngeal aspiration 
 
Coughing on food/drink/saliva 
Choking on food/drink/saliva 
Food/drink sticking in throat 
Wet/gurgly voice 
Shortness of breath post swallow 
Multiple clearing swallows (4+) 
 
 
2.4.3 Should Episodes of Aspiration be Considered Dysphagic? 
Aspiration is defined as the bolus entering the laryngeal vestibule, and 
continuing through the true vocal cords towards the lungs. The effects of 
aspiration vary from person to person; dependent on the frequency and 
nature of the aspiration, as well as the person’s general health, mobility, 
cognition, pulmonary status and ability to clear the aspirated material 
(Langmore, 1991).  
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Whether healthy individuals normally aspirate food or drink remains 
controversial. Some studies suggest healthy individuals normally aspirate 
either trace amounts and/or on an occasional basis (Huxley, Viroslav, Gray, 
& Pierce, 1978; Gleeson, Eggli, & Maxwell, 1997; Beal, Chesson, Garcia, & 
Caldito, et al., 2004; Butler, Stuart, & Kemp, 2009), whilst others state 
aspiration is abnormal in healthy individuals and should be classified as a 
dysphagic characteristic (Robbins, Hamilton, & Lof, 1992; Allen, White, 
Leonard, & Belafsky, 2010). Butler and Stuart et al (2009) investigated 
normal healthy individuals (n=40) swallowing food and drink boluses using 
Flexible Endoscopic Evaluation of the Swallow (FEES) and found 11/168 
swallows were silently aspirated. On closer inspection of the reported data, 
the 11/168 swallows aspirated could be further analysed to provide an 
estimate per volunteer. Although not stated explicitly within Butler and Stuart 
et al’s (2009) article, one can infer from their table that 11/168 swallows 
occured from one female (n=10), and three to six males (n=11). There are 
also a number of methodological weaknesses which may have influenced 
the results. This was part of a larger study which included simultaneous 
manometry assessment. The authors suggest the combined diameter of the 
two catheters (6.2mm) is similiar to the Leder and Suiter (2008) study which 
showed no effect of a nasogastric tube on swallowing. However, Leder and 
Suiter (2008) assessed the effect of the nasogastric tube using 
videofluoroscopy, thus only one tube was in situ. Additionally, the Butler and 
Stuart et al (2009) study is not explicit on the positioning of subjects during 
the study; however usual protocol for manometric studies dictates 
assessment whilst in a supine position. If manometric measures were taken 
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simultaneously with FEES as stated, the subjects were most likely assessed 
in a reclined position. Furthermore, the subjects were sprayed in the nasal 
cavity with lidnocaine for ease of catheter placement, and the liquid bolus 
was delivered via a syringe (for volume control) through the catheter. 
Combining a (probable) reclined position with an anaesthetised nasopharynx 
and the use of syringe boluses naturally increases the risk of aspiration, and 
therefore in my opinion, results from this study should be reviewed with 
caution. 
Studies comparing normal healthy subjects of differing ages have shown no 
statistically significant findings of aspiration during bolus trials (Robbins, 
Hamilton, & Lof, 1992; Logemann, Pauloski, Rademaker, & Colangelo, et al., 
2000; Logemann, Pauloski, Rademaker, & Kahrilas, 2002). Evidence on the 
normal healthy swallow led Marik and Kaplin (2003) to conclude that ageing 
by itself does not increase the risk of aspiration. However, the increase of 
disease and disorder seen in older people increases the risk of dysphagia 
with or without the presence of aspiration. Furthermore, studies that have 
suggested that aspiration is found in normal swallows agree aspiration 
occurs infrequently and in trace amounts. If this is the case, healthy 
individuals tend to also have normal mobility and pulmonary defence 
mechanisms (as will be discussed in section 2.7.1) and therefore have 
capacity to cope with these minor, infrequent episodes. However, if normal 
aspiration is coupled with disease, such as deteriorated lung function, 
pulmonary defence mechanisms may be reduced or ineffective. Therefore 
the issue may not be whether aspiration is a normal occurrence or not, but 
perhaps premorbid condition, the frequency of aspiration, and whether it 
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leads to any detrimental consequences should be the focus of further 
investigation. 
 
2.4.3i)  Silent aspiration 
Reflexive coughing from food or drink is the most noticeable sign of 
aspiration, normally elicited from sensory fibres found in the pharynx, larynx 
or large bronchi (innervated by vagus nerve) (Ebihara, Sekizawa, Nakazawa, 
& Sasaki, 1993; Morice, 2005). However silent aspiration (no obvious sign of 
aspiration such as absent reflexive cough) can occur in approximately half of 
cases already known to aspirate (Leslie, Carding, & Wilson, 2003; Ramsey, 
Smithard, & Kalra, 2005). These studies found silent aspiration in known 
dysphagics, the majority of cases included stroke, traumatic brain injury and 
tracheostomy. However these studies use a small sample size and report 
small percentages of silent aspiration. None of the studies were designed to 
investigate prevalence within general populations. 
Some studies suggest silent aspiration is also a common occurrence within 
the  normal healthy population (Huxley, Viroslav, Gray, & Pierce, 1978; 
Gleeson, Eggli, & Maxwell, 1997; Beal, Chesson, Garcia, & Caldito, et al., 
2004), however these studies have a several methodological weaknesses. 
Whilst subjects were sleeping, a radiotracer was injected (either continuously 
or using a timed bolus feed) via a tube placed  in the nasopharynx, which 
was later located in the body via scintigraphy. All studies have shown some 
level of silent aspiration using this method. However, the method of injecting 
a bolus into the nasopharynx excludes the oral preparatory and oral stage of 
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the swallow, losing important sensory and motor information to aid timing 
and coordination of the swallow as discussed earlier. The tube is placed past 
the known level for swallow initiation (ramus of the mandible or valleculae) 
therefore excludes a natural ‘trigger’ of the swallow. Also, it is unnatural to 
have a fluid bolus injected into your pharynx via your nose whilst sleeping. 
Results by this method are unable to differentiate the possible causes of the 
radiotracer being found in the lungs by either oropharyngeal aspiration, or 
caused by reflux. The results using this research methodology also do not 
enlighten us to what happens at the actual time of the swallow, during saliva 
swallows during normal sleep, or for saliva or bolus swallows when alert. 
These factors limit the validity of their findings and in my opinion the results 
from this style of methodology should be viewed with caution. 
In my opinion, the literature has not provided strong evidence to prove 
aspiration exists within a normal healthy or normal older population. 
Therefore the study within this thesis concurred with evidence to suggest that 
any episode of aspiration is considered abnormal thereby categorising it as a 
dysphagic characteristic; and is therefore reflected in the interpretation of the 
results for the study detailed in this thesis.  
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2.5 Causes of Dysphagia 
Signs and symptoms of dysphagia usually result from changes or damage to 
muscles, nerves or structures used in the swallowing process, as described 
earlier. Dysphagia may occur as the result of a number of aetiologies, 
ranging from generalised weakness to neurogenic and surgical intervention. 
Newly diagnosed dysphagia as a result of disease or disorder may resolve 
due to neuroplasticity of the brain (Logemann, 2008). However, if the disease 
is progressive, swallowing ability is likely to deteriorate also. It is important to 
identify causes of dysphagia due to its serious consequences (discussed 
later in section 2.7), and has important implications for managing healthcare 
costs and improving quality of life and wellbeing. A diagnosis of dysphagia is 
usually identified within medical diagnoses, allowing professionals to monitor 
‘at risk’ conditions and offer treatment in a timely manner. There has been 
only one known study; published after data collection for this thesis, that has 
indicated COPD as a causative factor for oropharyngeal dysphagia (Cvejic, 
Harding, Churchward & Turton, et al., 2011), and will be discussed in more 
detail section 2.8. 
 
2.6 Dysphagia Intervention 
Once oropharyngeal dysphagia has been identified, specific intervention 
strategies are indicated based on three broad factors; cause of the 
dysphagic characteristics, prognostic indicators and co-morbidities, and 
patient preference. Information from these three factors combine to form 
recommendations which aim to increase the efficiency and safety of the 
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swallow, and improve quality of life. Intervention may include one or multiple 
strategies; such as strengthening exercises (or the oral cavity and/or 
pharynx), swallowing manoeuvres, postural techniques, or modification to 
food and fluid consistencies (Logemann, 1993; Groher, 1990; Murry & 
Carrau, 2006; Logemann, 2008; Huckabee, 2009).  
There is a paucity of research investigating the efficacy of dysphagia 
management. However the limited evidence within the literature suggests 
successful management of dysphagia in ‘at risk’ populations can significantly 
reduce rates of pneumonia and the long term use of health resources 
(Langmore, 1991; Crary, Carnaby, Groher, & Helseth, 2004). Compensatory 
techniques such as postural techniques (chin tuck or head rotation) and 
swallowing manoeuvres (supraglottic and effortful swallow) have been shown 
to reduce or eliminate the incidence of bolus aspiration (Logemann, Kahrilas, 
Kobara, & Vakil, 1989; Logemann & Kahrilas, 1990; Logemann, 1999). 
Similarly, altering bolus consistency to either reduce the need for chewing, 
increase cohesion and/or increase viscosity of the bolus to improve oral 
control has shown to improve oral stage dysphagia and consequently reduce 
or eliminate aspiration (Logemann, 1998). Studies have also compared 
incidence of pneumonia when using a postural technique (chin tuck) with 
fluid modification (thickened fluids). In studies by Logemann and Robbins et 
al (2008) and Robbins and Gensler et al (2008), a postural technique (chin 
tuck) was compared with fluid consistency modification for incidence of 
aspiration in patients with either dementia or Parkinson’s disease. These 
studies found aspiration was more effectively eliminated when fluid was 
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modified to a ‘honey’ thick2 consistency in both conditions; however Robbins 
and Gensler et al (2008) also explored incidence of pneumonia over three 
months and found rates were lower for fluids modified to a ‘nectar’ thick3 
consistency, followed closely by a ‘chin tuck’ strategy. Both studies recruited 
patients with reduced cognitive ability which may have resulted in 
compliance issues when using the ‘chin tuck’ technique. Also, the difference 
between the modified fluid that was shown to be aspirated the least (‘honey’ 
consistency) versus the modified fluid shown to have the lower incidence of 
pneumonia (‘nectar’ consistency) over three months may have been due to 
the ‘honey’ consistency fluid requiring the least amount of oral stage control; 
and therefore is least likely to aspirate before the swallow is initiated 
(Huckabee & Pelletier, 1999). However as this consistency is more viscose 
than the ‘nectar’ consistency fluid, it is therefore harder to clear any residue 
that may remain in the pharynx post swallow; increasing the risk of aspirating 
post swallow from pharyngeal residue.  
These results highlight the need for careful consideration of the three factors 
discussed at the start of this section. Understanding the individual’s 
dysphagic characteristics is essential when recommending an intervention. 
Robbins and Gensler et al (2008) also reported the fluid modification groups 
were subsequently diagnosed with increased frequency of dehydration, 
urinary tract infections and fever than the ‘chin tuck’ group, and Logemann  
and Robbins et al (2008) commented that the ‘chin tuck’ technique recorded 
the highest level of patient preference. This highlights the need to include the 
                                            
2
 ‘Honey’ Thick fluid refers to the U.S.A term for the level of modification used to thicken fluids. This is 
equivalent to ‘Stage 2’ thickness fluids within the U.K. (British Dietetic Association, 2009) 
 
3
 ‘Nectar’ Thick fluid refers to the U.S.A term for the level of modification used to thicken fluids. This is 
equivalent to ‘Stage 1’ thickness fluids within the U.K. (British Dietetic Association, 2009) 
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third factor of patient preference when recommending a dysphagia 
intervention, however this was not explored further in these studies. 
However, a study by Pownall (2009) investigated differences in quality of life 
scores for stroke subjects using either ‘chin tuck’ technique or thickened 
fluids, and found subjects rated their quality of life as significantly lower when 
randomised to the modified fluid consistency groups compared to the ‘chin 
tuck’ strategy group. This has implications for patient compliance (of using 
the thickener) and the sequelae of health complications (such as dehydration 
and aspiration pneumonia) (Low, Wyles, Wilkinson, & Sainsbury, 2001; 
Whelan, 2001) as also noted in the Robbins and Gensler et al (2008) study. 
These findings also concur with a study by McHorney and Robbins et al 
(2002) who found patients who were recommended either modified food or 
drink consistencies reported lower quality of life, and reduced compliance to 
recommendations. This suggests that patient preference and improving 
quality of life is a key factor in the success of health status outcomes for 
dysphagia intervention.  
The majority of studies enlist a medical model approach, investigating a 
narrow field of health status outcomes such as rates of aspiration 
pneumonia, with even fewer studies investigating the impact on quality of life. 
Furthermore, the limited research on intervention strategies focuses on 
acknowledged ‘at risk’ groups; such as dementia, stroke or cancer, and 
therefore findings cannot be generalised to the COPD population. Research 
into treatment strategies specifically for dysphagia characteristics found in 
COPD are in their infancy. Two recent studies (published after data gathering 
stage for the study detailed in this thesis) have outlined findings for the 
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inclusion of swallowing assessment and education into existing pulmonary 
rehabilitation groups for COPD (McKinstry, Tranter, & Sweeney, 2009; Ilsley, 
2011) and are discussed in more detail in section 2.8. Finally, there are few 
studies within the literature that measure the use of spontaneous 
manoeuvres in subjects as a characteristic of determining (potential) 
undiagnosed dysphagia, as seen within the study detailed in this thesis and 
explored further in chapter seven.  
 
2.7 Implications of Dysphagia 
The biopsychosocial impact of dysphagia is significant, however the medical 
profession tends to focus on the medical impact of dysphagia. As a result, 
one of the most researched implications of dysphagia is aspiration, as this 
can result in the most visual medical complications with potential 
hospitalisation and death (Gupta & Kant, 2009). Even though aspiration can 
have significant cost implications for health resources, other implications; 
such as malnutrition, dehydration and reduced quality of life can indirectly 
incur long term consequences for the individual (and carer) and health 
services.  The following sections discuss the wider implications of dysphagia, 
focussing on two of the most common repercussions acknowledged when 
dysphagia is left unmanaged; aspiration pneumonia and reduced quality of 
life. 
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2.7.1 Aspiration Pneumonia 
Aspiration pneumonia is defined as a bronchopneumonia caused by 
aspiration of a bolus and subsequent colonisation of bacteria in a specific 
bronchopulmonary segment (Marik, 2001; Murry & Carrau, 2006). It is 
associated with high morbidity and mortality, with increasing risk in the older 
population. It is the fifth leading cause of death in the U.S. (>65 years), 
increasing to third leading cause of death with age (85+ years) (Robbins, 
Gensler, Hind & Logemann, et al., 2008).  
Pneumonia is usually prevented by pulmonary defence mechanisms. The 
normal swallowing mechanism (as discussed earlier in section 2.3) and 
protective cough prevent entry of foreign material into the lower airway, but if 
penetration occurs, the reflexive cough will be supplemented by host 
defences such as mucociliary clearance and epithelial phagocytic cells 
(aided by immunoglobulins) (Gleeson, Eggli, & Maxwell, 1997). Yet 
pneumonia may develop if sufficient foreign material penetrates to the lower 
airways and overwhelms the host defences. Historically, bacteria shown to 
cause aspiration pneumonia have been anaerobic, such as 
Peptostreptococcus, Bacteroides, Fusobacterium and Prevotella  (Bartlett & 
Gorbach, 1975); bacteria usually found colonising the oropharynx. More 
recently however, pathogens associated with community acquired and 
hospital acquired pneumonias have also been shown to also cause 
aspiration pneumonia (Marik, 2001). However there are multiple factors 
which contribute to aspiration pneumonia in addition to aspiration itself 
(Langmore, Terpenning, Schork, & Chen, et al., 1998). Presumably if a 
healthy person aspirates a food or drink bolus, there are low levels of 
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bacteria present alongside strong pulmonary defence mechanisms. When a 
disease or disorder is introduced into this scenario, impairment of the 
pulmonary defence mechanisms, and/or an increase in the amount aspirated 
coupled with factors such as poor mobility or cognition, and this may result in 
the body being unable to clear the aspirated material, which may lead to 
pneumonia.  Nevertheless, when all contributing factors are considered, 
oropharyngeal dysphagia is classified as the major pathophysiologic 
mechanism which leads to aspiration pneumonia (Marik & Kaplin, 2003); 
along with people who are less mobile, depressed and/or have altered saliva 
flow (secondary to their disease and medication) also increasing their risk for 
dysphagia and aspiration pneumonia. A study by Pikus and Levine et al 
(2003) investigated patients who are known aspirators and found they are 
significantly more at risk of developing pneumonia within six months. 
Similarly, a study by Martin-Harris (2008) found that people with dysphagia 
are seven times more likely to develop aspiration pneumonia, especially if 
seen during videofluoroscopy examination. 
Aspiration pneumonia in normal and normal older populations has been 
investigated in the literature since the 1970’s (Bartlett & Gorbach, 1975). 
However, not all studies differentiate between aspiration pneumonia 
(bacterial aspiration caused by oropharyngeal dysphagia) and aspiration 
pneumonitis (chemical pneumonia caused by aspiration of gastric contents). 
They also do not separate normal ‘healthy’ elderly from their research 
groups, thereby containing comorbidities acknowledged to be at high risk of 
aspiration pneumonia. Therefore it is difficult to draw conclusions based on 
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the results of these studies on true bacterial aspiration pneumonia rates in 
the normal healthy population.  
To date, progressive respiratory disease has not been extensively evaluated 
as a primary condition at risk of dysphagia leading to aspiration pneumonia. 
Yet patients with COPD, as a direct consequence of the condition, have 
reduced defence mechanisms (for example reduced mucociliary clearance 
especially if continuing to smoke). A study by Langmore and Terpenning et al 
(1998) and again later in Langmore and Skarupski et al (2002), investigated 
predictors of aspiration pneumonia in nursing home residents aged 65 years 
and older (49% 85+ years). They found COPD was the second strongest 
predictor of aspiration pneumonia (odds ratio 2.49 95% C.I. 2.27, 2.72), 
closely behind suctioning (odds ratio 2.55, 95% C.I. 2.06. 3.15). Dysphagia is 
not systematically explored in patients with COPD, yet estimated incidence 
of pneumonia in the COPD population in the UK for 1996-2005 was 22.4 per 
1000, with an increased risk for exacerbation for moderate ( OR= 1.28 ) and  
severe COPD (OR= 2.74) that required hospital admission  (Muellerova, 
Boudiaf, Hagan, & Chigbo, et al., 2007). Furthermore, pneumonia was rated 
the highest cause of death in respiratory illnesses in 2002 (British Lung 
Foundation, 2003). 
However most figures of pneumonia in COPD do not allow exploration of 
type or cause of pneumonia and it is therefore assumed that rates of 
aspiration pneumonia is included as a subgroup of the total figures quoted. 
Similarly, in a study by Xavier and Diniz et al (2002), causes of 
oropharyngeal dysphagia were categorised, with COPD as a subgroup of the 
‘respiratory group’. Furthermore, diagnosis of aspiration pneumonia was also 
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a subgroup within a larger group containing bronchiectasis and lung fibrosis, 
making it impossible to attribute any findings of aspiration pneumonia 
exclusively to COPD. Nevertheless, one possible theory is that pneumonia 
caused by oropharyngeal dysphagia induces an exacerbation, as postulated 
in a study by Veeramachaneni and Sethi (2006). However Hurst and 
Wedzicha (2007), and Guidelines for COPD (National Collaborating Centre 
for Acute and Chronic Conditions., 2010) dispute this and suggest other 
pathologies that ‘mimic’ exacerbations (such as pneumonia) should be 
considered as the primary diagnosis, and do not affect the underlying COPD 
disease process.   
In my opinion, evidence to suggest if acute exacerbations of the disease 
place the patient at increased risk of dysphagia with or without aspiration 
pneumonia, or conversely if aspiration may trigger acute exacerbations is 
largely under researched and warrants further investigation. 
 
2.7.2  Quality Of Life 
When people are diagnosed with oropharyngeal dysphagia as a result of 
disease or disorder, diet and/or fluid modification or strategies may be 
required to improve safety and efficiency of the swallow, as described earlier 
in this chapter. However, the dysphagic symptoms and/or the 
recommendations that follow may affect the perceived quality of life for the 
individual. In a study by Ekberg and Hamdy et al (2002), 42% of nursing 
residents with dysphagia reported a fear of eating alone, increased anxiety 
during mealtimes and 35% reported avoiding eating in public. Similarly, in a 
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study by Bladon and Ross (2007), 45% of subjects (n=95) with HIV/AIDS in a 
clinic in South Africa reported a reduced quality of life, with dysphagia 
increasing fear, anxiety and reduced pleasure of eating. As mealtimes are 
usually considered a social event, the impact may extend to caregivers. The 
use of altered utensils or dependence on caregivers may exert additional 
stress on the individual or family member. In a study by Miller and Noble et al 
(2006) the impact of dysphagia was assessed in subjects with Parkinson’s 
disease and found that subjects reported feeling guilty and selfish for 
creating additional burden on family members regarding shopping for specific 
foods, mealtime preparation and dependence with feeding. The psychosocial 
impact further included withdrawal of social events such as eating at a 
friend’s home or at a restaurant. Carers also reported a lowered quality of 
life, commenting on the disruption on family life and increased concern for 
their partner choking or losing weight. Furthermore, Low and Wyles et al 
(2001) found non compliance of recommendations (by either patient or carer) 
may create conflict between the patient and caregiver, in addition to the 
health implications. However some of these studies used self report 
symptoms of dysphagia within a general population and did not always 
confirm reports of dysphagia with clinical assessment (Ekberg, Hamdy, 
Woisard, & Wuttge-Hannig, et al., 2002; Bladon & Ross, 2007). However 
when Miller and Noble et al (2006) compared perceived findings with clinical 
evaluation, they reported a discrepancy between the two measurements; 
leading the researchers to suggest that swallowing impairments do not need 
to be severe to impose a significant impact on quality of life. In another study 
assessing known dysphagics, Khaldoun Woisard et al (2009) assessed for 
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the impact on swallowing related quality of life in various aetiologies. They 
found that perceived symptoms of dysphagia did not differ between the post 
stroke and the head and neck cancer groups; yet perceived quality of life 
was found to differ. Subjects post stroke reported a significantly lower eating 
duration, however subjects in the head and neck cancer group (post surgical 
intervention) rated their eating desire, and fear as significantly lower. 
Along with the symptoms of dysphagia, intervention may have an impact on 
quality of life also. Modifications to diet consistency have been shown to 
decrease the overall desire to eat and drink (McHorney, Robbins, Lomax, & 
Rosenbek, et al., 2002; Miller, Noble, Jones, & Burn, 2006; Bladon & Ross, 
2007). However, many studies have used quality of life outcomes to show 
the effectiveness of intervention strategies; with the majority of studies 
exploring intervention within oncological aetiologies. Findings have revealed 
dysphagia significantly negatively impacts quality of life outcomes before 
intervention (Lovell, Wong, Low, & Ngo, et al., 2005); more specifically within 
the fatigue, burden, and sleep domains (Greenblatt, Sippel, Leverson, & 
Frydman, et al., 2009), during intervention (Roe, Leslie, & Drinnan, 2007), 
but with improved quality of life outcomes post surgical intervention 
(Bandeira, Azevedo, Vartanian, & Nishimoto, et al., 2008; Greenblatt, Sippel, 
Leverson, & Frydman, et al., 2009). Furthermore, dysphagia intervention in 
other disease states have also shown to improve quality of life (Nagaya, 
Kachi, & Yamada, 2000; El Sharkawi, Ramig, Logemann & Pauloski et al., 
2002). Two known publications have used swallowing related quality of life in 
COPD to measure the effectiveness of pulmonary rehabilitation programmes, 
and they are explored in more detail in section 2.8. 
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It is clear from the literature that dysphagia affects quality of life; irrespective 
of aetiology, and intervention has proven to increase quality of life. However 
a standard intervention ‘package’ is unlikely to be effective due to differing 
morphology and prognosis of differing diseases or disorders affected by 
dysphagia (Miller, Noble, Jones, & Burn, 2006; Davis, 2007). Additionally, the 
literature has shown that subjects with varying aetiologies have different 
aspects of quality of life affected; specific to their own condition and 
individual to their own psychosocial environmental support structure. This 
highlights the inability to generalise swallowing related quality of life findings 
to other conditions.  
 
2.8 Oropharyngeal Dysphagia in COPD: A Literature Review  
This section reviews known studies specifically investigating oropharyngeal 
dysphagia in patients with COPD. A total of sixteen articles have been 
published from 1987 to present in peer review journals as broadly 
summarised in table 5; with eight published as full studies (Coelho, 1987; 
Stein, 1990; Good-Fratturelli, Curlee, & Holle, 2000; Mokhlesi, Logemann, 
Rademaker, Stangl, & Corbridge, 2002; Terada, Muro, Ohara, & Kudo, et al., 
2010; McKinstry, Tranter, & Sweeney, 2009; Cvejic, Harding, Churchward, & 
Turton, et al., 2011; Ilsley, 2011). Five studies have been published as 
summaries only; either as abstracts for conference poster presentations 
(Carney, Sheppard, & Laframboise, 2005; Mahoney, Foo, Goudge, & Scott, 
et al., 2004); abstract only provided in English (Matsuda, Teramoto, Ohga, & 
Tomita, et al., 2004), or only as a letter to the editor (Teramoto, Kume, & 
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Ouchi, 2002; Kobayashi, Kubo, & Yanai, 2007). The remaining three 
publications were editorials (Harding, 2002; Singh, 2011) and one systematic 
review (O'Kane & Groher, 2009). In an attempt to review full articles, all 
primary authors were contacted by email to request consent to access full 
publications of their work. Carney and Sheppard et al (2005) responded that 
there was no other accessible data for their study, Kobayashi and Kubo et al 
(2007) provided a copy of the abstract, and there was no response from 
Matsuda and Teramoto et al (2004). An abstract by Cvejic and Harding et 
al’s (2004) was later published as a full study, and therefore the review in this 
thesis refers only to the full article (Cvejic, Harding, Churchward & Turton, et 
al., 2011). Due to the limited number of full studies published, all types of 
publications are included in this review. Studies investigating the association 
of oesophageal dysphagia, gastro-oesophageal reflux disease (GORD) or 
chemical aspiration pneumonia in COPD exclusively were not included in this 
literature review as this was not the focus of the study in this thesis. 
However, two studies investigated gastro-oesophageal reflux as a 
contributing factor to oropharyngeal dysphagia in COPD, and have therefore 
been included in this review ( Stein, Williams, Grossman, & Weinberg, et al., 
1990; Terada, Muro, Ohara & Kudo, et al., 2010). 
Due to the innovative nature of this research thesis, it is essential to detail 
and discuss methodology used previously in order to justify the 
methodological design used within the study detailed in this thesis. All 
relevant articles reviewed in this section are summarised in table 6; 
alongside key articles investigating respiratory-swallow patterns in COPD 
(discussed in the next chapter). Additionally, key points found in the literature 
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regarding COPD induced swallowing changes are summarised alongside 
key points for normal and normal age swallow in table 7; which can also be 
located at the end of chapter three. 
 Six publications including one systematic review and one editorial occurred 
since 2007; hence after protocol development and data collection for the 
study detailed in this thesis.  However they are included within this review for 
completeness, and are also discussed in chapter seven. 
Table 5: Summary of publications from 1987 to present investigating oropharyngeal dysphagia 
in patients with COPD. 
  Total 
Publication Type Full Study 8 
 Abstract Only 3 
 Letter to Editor Only 2 
 Editorial 2 
 Systematic Review 1 
   
Country of Origin USA 6 
 Australia 4 
 Japan 4 
 UK 1 
 Canada 1 
   
Type of Study Prevalence Only - 
 Nature Only 9 
 Both Prevalence and Nature 2 
 Intervention 2 
   
Use of Control Group No controls 6 
 Case Control 3 
 Historical 2 
 Normative 1 
 Not documented 1 
   
Research Sample Size <15 2 
 16-30 6 
 30+ 5 
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2.8.1 Systematic Review and Editorials 
One systematic review has been published recently, which reviewed seven 
articles that investigated oropharyngeal dysphagia in patients with COPD 
(O'Kane & Groher, 2009). They reviewed studies investigating oropharyngeal 
dysphagia and respiratory patterns in COPD (Shaker, Ren, Townsend, & 
Dodds, et al., 1992) which was also conducted for the purposes of this 
thesis, however the literature review of respiratory- swallow patterns in 
patients with COPD was reviewed separately and discussed in chapter three. 
O’Kane and Groher (2009) graded the literature using the ‘Levels of 
Evidence Grading Chart’, adapted from the ‘Oxford Centre of Evidence 
Based Medicine’ (University of Oxford, accessed online 2011). Findings 
revealed no studies in this area were graded as Level A; as random control 
trials.  However three were graded Level B; cohort and case control studies 
(Shaker, Ren, Townsend, & Dodds, et al., 1992; Mokhlesi, Logemann, 
Rademaker, & Stangl, et al., 2002; Kobayashi, Kubo, & Yanai, 2007), three 
at Level C; case series (Coelho, 1987; Stein, Williams, Grossman, & 
Weinberg, et al., 1990; Good-Fratturelli, Curlee, & Holle, 2000), and one at 
Level D; expert opinion (Harding, 2002). The review within this thesis 
included more publications for oropharyngeal dysphagia and respiratory-
swallow patterns in patients with COPD; incorporating abstracts, expert 
opinion and full studies published up to 2011 (Teramoto, Kume, & Ouchi, 
2002; Mahoney, Foo, Goudge, & Scott, et al., 2004; Matsuda, Teramoto, 
Ohga, & Tomita, et al., 2004; Carney, Sheppard, & Laframboise, 2005; 
Gross, Atwood, Ross, & Olszewski, 2009; McKinstry, Tranter, & Sweeney, 
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2009; Terada, Muro, Ohara & Kudo, et al., 2010; Cvejic, Harding, 
Churchward & Turton, et al., 2011; Ilsley, 2011; Singh, 2011). 
Editorials by Harding (2002) and Singh (2011) reviewed the evidence for 
oropharyngeal dysphagia in patients with COPD, with reference to specific 
articles within the same publication (Mokhlesi, Logemann, Rademaker, & 
Stangl, et al., 2002; Cvejic, Harding, Churchward & Turton, et al., 2011). 
Whilst Singh (2011) summarised the evidence in dysphagia as a contributing 
factor in increasing the bacterial load during exacerbations, Harding (2002) 
summised that the use of a multidisciplinary research team, robust inclusion 
criteria and use of methodological design which assesses multiple 
components concurrently strengthens the validity of results. However both 
editorials concluded there is a paucity of research in this field and further 
investigation is warranted. 
 
2.8.2 Members of Research Group 
Most studies used relevant multidisciplinary team members when developing 
and conducting their research; including a speech and language therapist 
and respiratory physician as either the primary or secondary author. 
However three studies had a uniprofessional teams of respiratory physicians 
only (Stein, Williams, Grossman, & Weinberg, et al., 1990; Kobayashi, Kubo, 
& Yanai, 2007; Terada, Muro, Ohara, & Kudo, et al., 2010). As will be 
discussed in chapter four, using expert clinical professionals to develop study 
design and conduct assessment procedures is crucial in strengthening 
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clinical validity of the study. In view of the complex nature of the swallowing 
process, in my opinion a multidisciplinary team is essential. 
 
2.8.3 Geographical Origin 
Six publications originated from research conducted within the United States 
of America (Coelho, 1987; Stein, Williams, Grossman, & Weinberg, et al., 
1990; Good-Fratturelli, Curlee, & Holle, 2000; Harding, 2002; Mokhlesi, 
Logemann, Rademaker, & Stangl, et al., 2002; O'Kane & Groher, 2009). 
Four publications originated each from Japan (Teramoto, Kume, & Ouchi, 
2002; Matsuda, Teramoto, Ohga, & Tomita, et al., 2004; Kobayashi, Kubo, & 
Yanai, 2007; Terada, Muro, Ohara & Kudo, et al., 2010) and Australia 
(Mahoney, Foo, Goudge, & Scott, et al., 2004; McKinstry, Tranter, & 
Sweeney, 2009; Cvejic, Harding, Churchward & Turton, et al., 2011; Singh, 
2011), with one abstract from Canada (Carney, Sheppard, & Laframboise, 
2005). One article has been recently published within the United Kingdom 
which explored rehabilitation of dysphagia in COPD patients (Ilsley, 2011). 
However, the literature review revealed a paucity of research to date 
investigating prevalence or the nature of dysphagia in a British population as 
detailed in this thesis. 
 
2.8.4 Research Questions, Aims and Objectives 
As research in this field is still in its infancy, previously published research 
has been dominated by investigating prevalence and the nature of 
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oropharyngeal dysphagia in patients with COPD (Coelho, 1987; Good-
Fratturelli, Curlee, & Holle, 2000; Cvejic, Harding, Churchward & Turton, et 
al., 2011). However within this topic, several studies aimed to explore broad 
aspects; such as severity of COPD (Carney, Sheppard, & Laframboise, 
2005), or phase of COPD (Mokhlesi, Logemann, Rademaker, & Stangl, et 
al., 2002; Matsuda, Teramoto, Ohga, & Tomita, et al., 2004; Kobayashi, 
Kubo, & Yanai, 2007; Terada, Muro, Ohara & Kudo, et al., 2010) in 
assessing the impact of COPD on swallowing ability. Conversely, other 
studies that have focused on investigating one specific element of the 
swallow; such as Stein and Williams et al’s (1990) study which aimed to 
explore cricopharyngeal function, and four studies which investigated the 
initiation of the swallow reflex in patients with COPD (Teramoto, Kume, & 
Ouchi, 2002; Matsuda, Teramoto, Ohga, & Tomita, et al., 2004; Kobayashi, 
Kubo, & Yanai, 2007; Terada, Muro, Ohara & Kudo, et al., 2010).  
Two publications have assessed intervention strategies for dysphagic 
patients with COPD. Studies by McKinstry and Tranter et al (2009) and Ilsley 
(2011) aimed to evaluate the outcomes of including swallowing assessment 
and education into pulmonary rehabilitation sessions.  
The research questions and objectives covered in the current literature have 
initiated research in the nature of dysphagia in COPD and outcomes of 
pulmonary rehabilitation; however there are still many questions left 
unanswered. The literature to date has mainly focused on one or two clinical 
components contributing to dysphagia in COPD. Studies have not yet 
explored patient perspectives and impact of oropharyngeal dysphagia on 
quality of life; nor has clinically relevant data been compared to the patient 
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perspective to understand the impact of dysphagia from a combined clinical 
and patient perspective, thereby providing a truly holistic approach to 
exploring the nature and prevalence dysphagia has by phase of COPD.  The 
aim of the study detailed in this thesis addresses some of these 
acknowledged gaps in knowledge. 
 
2.8.5 Study Design 
All studies reviewed were categorised as observational studies. Of those 
stating study designs, all were prospective except for the study by Good-
Fratturelli and Curlee et al (2000); who used a retrospective approach. 
Studies by Coelho (1987), Mokhlesi and Logemann et al (2002) and Carney 
and Sheppard et al (2005) specified the use of consecutive sampling; 
however Stein and Williams et al (1990) reported their study used neither 
randomised nor consecutive sampling.  
The use of age matched controls completing the same methodology 
strengthens clinical validity of a study, and was enlisted in three studies 
(Matsuda, Teramoto, Ohga, & Tomita, et al., 2004; Terada, Muro, Ohara, & 
Kudo, et al., 2010; Cvejic, Harding, Churchward, & Turton, et al., 2011). Six 
studies did not include a control group (Coelho, 1987; Good-Fratturelli, 
Curlee, & Holle, 2000; Carney, Sheppard, & Laframboise, 2005; Kobayashi, 
Kubo, & Yanai, 2007; McKinstry, Tranter, & Sweeney, 2009; Ilsley, 2011), 
with two studies using historical controls to compare against the researched 
group (Stein, Williams, Grossman, & Weinberg, et al., 1990; Mokhlesi, 
Logemann, Rademaker, & Stangl, et al., 2002), or compared the research 
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group against normative data (Mahoney, Foo, Goudge, & Scott, et al., 2004). 
Only one study divided COPD subjects further into stable and exacerbation 
phase (Kobayashi, Kubo, & Yanai, 2007); however this was not a repeated 
measures design as it was not the same patient followed up. Random 
controlled trials or descriptive studies do not appear to have been used to 
explore dysphagia in patients with COPD to date. 
 
2.8.6 Methods 
2.8.6i) Sample Size and Demographics 
All studies recorded data using small samples, ranging from eight to 78 adult 
subjects in the research group, with mean age ranging from 50-77 years. Of 
the four studies reporting gender ratios within the research groups, there 
were a high percentage of males in each study ranging between 86-100% of 
the total sample (Coelho, 1987; Good-Fratturelli, Curlee, & Holle, 2000; 
Mokhlesi, Logemann, Rademaker, & Stangl, et al., 2002; Kobayashi, Kubo, & 
Yanai, 2007). 
 
2.8.6ii) Inclusion and exclusion criteria 
Confounding factors were not always clearly stated in all studies, creating 
challenges comparing the selection criteria for the research and control 
groups. Most of the studies used the main inclusion criterion for the research 
group as diagnosis of COPD as per recognised guidelines for the specified 
country of origin. A few of the studies defined the inclusion of COPD patients 
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further in terms of severity and type of COPD (Mokhlesi, Logemann, 
Rademaker, & Stangl, et al., 2002), or by phase of COPD (Carney, 
Sheppard, & Laframboise, 2005; Kobayashi, Kubo, & Yanai, 2007; Terada, 
Muro, Ohara, & Kudo, et al., 2010).  However definitions of exacerbation 
phase differed between studies. Inclusion criteria for the two Japanese 
studies into the exacerbation phase COPD group specified subjects were to 
be clinically stable when assessed (Kobayashi, Kubo, & Yanai, 2007; 
Terada, Muro, Ohara, & Kudo, et al., 2010). Although not stated in Matsuda 
and Teramoto et al’s (2004) abstract, the same inclusion criteria is likely 
given the similar methodology. The ‘exacerbation’ phase for this group of 
studies is defined as more than three exacerbations in a 12 month period. 
Whilst this is not providing information during acute exacerbation phase as 
reported in Carney and Sheppard et al’s (2005) abstract, their aim was to 
report any differences in swallowing reflex times between frequent and non 
frequent exacerbators.  
Excluding co-morbidities known to cause dysphagia from the study is a 
crucial step towards ensuring valid results. However confounding variables, 
such as age and co-morbidities are difficult to completely exclude from this 
population (Stein, Williams, Grossman, & Weinberg, et al., 1990), as majority 
of people diagnosed with COPD are over 50 years of age, and likely to have 
one or more medically pathologies (Langmore, Skarupski, Park, & Fries, 
2002). Earlier studies, such as Coelho (1987) and Good-Fratturelli and 
Curlee et al (2000) used inclusion criteria that was too broad and allowed co-
morbidities known to cause dysphagia into the research group. More recent 
studies have overtly described criteria to ensure co-morbidities that may 
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cause dysphagia were excluded, such as tracheostomy, history of 
neurological or head and neck surgery or dementia (Mokhlesi, Logemann, 
Rademaker, & Stangl, et al., 2002; Kobayashi, Kubo, & Yanai, 2007; Terada, 
Muro, Ohara, & Kudo, et al., 2010). This provides the most homogeneous 
group possible for the target aetiology; and was enlisted for recruitment 
criteria for the study detailed in this thesis (see section 5.6 and 5.7). 
 
2.8.6iii) Recruitment  
All studies recruited subjects within an outpatient hospital clinic. Two studies 
recruited mild to severe COPD patients (Mokhlesi, Logemann, Rademaker, & 
Stangl, et al., 2002; Cvejic, Harding, Churchward, & Turton, et al., 2011), 
with three studies recruiting either moderate to severe COPD only (Stein, 
Williams, Grossman, & Weinberg, et al., 1990) or advanced COPD only 
(Coelho, 1987; Mahoney, Foo, Goudge, & Scott, et al., 2004). The study by 
McKinstry and Tranter et al (2009) recruited within pulmonary rehabilitation, 
and reported that approximately 78% of their research group was diagnosed 
with COPD; with the remaining subjects classified as ‘chronic respiratory 
disease’. 
Demographical information provided further information on subjects recruited 
and information on inclusion criteria discussed earlier; such as Coelho’s 
(1987) study. Of the 14 patients included in the research group, 13 had 
tracheostomies and five were ventilator dependent. It is widely accepted 
tracheostomies increase the risk of dysphagia (Shaker, Milbrath, Ren, & 
Campbell, et al., 1995; Mokhlesi, Logemann, Rademaker, & Stangl, et al., 
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2002), thereby increasing the difficulty to draw conclusions on the actual 
cause of the dysphagia (as a consequence of the tracheostomy or COPD) 
due to the heterogeneous nature of the groups as discussed earlier.  
 
2.8.6iv) Assessment procedure 
Previous studies reveal there is not a clear standard in the use of measures 
to identify dysphagic characteristics in COPD. However the majority of 
studies enlisted videofluoroscopy as the main assessment tool. Only one 
study included a ‘bedside examination’ for an oral stage assessment 
(Coelho, 1987).  
The Swallowing Provocation Test (SPT) combined with submental 
electromyography (SEMG) was used by three studies (Kobayashi, Kubo, & 
Yanai, 2007; Matsuda, Teramoto, Ohga, & Tomita, et al., 2004; Terada, 
Muro, Ohara, & Kudo, et al., 2010). However both methods have 
methodological weaknesses as will be discussed in section 4.3.3iv). 
Few studies enlisted mulitple methods within their assessment procedure. 
Mokhlesi and Logemann et al (2002) and later studies (McKinstry, Tranter, & 
Sweeney, 2009; Ilsley, 2011) included self report symptom questionnaires 
and compared against videofluoroscopy or flexible endoscopic evaluation of 
swallow (FEES). This also included a disease specific quality of life 
questionnaire using the SWAL-QOL (Swallowing Quality Of Life), or basing 
questions from the SWAL-QOL in the latter two studies. Additionally, Cvejic 
and Harding et al (2011) combined three methods of analysis to 
simultaneously assess swallow and respiration; using submandibular 
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electromyography, videofluoroscopy and respiratory inductance 
plethysmography. Using a combination of methods to assess multiple factors 
of the swallow is recommended (Harding, 2002), and multiple methodology 
was enlisted in the study detailed in this thesis; discussed in chapter four. 
 
2.8.6v) Bolus trials and delivery 
Most studies assess the swallow using two to three different consistencies; 
normal fluid, semi-solid and solid bolus trials, with a minimum of two trials per 
bolus (Coelho, 1987; Good-Fratturelli, Curlee, & Holle, 2000; Mokhlesi, 
Logemann, Rademaker, & Stangl, et al., 2002). These studies also used the 
most natural delivery system for the bolus, which is via a spoon or cup. This 
is in direct contrast to the study by Kobayashi and Kubo et al (2007) which 
reports using the same method detailed in Ebihara and Sekizawa et al’s 
(1993) study of using a syringe to deliver the bolus, injected via a catheter 
placed in the nasopharynx during ‘altered consciousness’. The disadvantage 
of delivering a bolus via a syringe and nasopharyngeal catheter omits two 
stages of the swallowing process, therefore altering the validity of the study 
as discussed earlier (see section 2.4.3i).  
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2.8.7 Results 
Results from the studies can be categorised into four broad areas; overall 
prevalence of dysphagia, nature of the oropharyngeal dysphagia, prevalence 
of penetration and/or aspiration and effectiveness of intervention strategies; 
which will now be discussed. 
 
2.8.7i) Prevalence 
Prevalence of dysphagia within the COPD population is important to 
investigate, so as to provide a clear picture of the accuracy of identification 
rates for this disorder. Two studies in this review aimed to provide 
prevalence of oropharyngeal dysphagia in patients with COPD. These 
studies reported an estimated prevalence range between 2% (Good-
Fratturelli, Curlee, & Holle, 2000) and 3% (Coelho, 1987) of the sampled 
population in the recruitment periods of three years and 18 months 
respectively. Both studies recruited from patients referred to 
videofluoroscopy for suspected dysphagia, which was a subpopulation of 4% 
(Good-Fratturelli, Curlee, & Holle, 2000) and 5% (Coelho, 1987) of the total 
COPD population within the allocated recruitment timeframes. This 
recruitment strategy will obtain prevalence for the referred population, but not 
for a general COPD population. Furthermore, this sampling technique also 
relies on the referrer’s knowledge of dysphagic symptoms at bedside 
examination, or patient reporting skills, and does not allow for silent 
aspiration or subjects under reporting. To gain an understanding of true 
prevalence, recruitment from the general COPD population is essential. To 
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date there has not been a study sampling from a general COPD population 
in order to estimate true prevalence, as will be addressed in the study 
detailed in this thesis. 
 
2.8.7ii) Oropharyngeal dysphagic characteristics 
The majority of studies had either primary or secondary aims of defining 
dysphagic characteristics found in the sample population. Coelho (1987) 
reported on dysphagic characteristics further by documenting if they were 
observed as dysphagic but exhibiting a functional swallow; and this was 
defined as no aspiration observed. 
Dysphagic characteristics were noted in both the oral and pharyngeal stages 
of the swallow. Oral stage dysphagic characteristics noted were increased 
chewing duration, fatiguing quickly (Coelho, 1987) and oral residue (Good-
Fratturelli, Curlee, & Holle, 2000). Dysphagic characteristics noted in the 
pharyngeal stage were delayed pharyngeal initiation (Coelho, 1987; Good-
Fratturelli, Curlee, & Holle, 2000; Mokhlesi, Logemann, Rademaker, & 
Stangl, et al., 2002; Mahoney, Foo, Goudge, & Scott, et al., 2004), slower 
laryngeal elevation (Mokhlesi, Logemann, Rademaker, & Stangl, et al., 
2002), reduced hyoid elevation (Cvejic, Harding, Churchward, & Turton, et 
al., 2011), and pharyngeal residue (Good-Fratturelli, Curlee, & Holle, 2000; 
Mahoney, Foo, Goudge, & Scott, et al., 2004; Cvejic, Harding, Churchward, 
& Turton, et al., 2011). Additionally, Mokhlesi and Logemann et al (2002) 
attributed the observed pharyngeal dysphagia to lower laryngeal resting 
position and lower mid swallow position than normals (p<0.001). They also 
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noted the use of spontaneous manoeuvres, such increased airway closure 
duration; suggesting that COPD subjects compensated for the delayed 
initiation of swallow and slower laryngeal elevation and closure, by holding 
the larynx in an elevated position for longer. As this was seen in stable phase 
COPD subjects, it remains uncertain if this technique remains effective at 
protecting the airway during exacerbations; and will be explored further in the 
study detailed in this thesis. 
A few studies investigated specific dysphagic characteristics, such as 
cricopharyngeal sphincter function (Stein, Williams, Grossman, & Weinberg, 
et al., 1990) and timing of the swallowing reflex initiation (Matsuda, 
Teramoto, Ohga, & Tomita, et al., 2004; Kobayashi, Kubo, & Yanai, 2007; 
Terada, Muro, Ohara, & Kudo, et al., 2010). Stein and Williams et al (1990) 
found 17/25 COPD subjects with ‘marked’ clinical dysphagia, and  21/25 
Moderate-Severe COPD subjects exhibiting cricopharyngeal dysfunction 
compared to 14/128 unmatched historical controls. However it was difficult to 
interpret this article and understand the overall findings, as they did not 
define ‘clinical dysphagia’  and utilised an oropharyngeal assessment 
technique (videofluoroscopy) to assess cricopharyngeal function without 
reporting the standardised assessment protocol as seen in Logemann 
(1993). If cricopharyngeal dysfunction was attributable to oropharyngeal 
dysphagia, videofluoroscopy assessment would require analysis of the hyoid 
movement and laryngeal elevation and closure as the potential cause of the 
cricopharyngeal dysfunction (Huckabee, 2009). Whereas Stein and Williams 
et al (1990) reported that their subjects’ cricopharyngeal dysfunction was 
attributed to aspiration of reflux, and suggested this was an oropharyngeal 
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dysphagic characteristic. However Stein and Williams et al (1990) have 
confused oropharyngeal aspiration with aspiration caused by 
laryngopharyngeal reflux (or oesphageal reflux); which is normally attributed 
to oesophogeal dysphagia. Furthermore, they reported 10/25 subjects 
proceeded to have cricopharyngeal myotomies which resolved the 
swallowing issues, whereas cricopharyngeal dysfunction due to 
oropharyngeal dysphagia would not have been resolved with this surgical 
procedure.  
The swallowing reflex in ‘frequent exacerbators’ (exacerbation group) was 
explored in three studies (Matsuda, Teramoto, Ohga, & Yomita, et al., 2004; 
Kobayashi, Kubo, & Yanai, 2007; Terada, Muro, Ohara, & Kudo, et al., 
2010). Kobayashi and Kubo et al (2007) compared frequent exacerbators 
with non frequent exacerbators, whilst Matsuda and Teramoto et al (2004) 
and Terada and Muro et al (2010) compared frequent exacerbators against 
age matched controls. Longer latency times for onset of swallowing reflex 
was found in all exacerbation groups which were statistically significant; and 
relative risk ratios of 2.8 (95% CI 1.5-5.0) (Matsuda, Teramoto, Ohga, & 
Yomita, et al., 2004) and 6.24 (95% CI 0.90-43.34) (Terada, Muro, Ohara, & 
Kudo, et al., 2010). However the definition used in these set of studies for 
swallow onset time differs from the acknowledged initiation of swallow in 
normal swallows, as discussed in section 4.3.3iv. 
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2.8.7iii) Penetration and aspiration 
Penetration and aspiration of a bolus could only be reported if a study’s 
methodology allowed for visualisation of the bolus through the pharynx 
during a swallow. Thus six studies were able to comment (Coelho, 1987; 
Stein, Williams, Grossman, & Weinberg, et al., 1990; Good-Fratturelli, 
Curlee, & Holle, 2000; Mokhlesi, Logemann, Rademaker, & Stangl, et al., 
2002; Carney, Sheppard, & Laframboise, 2005; Cvejic, Harding, 
Churchward, & Turton, et al., 2011), however Stein and Williams et al (1990) 
did not report rates of penetration or aspiration. Of those that did, three 
separated data for rates of penetration and aspiration. Similar proportions of 
subjects penetrating were seen in Mahoney and Foo et al (2004); reporting 
25% (2/8) of subjects penetrated, and in Good-Fratturelli and Curlee et al 
(200) with 27% (21/78) of subjects, and a higher proportion reported in 
Carney and Sheppard et al’s (2005) study with 48% (10/21) subjects seen to 
penetrate.  
Reports of aspiration exclusively varied, ranging from no subjects aspirating 
(Mokhlesi, Logemann, Rademaker, & Stangl, et al., 2002; Mahoney, Foo, 
Goudge, & Scott, et al., 2004); versus 21% (3/14) of subjects in Coelho 
(1987); 41% (32/78) in Good-Fraturelli and Curlee et al (2000); and 48% 
(10/21) of subjects aspirating in Carney and Sheppard et al (2005). The 
study by Cvejic and Harding et al (2011) combined scores and reported 38% 
(6/16) of their study penetrated and/or aspirated. Penetration and/or 
aspiration was also noted to be more prevalent for liquids than solid boluses 
in the COPD groups (Good-Fratturelli, Curlee, & Holle, 2000; Mokhlesi, 
Logemann, Rademaker, & Stangl, et al., 2002).  
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Cvejic and Harding et al (2011) is the only study to assess the long term 
impact of rates of penetration and/or aspiration in patients with COPD. 
Interestingly, they found COPD patients with penetration/aspiration (n=6) had 
more negative health outcomes compared to COPD patients without any 
penetration/aspiration (two had hospitalisations and two deaths, p=0.05); 
with a non significant difference reported for aspiration only versus no 
aspiration seen (p=0.07). However the follow-up reported in this study was a 
telephone based interview conducted with the COPD subject, 36 months 
post initial assessment. This consisted of patient report of number of 
hositalisations over the three year period; however there was no 
documentation of any intervention provided by the research team or the local 
Speech and Language Therapy department.  
Of the studies that used age matched healthy control groups, Mokhlesi and 
Logemann et al (2002) stated their control group did not show any evidence 
of dysphagia, however  Stein and Williams et al (1990) reported 11% 
(14/128) of control subjects with mild cricopharyngeal dysfunction, and 7% 
(1/15) of Cvejic and Harding et al’s (2011) control group were reported to 
have either penetrated or aspirated. 
As the reported mean ages from the group are over 65 years of age, a 
degree of penetration of the bolus is expected and still considered within the 
normal age related swallow as discussed in section 2.3.3 and summarised in 
table 7. However controls used in studies reviewed in this section, and the 
general consensus of published normative data reports aspiration should not 
be evident within a normal and normal aged swallow, therefore the findings 
 86 
 
of aspiration in the COPD groups are clinically significant and warrant further 
investigation. 
 
2.8.7iv) Effectiveness of intervention strategies 
Two studies investigated the effect of including oropharyngeal dysphagia 
assessment and education into existing pulmonary rehabilitation sessions; 
and assessed effectiveness using the Swallowing Quality Of Life (SWAL-
QOL) questionnaire as an outcome measure. McKinstry and Tranter et al 
(2009) reported a significant improvement in levels of understanding of 
dysphagia and swallowing related quality of life as measured pre and post 
one hour education sessions. Furthermore improvement was shown to be 
maintained in three quality of life domains (Burden, Symptoms and Food 
Selections) three months after completing the education sessions. These 
findings concur with a later study that also investigated assessment and 
education sessions within a pulmonary rehabilitation setting (Ilsley, 2011). 
Interestingly both reported using clinical assessment with and without 
instrumental analysis, yet neither commented nor compared findings with the 
perceptions recorded from the subjects.  
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2.9 Concluding Thoughts 
Whilst what is expected from a normal and normal ‘age related’ swallows is 
well documented, controversy continues regarding definitions of dysphagic 
characteristics. On considering the strength of the evidence documented 
within the literature, it is my opinion that a swallow may initiate at the level of 
the valleculae; and minor, infrequent episodes of penetration of a bolus 
should be considered normal within older adults. However the literature does 
not provide convincing evidence to support the theory that episodes of 
aspiration occur within normal and older adults; and is therefore considered a 
dysphagic characteristic within the study detailed in this thesis. Once clear 
definitions were established, the literature could then be compared with 
studies investigating oropharyngeal dysphagia in patients with COPD.  
A literature review revealed a dearth of publications specifically investigating 
swallowing disorders in patients with COPD; with over half being published 
after protocol development and data collection for the study detailed in this 
thesis. Nevertheless, the review revealed ‘proof of concept’ in this area is still 
in its infancy and requires further investigation. To date there have been no 
known British studies to investigate the nature of oropharyngeal dysphagia in 
patients with COPD, nor any known studies investigating swallowing 
changes by phase of COPD using a repeated measures design, or 
evaluating the impact of dysphagia on quality of life. Furthermore exploration 
not only into the presence of oropharyngeal dysphagia in this population is 
still required, but also any detrimental effects this may have on health and 
quality of life is warranted.   
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Chapter Three: The Respiratory- Swallow Pattern and COPD 
3.1 Introduction 
The importance of the respiratory system during swallowing is often 
understated or, at best, considered an adjunct to the swallowing assessment.  
However more recently the respiratory system has been shown to influence 
the timing of the swallow and generate the appropriate amount of subglottic 
pressure to ensure a safe swallow (Gross, Atwood, Ross, & Olszewski, et al., 
2009). Hence any alterations to the finely tuned coordination between 
respiration and swallowing may affect the efficiency and safety of the 
swallow. Even though the respiratory-swallow pattern is now acknowledged 
as an interconnected working mechanism, previous research tended to 
explore each mechanism as stand alone systems (Martin-Harris, 2008). 
Even fewer investigated how they interact or impact on each other (Gross, 
Atwood, Ross, & Olszewski, et al., 2009).  A normative respiratory-swallow 
pattern is acknowledged within the literature; however alteration to the 
respiratory-swallow pattern due to COPD, is surprisingly under researched. 
Furthermore, there appears to be a paucity of research in the repercussion of 
deviating from the predominant pattern; on the nature of dysphagia or on 
health outcomes. 
This chapter reviews the literature exploring the relationship between 
respiration and swallowing to establish the existing evidence base and to 
inform the study design utilised in this thesis; summarised in tables 6 and 7 
at the end of the chapter. This evidence is then used in this thesis as a 
benchmark to compare against studies exploring alterations due to 
behavioural changes, or disease and disorder. Finally, three studies have 
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been found which investigate the impact of the respiratory-swallow pattern 
specifically in COPD (Shaker, Ren, Townsend, & Dodds, et al., 1992; Gross, 
Atwood, Ross, & Olszewski, et al., 2009; Cvejic, Harding, Churchward, & 
Turton, et al., 2011), and are discussed in light of the normative information. 
 
3.2 Anatomy and Physiology 
The human system is unable to breathe and swallow at the same time, 
revealing a synergistic relationship between the respiratory and swallowing 
mechanisms. Historically, it was thought that swallowing and respiration 
worked alongside each other in a ‘turn taking’ style. More recently, studies 
suggest respiration and swallowing are more than just a ‘turn-taking 
partnership’, but an ‘integrated paradigm’, where respiration provides afferent 
information to the swallow process (Gross, Atwood Jnr, Grayhack, & 
Shaiman, 2003); discussed in chapter two . It is now understood that Central 
Pattern Generators (CPG) for breathing and swallowing within the medulla 
share neurons and therefore influence each other’s action.  The breathing-
swallowing pattern is largely controlled by the brainstem with some cortical 
control, which can be seen during volitional swallows (Kelly, Huckabee, 
Jones, & Carroll, 2007), most likely recruiting from planning areas for the 
swallow such as the cingulated cortex, and frontal operculum.  
3.2.1 Swallow Apnoea 
During the pharyngeal stage of the swallow, the larynx is tightly sealed and 
respiration is temporarily inhibited due to airway protective mechanisms 
which prevent the bolus entering the respiratory tract (discussed previously 
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in chapter two). This temporary inhibition of respiration during the pharyngeal 
stage is known as a ‘swallow apnoea’. In a recent study, the swallowing 
system was shown not only to rely on respiration inhibition to perform 
swallow apnoea during the pharyngeal stage of the swallow, but also to 
provide sensory information for the crucial timing of the apnoea (Gross, 
Atwood Jnr, Grayhack, & Shaiman, 2003). The timing of the swallow apnoea 
is understood to occur via the synergy between thoracic and laryngeal 
sensory information. Afferent impulses (from the sensory branch of the vagus 
nerve) situated in the thorax are carried to the medullary centre. There it 
crosses with efferent fibres of the recurrent laryngeal nerve, which initiates 
airway protection (vocal fold adduction) milliseconds before the respiration is 
inhibited (Perlman & Schulze-Delrieu, 2003). There is little understanding or 
research into neuronal mechanisms influencing respiratory inhibition, 
however one study suggests α2- adrenergic receptors may have an inhibitory 
effect on respiration during swallow (Yamanishi, Takao, Koizumi, & 
Ishihama, et al., 2010). 
Martin- Harris and Brodsky et al (2005) found onset of swallow apnoea to 
start during the oral preparatory stage, when the bolus is entering the mouth, 
and offset usually occurring in the late stages of the pharyngeal stage of the 
swallow. Durations of swallow apnoea ranged from 0.50 sec to 10.02 sec 
(Md= 1sec), with extreme outliers in the older subjects. Klahn and Perlman 
(1999) suggested gender and viscosity differences vary the duration of 
swallow apnoea. They suggest males require a longer pharyngeal stage due 
to anatomical differences, however this is disputed in more recent studies 
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(Hiss, Treole, & Stuart, 2001; Gross, Atwood Jnr, Grayhack, & Shaiman, 
2003; Logemann, 2008). 
 
3.3 The Normal Respiratory-Swallow Pattern 
The respiratory-swallow pattern is a term used for the respiratory phase 
surrounding the swallow apnoea (and hence surrounding bolus movement 
through the pharynx). Martin-Harris and Brodsky et al (2005) provided a 
normative model for an adult breathing-swallow pattern. They describe four 
main respiratory-swallow patterns surrounding the swallow apnoea;  
 Inhalation - (swallow apnoea) - Inhalation (INH/INH)  
 Inhalation - (swallow apnoea) - Exhalation (INH/EXH)  
 Exhalation - (swallow apnoea) - Exhalation (EXH/EXH)  
 Exhalation - (swallow apnoea) - Inhalation (EXH/INH).  
 
These four patterns have also been described at the moment swallow 
apnoea is initiated; as mid exhalation (EXH/EXH), end exhalation (EXH/INH), 
mid inhalation (INH/INH) or end inhalation (INH/EXH) (Charbonneau, Lund, 
& McFarland, 2005).  
The majority of studies investigating the respiratory phase post swallow 
concur that the predominant pattern in normal healthy adults is to exhale 
post swallow (Selley, Flack, Ellis, & Brooks, 1989; Smith, Wolcove, 
Colacone, & Kreisman, 1989; Shaker, Ren, Townsend, & Dodds, et al., 
1992; Martin, Shaker, & Dodds, 1994; Paydarfar, Gilbert, Poppel, & Nassab, 
1995; Preiksaitis, Mayrand, Robins, & Diamant, 1996; Klahn & Perlman, 
1999; Gross, Atwood Jnr, Grayhack, & Shaiman, 2003; Martin-Harris, 
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Brodsky, Michel, & Ford, et al., 2005). Smith and Wolcove et al (1989) and 
Paydarfar and Gilbert et al (1995) went further to document the irregular 
breathing pattern compared to resting respiration and a resetting phase of 
respiration post swallow.  
Exhalation post swallow requires the swallow to be initiated during either mid 
or high lung volumes, thus placing the onset of swallow in either mid 
exhalation or end inhalation (and hence post swallow exhalation). However 
two studies suggested swallows are more efficient when onset of swallow 
apnoea occurs during mid to end exhalation (McFarland, Lund, & Gagner, 
1994; Charbonneau, Lund, & McFarland, 2005; Martin-Harris, 2008). 
Swallow onset at end exhalation would result in an inhalation post swallow 
respiratory phase, in direct contrast to the exhalation post swallow studies. 
These studies report a swallow is benefitted by mid to low lung volumes, 
suggesting this produces least diaphragmatic resistance, and thereby 
providing the least amount of resistance on laryngeal elevation. Whereas 
Paydarfar and Gilbert et al (1995), and further expanded in Gross and 
Atwood et al (2003) and later in Gross and Steinhauer et al 2006 suggested 
the coupling of exhalation post swallow with higher lung volume (INH/EXH) is 
required to stimulate subglottic mechanoreceptors, and therefore attain 
adequate subglottic pressure for a safe and efficient swallow. The sudies by 
Gross and Atwood et al (2003), and Gross and Steinhauer et al (2006) 
postulate that the larynx has more than a ventilatory function, but also 
provides essential neurosensory regulation for swallowing.  These findings 
are confirmed in Martin-Harris and Brodsky et al (2003) where they proposed 
protection of the airway is enhanced during exhalation (swallow onset), as 
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the arytenoid to vocal fold position is slightly adducted during exhalation, 
becoming a ‘protective set point’ for laryngeal closure during the swallow 
process, and avoids inhaling (potential) residue in the pharynx post swallow. 
This theory is supported by physiological findings, suggesting recruitment 
from the supplementary motor area and insular cortex (and indirectly from 
basal ganglia and thalamus) for respiratory and swallowing regulation plays a 
crucial role in inhibiting inhalation post swallow (Dziewas, Soros, Ishii, & 
Chau, et al., 2003; Huckabee, Deecke, Cannito, & Gould, et al., 2003), and 
further protecting the airway during pharyngeal transit of the bolus (Hukuhara 
& Okada, 1956; Shaker, Ren, Townsend, & Dodds, et al., 1992).  
Differences in findings may be a due to protocol differences related to small 
sample size, physiological factors such as differing bolus consistency or 
delivery, or terminology used to describe the lung volume post swallow.  The 
studies investigating swallow apnoea at onset of swallow do not comment on 
post swallow respiration phase, so it may be possible that ‘end exhalation’ 
phase  may still (briefly) exhale post swallow. This would still place 
respiration in exhalation phase post swallow, although it would not conform 
with theories suggesting higher lung volumes are required to activate 
subglottic mechanoreceptors.  
 
3.3.1 Age related changes 
Normal healthy older adults have shown a general deterioration of 
respiratory muscle mass and function with increasing age. Previous studies 
demonstrate decreased chest-wall compliance and lung elasticity, and 
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increased atrophy in expiratory muscles (more than inspiratory muscles) with 
increasing age (Kim & Sapienza, 2005). These changes result in the 
respiratory muscles working harder to maintain breathing. Although there is 
clear evidence to support a general decline in respiratory function in an older 
population, evidence as to whether the documented decline is a contributing 
factor on altering the respiratory-swallow pattern remains unclear. As with 
studies on the normal healthy respiratory-swallow pattern, it is difficult to 
compare findings regarding age related changes as studies have not 
explicitly detailed definition; such as age or sample size, or have differing 
bolus trials or outcome measures.  
The literature remains equivocal regarding age related changes impacting 
the duration of swallow apnoea. Shaker and Ren et al (1994) and Martin-
Harris and Brodsky et al (2003) reported no change in duration of swallow 
apnoea, however in their later study (Martin-Harris, Brodsky, Michel & Ford, 
et al., 2005), they found age accounted for 18% of variation in swallow 
apnoea duration, with the elderly group (over 81 years) using a longer 
swallow apnoea (mean 1.69sec S.D. 1.14sec) when compared with a 
younger group (21-40 years) (mean 1.04sec, S.D.0.24 sec), p<0.01. Other 
studies also suggested older adults had longer swallow apnoea duration 
times due to the ‘normal ageing slowing process’ (Hiss, Treole, & Stuart, 
2001; Hirst, Ford, Gibson, & Wilson, 2002; Leslie, Drinnan, Ford, & Wilson, 
2005). However none of the studies found (or reported) evidence of 
dysphagia or aspiration accompanying the increase in swallow apnoea 
observed. 
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As with duration of swallow apnoea, there is no consensus within the 
literature regarding age related changes in post swallow respiration phase. 
However, the majority of studies suggest the respiratory-swallow pattern is 
not significantly altered with age (Zamir, Ren, Hogan, & Shaker, 1996; Hiss, 
Treole, & Stuart, 2001; Hirst, Ford, Gibson, & Wilson, 2002; Charbonneau, 
Lund, & McFarland, 2005; Leslie, Drinnan, Ford, & Wilson, 2005; Kelly, 
Huckabee, Jones, & Carroll, 2007;). Contrary to these findings, Shaker and 
Ren et al (1992) and Martin-Harris and Brodsky et al (2005) found older 
adults used inhalation post swallow significantly more than younger adults.  
The majority of studies analysed the respiratory-swallow pattern indirectly, 
using techniques such as surface electromyography (McFarland, Lund, & 
Gagner, 1994; Preiksaitis, Mayrand, Robins, & Diamant, 1992; Hiss, Treole, 
& Stuart, 2001; Charbonneau, Lund, & McFarland, 2005; Gross, Atwood, 
Ross, & Olszewski, et al., 2009). Whilst these studies provide valuable 
information, there is a need to confirm these findings using visual 
confirmation of the swallow as none of the studies were able to report on the 
nature of biomechanical dysphagia, or rates of aspiration due to changes of 
the respiratory-swallow pattern. The weaknesses of using non visual 
instrumentation to assess the swallow are discussed further in section 
4.3.3iv.  
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3.4 Alterations to the respiratory-swallow pattern 
Deviations from the normal swallowing pattern can be described within two 
broad categories; physiological factors, or disease or disorder, which are 
now discussed. 
 
3.4.1 Physiological factors 
The respiration-swallow pattern has been argued to be controlled by 
volitional verses non volitional swallow, alertness level and bolus volume. 
Findings appear to conflict, however when further analysed, the differences 
are mostly due to terminology used to describe study design and results, this 
also increases the difficulty to compare findings. There are varied definitions 
for terms such as alertness levels, and ‘volitional’ swallows (reactive verses 
self timed, or reflexive) (Nishino & Hiraga, 1991; Kelly, Huckabee, Jones, & 
Carroll, 2007).  
Studies exploring altered respiratory-swallow pattern with differing bolus 
type, volumes and timing of delivery have shown varied findings. Paydarfar 
and Gilbert et al (1995) studied the impact of timing of the swallow and found 
‘respiratory phase resetting’ occurs post swallowing as compared to the 
respiratory phase at rest. They also noted swallow apnoea duration reduced 
if a liquid bolus swallow is initiated during late expiration phase, compared to 
swallows initiated during late inhalation or mid exhalation phase. Whereas 
Hirst and Ford et al (2002) studied the effect of different bolus volumes in an 
older swallow (Mean age= 73 years), with 5ml, 20ml and 100ml liquid bolus 
delivered via syringe, straw or cup. They found that exhalation phase 
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predominated post swallow, occurring on an average 64% of all swallows 
(range 44%-91% for differing volumes). These results confirmed previous 
findings by Paydarfar and Gilbert et al (1995), who suggest that these 
alterations do not occur to the respiratory-swallow pattern with differing bolus 
types. Contrary to these findings, however, Dozier and Harris et al (2006) 
suggested the respiratory-swallow pattern can be altered by bolus volume, 
suggesting large (50ml) sequential swallows of liquid increased the use of 
inhalation post swallow when compared with smaller (5ml) single historical 
swallows. These findings may be due to bolus volume, but equally may be 
due to task dependent variability (Preiksaitis, Mayrand, Robins, & Diamant, 
1992; Nishino, Hasegawa, Ide, & Isono, 1998). Although exhalation during 
and post swallow predominated, a non significant increase in the use of 
inhalation post swallow was noted with increased liquid volume, type of 
delivery of bolus (cup and straw) and with a solid bolus. Similarly,  more 
recent studies investigating respiration-swallow patterns with a solid bolus 
revealed the importance of the finely tuned relationship between breathing 
and swallowing, especially during the oral preparatory and oral stage; with 
increased variation of respiratory pattern for foods that require chewing 
(Palmer & Hiiemae, 2003; Matsuo, Hiiemae, Gonzalez-Fernandez, & Palmer, 
2008; Gross, Atwood, Ross, & Olszewski, et al., 2009). Conflicting findings 
between Martin-Harris and Brodsky et al (2003) and Martin-Harris and 
Brodsky et al (2005) also support the theory that respiratory patterns are 
potentially affected by bolus volume, and/or sip drinking versus sequential. 
This is also confirmed in a recent study by Cvejic and Harding et al (2011) 
discussed later in section 3.5.  
 99 
 
Alteration to the respiratory-swallow pattern has been explored further as a 
result of postural changes, with conflicting results. McFarland and Lund et al 
(1994) found a significant difference in respiration phase post swallow 
between two positions; late exhalation post swallow in upright position 
compared with early exhalation post swallow when subjects were positioned 
‘on hands and knees’ during the swallowing task. Ayuse and Ayuse et al 
(2006) confirmed posture alters the predominant pattern. Results suggested 
a reclined position by 60 degrees in combination with chin tuck position 
significantly increased swallow apnoea duration (p<0.001), however 
respiratory phase post swallow was not recorded. 
 
3.4.2  Disease or disorder 
The neural respiratory-swallow coupling can also be seen through studies 
investigating deviations to the normal pattern due to damage or disease. 
Charbonneau and Lund et al (2005) studied respiratory- swallow cycle in 
patients post laryngectomy. They found exhalation post swallow was 
maintained, even though the laryngeal structures had been removed and the 
requirement for airway protection was no longer necessary in this patient 
population (due to neck breathing); with no significant differences observed 
between the laryngectomy group and the normal control group. This finding 
suggests there is stability in respiratory inhibition during swallowing post 
surgery. In contrast to Charbonneau and Lund et al’s findings, Terzi and 
Orlilowski et al (2007) found significant alterations to the predominant 
respiratory-swallow pattern; with only 50% of tracheostomy patients studied 
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producing exhalation post swallow compared to 100% of swallows in the 
healthy control group (p<0.0001). As part of Terzi and Orlilowski et al’s 
(2007) study, they also explored the impact of mechanical ventilation on the 
respiratory-swallow pattern and found shorter swallow durations and fewer 
swallows per bolus. However methodological weaknesses to this study 
include the heterogeneous nature of the group; as there are varied 
neurological conditions sampled, and failure to document the respiratory-
swallow pattern before tracheostomy. Therefore I suggest the findings are 
ambiguous regarding the cause of the alterations. However other studies are 
in agreement with Terzi and Orlilowski et al’s (2007) findings of altered 
respiratory-swallow pattern in neurological disorders. Hadjikoutis and 
Pickersgill et al (2000) studied respiratory phase post swallow in patients 
with spinal, neurological and peripheral impairment, and also found deviation 
to the normal pattern irrespective of site of lesion, and noting inhalation 
occurring more frequently post swallow in the motor neuron disease group, 
and also with increased severity of dysphagia. Butler and Stuart et al (2007) 
also included rates of aspiration alongside alterations in the respiratory-
swallow pattern exclusively in stroke patients; demonstrating an association 
between severity of dysphagia and inhalation respiratory phase post 
swallow. They found stroke patients with known dysphagia without aspiration 
used inhalation post swallow (3.0%) more than normal controls (0.1%), and 
stroke patients with aspiration used inhalation post swallow the most out of 
the three groups (9.0%).  
Alterations in the respiratory-swallow pattern have also been investigated in 
other neurological disorders. Parkinson’s disease is a known disorder which 
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interrupts the breathing pattern of the individual, and therefore has 
implications on providing efficient swallow apnoea. Pinnington and Muhiddin 
et al (2000) found that exhalation was used post swallow in 80% of 
Parkinson’s disease patients during drink swallows compared to 99% of 
controls. A study by Gross and Atwood et al (2008) also found a higher 
frequency of inhalation during the swallow and also post swallow in patients 
with Parkinson’s disease compared to controls; however they assessed 
using solid bolus trials.  
 
3.5 Relevance to COPD 
COPD may impact on the intricate timing of the respiratory-swallow pattern 
due to altered lung capacity and physiology, as discussed in chapter one. 
There appears to be three studies to date that have exclusively investigated 
the respiratory-swallow pattern specifically in patients with COPD; either in 
stable Moderate-Severe COPD (Gross, Atwood, Ross, & Olszewski, et al., 
2009), in exacerbation phase with follow up in stable phase (Shaker, Ren, 
Townsend, & Dodds, et al., 1992) or examined during stable phase (Cvejic, 
Harding, Churchward, & Turton, et al., 2011). The latter study simultaneously 
assessed the respiratory-swallow pattern in patients with COPD alongside 
biomechanical analysis; therefore the respiratory-swallow pattern findings 
are reported in this section, with the biomechanical analysis reported earlier 
in chapter two. These studies are clinically relevant to this thesis, and are 
therefore discussed in detail and included in summarised in table 6 at the 
end of the chapter.  
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All three studies compared a COPD cohort with healthy control groups; 
however they all used varying bolus consistencies. Cvejic and Harding et al 
(2011) assessed subjects using liquid bolus trials at four volumes (5ml, 10ml, 
20ml and 100ml), Gross and Atwood et al (2009) compared semi-solid and 
solid bolus trials across groups in COPD (n= 25) with age matched control 
(n=25), and Shaker and Ren et al (1992) compared dry swallows (saliva) in 
COPD (n=10) with a healthy young (18-34 years) (n=10) and healthy older 
(65-83 years) (n=11) group. The latter study also evaluated water trials; 
however these were completed only by the control groups and therefore will 
not be detailed in this section.  
Shaker and Ren et al (1992) experienced a low retention for the COPD 
group (12/22) and the young healthy for respiratory rate 30-34 bpm (6/10) 
with no explanation by the authors. Inclusion and exclusion criteria were also 
not detailed in their study. However Gross and Atwood et al (2009) and 
Cvejic and Harding et al (2011) maintained adequate retention of subjects; 
with Cvejic and Harding et al (2011) losing only three subjects during the 36 
month follow-up, and documented strict recruitment criteria ensuring known 
aetiologies associated with dysphagia were excluded from research and 
control groups. 
Surface electromyography (SEMG) was used for pharyngeal phase swallow 
assessment in all studies, along with plethysmography or pneumobelt to 
assess respiratory phases during swallow initiation and post swallow. 
However Cvejic and Harding et al (2011) combined the information from the 
SEMG along with videofluoroscopy assessment to measure onset of the 
swallow; improving on the methodological weakness of using SEMG in 
 103 
 
isolation. The advantages and disadvantages of using SEMG exclusively to 
assess swallowing is discussed later in chapter four, however to reiterate the 
main disadvantage of using SEMG is the inability to visualise the swallow, 
dysphagia characteristics and any penetration and /or aspiration occurring, 
thus adding an extra element of error in timing the respiration and swallow 
components accurately. 
 Although analysing swallows of differing bolus types, two studies found the 
COPD group used inhalation during the swallow and post swallow 
significantly more than the control groups (Shaker, Ren, Townsend, & 
Dodds, et al., 1992; Gross, Atwood, Ross, & Olszewski, et al., 2009); 
whereas in Cvejic and Harding et al (2011), the use of inhalation increased 
only during the swallow. Contrary to Cvejic and Harding et al’s (2011) 
findings, Shaker and Ren et al (1992) found inhalation post swallow was 
used significantly more in the COPD group than the older healthy group 
(p<0.001), as well as inhalation during the swallow (p<0.05). Furthermore, 
two studies revealed statistically significant differences between bolus types.  
Gross and Atwood et al (2009) found the COPD group used inhalation post 
swallow more on semi-solid than solid boluses (p=0.001) and had a shorter 
swallow apnoea on semi-solid than solid boluses (p=0.03); whereas Cvejic 
and Harding et al (2011) found an increased use of inhalation during the 
swallow occurred during large liquid trials (100ml, p=0.01).  
From the combined findings from the three studies, three main areas of 
impairment to the swallow-respiratory pattern is highlighted in patients with 
COPD, with one study recording further aberration from older healthy control 
group (Shaker, Ren, Townsend, & Dodds, et al., 1992). Firstly, the COPD 
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group generally swallowed significantly more during inhalation; or inhaled 
post swallow significantly more than their normal control group. Secondly, 
swallows for food requiring chewing occurred more during inhalation.Thirdly, 
the COPD group inhaled post swallow significantly more on semi-solids than 
solids (Gross, Atwood, Ross, & Olszewski, et al., 2009); or used inhalation 
during the swallow during large liquid trials (Cvejic,Harding, Churchward & 
Turton, et al., 2011). These aberrant findings in the respiratory- swallow 
pattern observed in patients with COPD may account for dysphagic 
characteristics, and increase the risk of aspiration leading to pneumonia. 
Only Cvejic and Harding et al (2011) assessed the respiratory-swallow 
pattern alongside visual biomechanical analysis, and therefore had capacity 
to analyse any relationship between the two. However this was not reported 
within the study’s findings.  
The respiratory-swallow pattern has been shown to be altered from the 
normal pattern in patients with COPD in the three studies, yet none assess 
whether the swallow may still be functioning adequately; maintaining health 
and quality of life. Combining the respiratory assessment concurrently with a 
robust objective direct swallow assessment (such as videofluoroscopy) 
would ensure accurate conclusions regarding the timing of the swallow with 
respect to the respiratory phase as shown in Cvejic and Harding et al (2011); 
however evaluating the relationship between biomechanical dysphagia and 
respiration, and the effect of spontaneous manoeuvres would provide further 
information on the effectiveness of the overall respiratory- swallow pattern 
used. 
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3.6 Summary of Chapter 
Respiration shares neural receptors with the swallowing central pattern 
generator (CPG), and has been proven to play a key role in influencing the 
onset and duration of the swallow. Consensus suggests the predominant 
respiratory phase most frequently used in normal healthy adults is exhalation 
post swallow; with the swallow apnoea initiation during mid to high lung 
volumes (Gross, Steinhauer, & Zajac, 2006). This pattern is likely to continue 
despite atrophy of respiratory muscles and decreased chest wall excursion 
seen with increasing age (Kelly, Huckabee, Jones, & Carroll, 2007).  
Alteration to the respiratory- swallow pattern has been shown during 
behavioural changes such as bolus volume or texture, and due to disease or 
disorders. Conflicting findings between Martin-Harris and Brodsky et al’s 
2003 and 2005 findings may also highlight task dependent variability in 
respiratory phase post swallow. Studies using patient diagnostic groups such 
as stroke, Parkinson’s disease and laryngectomy also reveal an alteration in 
the predominant respiratory-swallow pattern due to the disease process. 
Three studies were found investigating the respiratory-swallow pattern 
specifically in COPD. Of which, two found an increased frequency of 
inhalation post swallow for varied bolus volumes and textures with altered 
swallow apnoea duration (Shaker, Ren, Townsend, & Dodds, et al., 1992; 
Gross, Atwood, Ross, & Olszewski, et al., 2009); with one study finding 
inhalation during the swallow altered during large liquid volumes (Cvejic, 
Harding, Churchward & Turton, et al., 2011).  
The literature predicts inhalation post swallow; coupled with increasing age 
and disease increases the risk of aspiration. Although a direct causal 
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relationship between altered respiratory-swallow pattern and increased risk 
of oropharyngeal dysphagia has been clinically suspected; the nature of the 
biomechanical dysphagia, or detrimental health outcomes such as aspiration 
or reduced quality of life have not been documented in the literature and 
therefore not yet confirmed. The literature eludes to, but does not investigate 
the nature of oropharyngeal dysphagic symptoms caused by an altered 
respiratory-swallow pattern in patients with COPD, or assessment of 
functionality of the swallow by phase of COPD. These findings suggest 
further research is required in exploring the respiratory-swallow pattern 
concurrently with the oropharyngeal swallow. Methodologies documenting 
the respiratory-swallow pattern can provide a solid base to support further 
research, and enable futher investigation into the impact of an altered 
respiratory- swallow pattern on the swallow in the stable and exacerbative 
phases of COPD.  Although too late to influence the protocol development 
and methodological design, the study by Cvejic and Harding et al (2011) 
provides similar aspects to the study’s methodology detailed in this thesis. 
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3.7 Pre-Clinical Theory I and II: Concluding Thoughts 
Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory 
disease with reduced pulmonary defence mechanisms and exhibits periods 
of decline during exacerbations of the condition. Causes of exacerbations 
are currently not identified in 30% of cases; with bacterial infections as a 
contributing factor considered controversial in the literature, and antibacterial 
intervention showing mixed results. Yet the mechanism leading to bacterial 
infection is largely under researched. Undiagnosed aspiration pneumonia 
due to oropharyngeal dysphagia may play a significant role in increasing the 
bacterial load found in the lungs during exacerbations; however how 
oropharyngeal dysphagia contributes to the onset or frequency of acute 
exacerbations, severity of the overall condition or impact on swallowing 
related quality of life is largely unknown. Furthermore COPD guidelines 
discussed in chapter one currently do not acknowledge the potential 
devastating impact of oropharyngeal dysphagia in patients with COPD, nor 
do care pathways routinely include oropharyngeal assessment for this 
population. This may be due to the dearth of evidence within the literature, as 
shown in chapters two and three.  
Nevertheless a total of eighteen key studies were found investigating either 
oropharyngeal dysphagia or respiratory-swallow pattern in patients with 
COPD (summarised in table 6); eleven of which were published before 
protocol development for the study detailed in this thesis. Combining these 
pertinent studies with normative data acknowledged within the literature to 
occur within normal and normal age related swallows (summarised in table 
7) highlighted gaps within the literature and informed the methodological 
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design of the study detailed in this thesis; which is now discussed in the 
following chapter. 
  
Table 6: Summary of literature investigating oropharyngeal dysphagia and respiratory-swallow pattern in patients with COPD. 
a) Oropharyngeal Dysphagia in patients with COPD: 
Author  (Year) 
Article Title 
Country of Origin 
 
Type of Publication 
Sampling Method 
Sample  
Size (n) 
Mean Age 
Inclusion/ Exclusion 
criteria 
Study Type 
Methodology 
Results Comments 
1. Coelho C., (1987)  
Preliminary findings on nature of dysphagia 
in patients with COPD 
 
USA 
Full Article 
Prospective 
consecutive sampling  
n=14 Advanced COPD 
(12 males) 
mean age=68y 
 
no controls 
Incl: Referred for 
swallowing assessment. 
Primary diagnosis of 
COPD 
Excl: Neurogenic or 
myopath history 
Cross sectional 
Oral phase assessment. 
 Videofluoroscopy 
(normal fluid, semi-solid 
and solid) 
Descriptive: 
3/14 Aspirated 
7/14 Swallow dysfunction 
without aspiration 
4/14 Normal swallow 
14/ 289 COPDs referred for 
swallowing assessment in 18 
month period.  
13/14 research group had a 
tracheostomy and 5/14 were 
ventilator dependant 
Subjects were assessed 
between clinical exacerbation 
and stable phase  
2. Stein and Williams et al (1990)  
Cricopharyngeal dysfunction in COPD 
 
USA 
Full Article 
 
 
Prospective    Non 
consecutive, non 
randomised 
n=25 COPD (Mod- 
Severe) 50+ years 
n= 128 unmatched 
historical control 
COPD Incl: Historical 
data including ‘food 
stuck in throat’, 
aspiration pneumonia 
Frequent COPD 
exacerbations 
 
Control Excl:  Known 
dysphagia and 
pulmonary disease 
Cross sectional 
Videofluoroscopy or 
Cineradiography (bolus 
type not stated) 
Chest X-Ray 
Descriptive: 
17/25 COPD marked 
dysphagia 
21/25 COPD had CP 
dysfunction, 10 proceeded to 
CP myotomy 
5/17 COPD GERD 
COPD FEV1 did not correlate 
with CP dysfunction 
14/128 controls Mild CP 
dysfunction 
Clinical dysphagia not defined 
Selection bias of research 
group 
Use of unmatched non 
randomised controls from 
previous videofluoroscopy 
assessment 
Combining 
pharyngoesophageal 
assessment information 
inappropriately 
1
1
0
 
  
3. Good-Fratturelli and Curlee et al (2000)  
Prevalence and nature of dysphagia in VP 
patients with COPD referred for 
videofluoroscopy 
 
USA 
Full Article 
 
 
Retrospective 
n= 78 (male) mean 
age= 69y 
Incl: Referred for 
swallowing assessment;  
Primary diagnosis of 
COPD  
 
Excl: not stated 
Cross sectional 
Videofluoroscopy 
(normal fluid, thick fluid, 
puree, paste, solid) 
 
Descriptive 
66/78 dysphagic Liquid >Solid 
32/78 Aspirated 
21/78 Penetrated 
 
44/78 penetrated or aspirated 
High percentage of silent 
aspiration. 
84/1996 COPD referred for 
videofluoroscopy 1992-1995. 
No control group. 
Research group was 100% 
male 
Limited exclusion criteria 
4. Mokhlesi and Logemann et al (2002)  
Oropharyngeal deglutition in stable COPD 
USA 
Full Article 
 
Prospective 
consecutive sampling 
n=20 Stable, 
hyperinflated COPD              
(19 men)      Mean 
Age= 69y 16/20= 
FEV1<50% predicted 
 
n= 20 historical 
controls (age and 
gender matched) 
Inclusion: Diagnosis of 
COPD (ATS);    
FEV1≤65% predicted;        
FEV1/FVC Ratio ≤70%;       
≥55years old; Smoke 
≥30 pack years 
Exclusion:       Other 
respiratory diseases; 
Tracheostomy within last 
3 months;     Intubated;        
Head and Neck Cancer;             
CNS muscle pathway 
disease; Oesophageal 
disease;    Increased 
alcohol consumption; 
Diabetic 
Control Group: 
Excl: Dysphagia, 
respiratory disease, 
neurology history, 
smoking, GORD,  
Case-control 
Chest X-Ray     PFT 
Dysphagia questionnaire 
Videofluoroscopy 
(normal fluid and paste) 
Pulse Oximetry 
 
Controls: 
Videofluoroscopy 
 
Analytic 
No aspiration for either group 
9/20 COPD prolonged airway 
closure 
longer pharyngeal delay 
27/648 Pearson correlation 
significant for Correlated 
swallow variables with 
respiratory variables (statistics 
not reported) 
Laryngeal elevation was 
reduced COPD>Normals 
(p<0.001) 
Controls= no dysphagia 
Only reduced laryngeal 
elevation was statistically 
significant. 
1
1
1
 
  
5. Harding (2002) 
Oropharyngeal dysfunction in COPD: The 
need for clinical research 
USA 
Editorial 
 
N/A N/A N/A The association between 
COPD and dysphagia has not 
been systematically 
investigated. 
Using multiple methods 
overcomes weaknesses of 
individual assessments 
Editorial commenting on 
Mokhlesi et al’s study 
Discusses oropharyngeal and 
oesophageal dysphagia 
studies 
6. Teramoto and Kume et al (2002) 
Altered swallowing physiology and aspiration 
in COPD. 
Japan 
Letter to Editor 
 
Not stated 
N=48 COPD 
Control group not 
stated 
Not stated Not stated 
SPT 
8/48 COPD subjects showed 
abnormal swallow function 
therefore at risk of aspiration 
Full study not available 
combines  conclusions of 
oropharyngeal oesophageal 
dysphagia 
7. Mahoney and Foo et al (2004) 
Chronic obstructive pulmonary disease and 
dysphagia; the effects of varying bolus 
viscosity, swallowing mode and level of lung 
hyperinflation. 
Australia 
Abstract only 
Prospective 
n= 8 stable COPD 
mean age= 67y 
no controls 
Incl:                           
Severe COPD with no 
bronchodilator 
reversibility ;                
no exacerbation in 
previous 4 weeks; 
 
Cross sectional  
Videofluoroscopy 
PFT 
 
Descriptive 
Pen/Asp scale:                     
score 2- 1/8                       
score of 3- 1/8 
Delayed initiation- level of 
valleculae 
Pyriform residue post swallow 
 
 
Full study not available 
Initiation at level of valleculae 
normal for 60+ years. 
1
1
2
 
  
8. Matsuda and Teramoto et al (2004) 
A study of swallowing function in patients 
with COPD. 
 
Japan 
 
Abstract only 
Not stated 
n= 48 COPD 
n=48 Control (age 
matched) 
Not stated Case control 
S-SPT 
Analytic 
18/48 COPD swallowing 
dysfunction 
Latent Time COPD>Normals 
Full study not available 
Use of S-SPT and definition of 
‘delay pharyngeal response’ 
inaccurate 
9. Carney and Sheppard et al  (2005) 
The Penetration/Aspiration risk in patients 
presenting with an acute exacerbation of 
COPD. 
Canada 
Abstract  
Prospective 
consecutive sampling 
n=21 COPD no 
controls 
Incl: Acute exacerbation 
COPD 
Excl: not specified 
Cross sectional 
Videofluoroscopy 
(normal fluids)  
Spirometry 
Descriptive 
10/21 Penetration 
10/21 Aspiration +/- Silent 
No relationship between 
COPD severity and Pen/Asp 
rating 
Full study not available 
b) Oropharyngeal dysphagia in patients with COPD: Studies published after protocol development and data collection for the study detailed in this thesis: 
Author  (Year) 
Article Title 
Country of Origin 
Type of Publication 
Sampling Method 
Sample  
Size (n) 
Mean Age 
Inclusion/ Exclusion 
criteria 
Study Type 
Methodology 
Results Comments 
1. Kobayashi and Kubo et al (2007) 
Impairment of the swallowing reflex in 
exacerbations of COPD. 
Japan 
Letter to editor 
n= 50 stable COPD 
divided: 
(n= 25 1+ 
exacerbation /12 
months; 22 male 
mean age= 75y 
n=25 stable; 21 male 
mean age=77y 
Incl: not stated 
Excl:                          
current smokers;       
oral corticosteroids; H+N 
cancer;              
neuromuscular disease; 
oesophageal disease 
Cross sectional 
S-SPT 
(1ml water injected into 
nasal catheter) 
Delayed Latent time of 
swallowing reflex > 3 
sec 
Analytic 
Longer Latent Time 
Exac>Stable (p<0.001) 
22/25 Exac vs 8/25 Stable 
impaired response (>3sec) 
(p<0.001) 
Relative Risk 2.8, (95% C.I. 
1.5-5.0) 
Full study not available 
All subjects were clinically 
stable 
Placement of catheter not 
stated 
Definition of delay pharyngeal 
response inaccurate 
1
1
3
 
  
2. McKinstry and Tranter et al (2009) 
Outcomes of dysphagia intervention in a 
pulmonary rehabilitation. 
Australia 
Full Article 
Not stated 
n= 253 Group 1  
n= 383 Group 2  
n= 55 Group 3  
no controls 
 
Incl: Enrolled in 8 week 
Pulmonary 
Rehabilitation Program 
between 2002-2007 with 
COPD and chronic 
respiratory disease 
Group1: Attendance of 
1hour education and 
successful completion of 
questionnaires 
Group 2: Completed 
basic dysphagia 
screening and self report 
questionnaire 
Group 3: Completed 
individual dysphagia 
assessment and pre and 
3month post SWAL-
QOL 
Excl: Not stated 
Cross sectional 
Dysphagia screen and 
self report questionnaire 
SWAL-QOL 
Analytic 
Group 1:                              
Pre 5/11 vs Post scores 8/11 
(p<0.001) 
Group 2: 104/383 subjects 
exhibited or reported 
dysphagic symptoms and went 
on to individual assessment. 
Group 3: Stat sig improvement 
Burden (p<0.009)                        
Physical Problem (p<0.012)      
Food Selection (p<0.016)         
Exclusion criteria not stated 
Contents of dysphagia 
education programme not 
stated 
Approx 78% of sample seen 
for education and screen 
diagnosed with COPD. 
Individual assessment results 
not reported 
3. Terada and Muro et al (2010)  
Abnormal swallowing reflex and COPD 
exacerbations 
Japan 
Full Article 
 
Prospective 
n= 67 Stable COPD           
mean age= 73y 
n= 19 Control (age 
matched) mean age= 
70y 
COPD incl:                
Stable COPD 
COPD Excl:               
add. respiratory disease;                     
malignancy;                
otorhinolaryngeal; 
stroke;                       
active inflammation 
disorder;                    
change in COPD 
medication;                  
use of corticosteroids;         
LTOT use;                    
ventilation 
Case Control 
STS-SPT 
CRP 
LFT+ABG 
Sputum sample (COPD) 
GERD self report 
questionnaire (COPD) 
Analytic 
0/86 response to 2
nd
 stage 
SPT (2ml injection) 
22/67COPD vs 1/19 Control 
delay response 1
st
 stage SPT 
(0.4ml injection) 
RR=6.24(0.90-43.34, p=0.02) 
COPD vs Control CRP p=0.38 
CRP:                               
COPD delay RR= 2.72 (1.46-
All COPDs clinically stable at 
time of testing 
STS-SPT given supine and 
injected at end exhalation 
STS-SPT design flawed 
Definition of delay >3sec 
inaccurate 
Inappropriate combination of 
oropharyngeal and 
oesophageal information 
1
1
4
 
  
Control  excl:             
Respiratory 
comorbidities;           
comorbidity affecting 
swallow;       
 
 
 
 
3.98) vs          COPD normal 
RR= 1.56 (0.92-2.19), p=0.04 
Freq. Of Exacerbations: 
COPD delay RR=2.82 (1.92-
3.72) vs                      COPD 
normal  RR=1.56 (0.92-2.19), 
p=0.007 
Incidence of exac requiring 
add. medical  support:                  
14/22 COPD delay  vs 10/45 
COPD normal  RR= 2.86 
(1.52-5.38), p<0.001 
GERD:                  COPD 
delay RR= 6.75 (3.84-9.66) vs        
COPD normal RR=4.10 (1.98-
2.22), p=0.04                     
4. Cvejic and Harding et al (2011) 
Laryngeal penetration and aspiration in 
individuals with stable COPD. 
 
Australia 
Full Article 
Prospective  
n= 16 stable COPD 
n= 15 control (age 
matched) 
 
Incl:  
Doctor diagnosis of 
COPD;  FEV1/FVC ratio 
≤70% predicted; TLC, 
FRC, RV 
plethysmography≥120% 
predicted 
Stable COPD for 
preceding 4 weeks 
>10 year pack history 
 
Control: normal lung 
function, non smoker, no 
history of respiratory, 
neurology or reflux 
disease 
 
Excl: No history of 
swallowing difficulty, 
neurological or 
gastroesophageal 
Case control 
Videofluoroscopy (5, 10, 
20, and 100ml liquid 
trials) 
EMG 
Intranasal and inductive 
plethysmography 
Pulse Oximetry 
Analytic 
6/16 COPD Pen/Asp;           
1/15 Control Pen/Asp (p=0.04) 
4/16COPD Asp vs 1/15 Asp 
only (p=0.07) 
EXH/EXH 11/16 COPD and 
10/15 Control for 5, 10 and 
20ml 
INH/EXH 10/16 COPD vs 3/15 
controls for 100ml 
 
Combined biomechanical and 
respiratory-swallow pattern 
assessment 
Number of trials per 
volume/subject not recorded 
Resp phase vs pen/asp not 
analysed 
Large proportion group 3 
excluded (47%) 
1
1
5
 
  
disease, head and neck 
surgery, LTOT, current 
smokers 
5. Ilsley (2011) 
Dysphagia and chronic obstructive 
pulmonary disease. 
UK 
Full Article 
Prospective 
n= 20 
no controls 
 
Incl: Attend Breathing 
Space, referred to 
speech and language 
therapy 
Cross sectional 
Pre and post 
questionnaire (8 
questions) 
Improvement noted for all 
questions relating to education 
program, between 10% 
(drinking) to 61% oral hygiene) 
Service evaluation article 
6. Singh (2011) 
Impaired swallow in COPD 
Australia 
Editorial 
N/A N/A N/A Further research with larger 
cohorts required to quantify 
the extent of difficulty, identify 
risk factors and evaluate 
intervention. 
Editorial commenting on 
Cvejic et al’s study. 
 
  
1
1
6
 
  
c) Respiration-Swallow Pattern in Patients with COPD:  
Author (Year)  
Title of Article 
Country of Origin 
Type of Publication 
Sample size 
Age range 
Inclusion/Exclusion 
Criteria 
Methodology Results Comments 
1. Shaker and Ren et al (1992) 
Coordination of deglutition and phases of 
respiration: effect of aging, tachypnea, bolus 
volume and chronic obstructive pulmonary 
disease. 
 
 
USA 
Full Article 
n= 22 Exac COPD 
age=46-72y, 
reassessed in stable 
phase (10/22)  
Controls: 
n=10 Young Healthy 
group  
Age=18-34 
n=11 Older healthy 
group 
Age=63-83 
Not stated Respirography 
SEMG 
Position: Upright and  
(controls only) Supine 
Saliva Swallow:           
All Groups 
Water Swallow:           
15x 5ml syringe water 
trials: Younger Group 
only 
Respiratory Rate: 
Younger Group Only 
Swallows analysed:10/22 
COPD analysed (due to drop 
out rate) 
Exac COPD> Stable COPD 
Inhalation post swallow p<0.05 
COPD> Older swallow 
initiation in exhalation p<0.05 
Exac COPD > Older Inhalation 
post swallow p<0.01 
Older>Younger swallow 
initiation in inhalation p<0.05 
 
d) Respiration-swallow pattern in patients with COPD- Studies published after protocol development and data collection for the study detailed in this thesis: 
2. Gross and Atwood et al (2009) 
The coordination of breathing and swallowing 
in chronic obstructive pulmonary disease. 
 
 
 
USA 
 
Full Article 
n= 25 COPD (all male; 
6 Moderate, 19 
Severe) 
mean age= 69y 
n= 25 Control (12 
male) 
mean age= 64 
Excl: 
Tracheostomy; NG; 
Neuro/degen; dementia; 
exac COPD; cardiac; 
metabolic. 
Controls and COPD: 
Semi solid and solid 
bolus trials; volume 
controlled 
Inductance 
plethysmography and 
nasal thermistry 
SEMG 
COPD>Control Inhalation post 
swallow on Solids p=0.002 
COPD>Control Inhalation post 
swallow Semi Solids p=0.001             
Semi solid>Solid COPD 
inhalation post swallow 
p=0.001                             
Semi solid<Solid COPD 
swallow apnoea duration 
p=0.03 
 
1
1
7
 
  
Table 7: Summary of findings for normal, normal age, and COPD swallow and respiration patterns. 
 Normal Swallow Normal Age Swallow COPD 
Definition of Age 20-59 
 
60+ 
 
Usually 50+ 
((National Clinical Guideline Centre, 
2010) 
Oral Preparatory Stage  Increased Chewing  
 
 
Oral Stage  Initiation >60 years 1-2 sec  (Logemann, 2008) 
 
 
Pharyngeal Stage Initiation <1 sec  (Logemann, 2008) 
 
 
Laryngeal elevation <80 years is 2cm 
males vs 1½ cm females (Logemann 
2008) 
Initiation <1 sec  (Logemann, 2008) 
 
 
Laryngeal elevation >80 years is 1½ cm 
males. No change for females (Logemann 
2008)  
 
 
 
Lower laryngeal position mid swallow  
(Mokhlesi etal, 2002) 
 
Use of spontaneous protective 
manoeuvres  (Mokhlesi et al,  2002) 
 
Respiration Exhalation post swallow (Gross, et al 
2003) (Martin-Harris, et al 2005) 
 
 
Swallow apnoea increases with age  (Leslie et 
al,  2005) (Martin-Harris B. et al,  2005) 
Inhalation post swallow significantly 
more than healthy controls  (Gross,et 
al, 2009) 
 
 
 
 
1
1
8
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Chapter Four: Methodology 
4.1  Introduction  
Several methodologies were employed within this study, informing the 
development of each stage of the study. This included a literature review, 
feasibility testing, and a prospective longitudinal study including a cross 
sectional control research arm.  This chapter discusses the research 
methodology using the Medical Research Council (MRC) (2000), and the 
revised MRC (2010) framework for defining and developing a complex 
intervention. The complexity of the research is defined using the framework’s 
criteria, and the methodology is further developed in the modelling phase 
using ‘between methods’ triangulation (Denzin, 1978) and evidence based 
practice modelling (Sackett, Rosenberg, Gray, & Haynes, et al., 1996). 
Justification of tools to measure the identified key components which 
address the aim and objectives of the study in this thesis (summarised in 
table 8) is also discussed.  
Table 8: Aim and objectives of study 
Aim of Study 
To investigate the nature and extent of oropharyngeal dysphagia in COPD; during 
stable and exacerbative phases of the disease, and its impact on health. 
Objectives of the study 
 
1. Compare perception of dysphagia symptoms and impact on swallowing related 
quality of life between Normal Controls and by phase of COPD. 
2. Investigate prevalence of oropharyngeal biomechanical dysphagia by phase of 
COPD. 
a) Explore the nature of the oropharyngeal biomechanical dysphagia by 
phase of COPD 
b) Compare the perception of dysphagia symptoms with biomechanical 
analysis by phase of COPD 
3. Investigate the nature of the respiratory-swallow pattern by phase of COPD. 
a) Compare the respiratory-swallow pattern with biomechanical analysis by 
phase of COPD. 
The MRC guidelines note complex studies frequently require original 
research to be undertaken. This is highlighted within the feasibility and 
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evaluation stages of the framework undertaken within this study and 
discussed in previous chapters, revealing a lack of clear evidence base 
within the literature.  
 
4.2   Medical Research Council Framework 
In 2000, the MRC developed a framework for defining and developing 
complex interventions. The guideline describes a complex intervention as 
being  
‘built up from a number of components, which may act both 
independently and inter-dependently..... and not easy to 
precisely define the active ingredients’ (p. 2).  
The complex nature of oropharyngeal dysphagia (discussed previously in 
chapter two) and COPD (discussed previously in chapter one) complies with 
the definition of a complex intervention within this framework. Additionally, 
the study intends to improve patient care using triangulation methodology 
and evidence based practice to assess three inter-dependent components in 
order to define potential ‘active ingredients’ (patient perception, respiratory-
swallow pattern and biomechanical swallow); further satisfying criteria stated 
within the framework.  
A review of the MRC framework was published in 2010, containing two 
important changes pertinent to this study. Firstly, the revised framework 
recognised the importance and inclusion of varied methodologies; such as 
cross sectional studies, rather than focusing exclusively on a clinical trials 
template; such as randomised controlled trials. Secondly, the framework 
provided a less linear model to the research process; as shown in figure 3, 
 122 
 
thereby further highlighting the importance of the development and feasibility 
stages in the research process.  
Figure 3: Framework for development and evaluation of complex interventions (Medical 
Research Council, 2010). 
 
 
4.3 Development 
4.3.1  Identifying the evidence base 
The first stage of the study detailed in this thesis was to explore relevant 
theory, and establish a benchmark to inform the aim of the research. This 
stage aims to establish the extent of the evidence base; highlight strategic 
design issues and confounding factors that may arise. Previous studies 
investigating the normal swallowing and respiration processes were utilised 
as a benchmark to explore deviations due to disease or disorder, types of 
methodology and the design employed, and use of valid tools for measuring 
specified outcomes. The literature review also served to highlight the paucity 
of research and many aspects of the association with oropharyngeal 
Feasibility/Piloting 
1. Testing procedures 
2. Estimating recruitment and 
retention 
3. Determining sample size 
 
Development 
1. Identifying the evidence base 
2. Identifying/developing theory 
3. Modelling process and 
outcomes 
Evaluation 
 
1. Assessing effectiveness 
2. Understanding change process 
3. Assessing cost effectiveness 
Implementation 
1. Dissemination 
2. Surveillance and monitoring 
3. Long term follow-up 
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dysphagia and COPD still requiring investigation. Results from the literature 
search were documented in chapters two and three. The review concluded a 
lack of evidence published within the literature which explores the 
association between oropharyngeal dysphagia by phase of COPD. 
Furthermore, there do not appear to be studies which concurrently measure 
respiratory-swallow pattern and biomechanical swallow alongside patient 
perception of swallowing ability and quality of life by phase of COPD; 
internationally or within the U.K., as presented in this study.  
 
4.3.2 Identifying/developing theory 
A novel and innovative theory was developed from identifying gaps in the 
evidence base during the first stage of the research process. The revised 
MRC framework states:  
‘A vitally important early task is to develop a theoretical 
understanding ....... by drawing on existing evidence and 
theory, supplemented if necessary by new primary 
research.... There may be lots of competing or partly 
overlapping theories and finding the most appropriate ones 
will require expertise in the relevant disciplines’ (2010, pg 8). 
 
The MRC framework (2000) also suggests complex interventions are 
‘marked by a paucity in high quality literature’, and is likely ‘original research 
will have to be undertaken in the early phases’. Conclusions drawn from the 
literature review; in combination with clinical expertise and patient 
observation, led to my opinion that the evidence in this specialist field 
needed to be supplemented by further original research. An extensive 
theoretical stage was deemed essential within this study, as the evidence 
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does not provide a clear understanding of the ‘mechanisms of action’; 
resulting in assessment of oropharyngeal dysphagia not routinely instigated 
for patients with COPD. Thus, an exploratory ‘proof of principle’ study was 
warranted to investigate the prevalence of oropharyngeal dysphagia in a 
COPD population, and identify the key components causing this association 
to occur.  
 
4.3.3 Modelling process and outcomes 
Modelling phase describes the standardisation of the research delivery by 
delineating the key components to the study, and defining how they relate to 
and impact on each other. This stage is crucial in order to develop a 
reproducible protocol that can relate overall aims of the study to the results. 
In this study, this was achieved by using an evidence base practice model 
and triangulation methodology, which are now discussed.   
 
4.3.3i)  Evidence Based Practice Model 
Research methodology employed in this thesis complies with the Evidence 
Based Practice model as outlined by Sackett and Rosenberg et al (1996). 
This model integrates best available evidence presented in the literature, 
with clinical expertise, and patient values and preferences as shown in figure 
4.  
Figure 4: Evidence Based Practice Model (Roddam and Skeat, 2010). 
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This study has incorporated all three fields within the design of this study: 
 Best Available Evidence – Current policies and guidelines in 
assessment of oropharyngeal dysphagia in COPD have been 
reviewed for relevance to oropharyngeal dysphagia and documented 
in chapter one. Pre-clinical theory chapters reviewed the literature of 
what has been established in this field, and what requiring further 
research. 
 Patient Experience - This study incorporates the patients’ 
perceptions of their swallowing skills and any changes in quality of life 
due to swallowing impairment. Feasibility testing of the questionnaire, 
as discussed in section 4.4 included a qualitative analysis of patient 
views regarding suitability of the questionnaire, and was used to 
inform the ‘Evaluation’ stage. 
 Clinical Expertise – I have extensive experience in oropharyngeal 
dysphagia assessment, including videofluoroscopy assessment. Other 
specialist professionals were recruited for advice particularly on 
Best Available 
Evidence
Patient 
Experience
Clinical 
Expertise
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respiratory and radiology, and other areas relevant to the study aim 
and methodology chosen. Together this clinical expertise added to the 
development of the methodology.  
 
4.3.3ii) Triangulation Model 
Triangulation methodology is the use of two or more methods to investigate a 
research question. One type of triangulation, as described by Denzin (1978) 
is ‘between-method’ triangulation. This involves utilizing contrasting research 
methods to enhance confidence in results and test the degree of external 
validity. In this study, between-method triangulation was employed to 
address the main aim of this study, which was to identify the nature and 
extent of oropharyngeal dysphagia by phase of COPD using three previously 
validated and contrasting methods, as shown in figure 5. Exploring 
oropharyngeal dysphagia from differing perspectives increases the richness 
and complexity of the research.  
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Figure 5: Between-Method Triangulation Model. 
 
 
The three key components identified from the theoretical stage as potential 
‘active ingredients’ for triangulation were;  
 patient’s perspective of dysphagia symptoms and impact on 
quality of life.  
 assessment of the biomechanical swallow  
 respiratory-swallow pattern  
Suitable measures were required to assess the key components. Possible 
tools were highlighted in the literature, and reviewed for their validity, 
reliability, and suitability to answer the study’s aim and objectives. The MRC 
framework (2010) states ‘best available methods should still be used to yield 
useful results’ (p 8), therefore justification for the tools chosen for this 
methodology is now discussed. 
Self Report 
Dysphagia 
Symptoms and 
Quality of Life (QOL) 
Biomechanical 
Swallow Analysis 
 
Respiratory-
Swallow Pattern 
Analysis 
Between Method 
Triangulation 
Aim of Study:  
To investigate the nature and 
extent of oropharyngeal 
dysphagia by phase of COPD, 
and its impact on health. 
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4.3.3iii) Justification for Self report Quality of Life (QOL) and 
dysphagia symptom tool 
In order to generate an outcome measure to explore perception of 
swallowing skills and quality of life in COPD, the use of pre-validated tools 
was investigated. Health related quality of life questionnaires (HRQOL), and 
disease specific questionnaires are most commonly used by the medical 
profession to gain an insight into the service user’s perception of their 
difficulties. Generic HRQOL are applicable to different diseases and 
therefore able to measure changes between disease states. The most 
frequently used HRQOL questionnaires in COPD are the Medical Outcome 
Study, Short Form 36 (MOS-SF36) (Mahler & Mackowiak, 1995; Wyrwich, 
Tierney, Babu, & Kroenke, et al., 2005; Nguyen, Donesky-Cuenco, & 
Carrieri-Kohlman, 2008); Sickness Impact Profile (SIP) (Bergner, Bobbit, 
Carter, & Gilson, 1981); Nottingham Health Profile (NHP) (van Schayck, 
Dompeling, Rutten, & Folgering, et al., 1995; Ramirez- Velez, 2007); and 
Quality Well Being (QWB) (Kaplan, Atkins, & Timms, 1984). Disease specific 
questionnaires focusing on respiratory disease have also been developed, 
with the most frequently used tools being Chronic Respiratory Disease 
Questionnaire (CRDQ) (Nguyen, Donesky-Cuenco, & Carrieri-Kohlman, 
2008); St. George Respiratory Questionnaire (SGRQ) (Sant'Anna, Stelmach, 
Feltrin, & Filho, et al., 2003); and The Quality of Life for Respiratory Illness 
Questionnaire (QLRIQ) (Maille, Koning, & Kaptein, 1994). Although there are 
numerous HRQOL and disease specific questionnaires valid to investigate 
quality of life in COPD population, the questions are too general for the 
purposes of this study. Generic HRQOL and disease specific (COPD) tools 
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provide general measures of holistic quality of life, or general functioning, 
and ask one to two questions about general nutrition status(Gupta & Kant, 
2009). Furthermore, they do not explore specific swallowing difficulties in 
detail, or the impact any swallowing difficulties may have on quality of life. 
Thus a quality of life tool was required to analyse the dysphagia specific 
quality of life; that is, questions regarding the impact on quality of life as a 
result of swallowing.  
There are two acknowledged oropharyngeal dysphagia disease specific 
quality of life tools published in the literature; the M.D. Anderson Dysphagia 
Inventory (MDADI) (Chen, Frankowski, Bishop-Leone, & Herbert, et al., 
2001) and the Swallowing Quality of Life (SWAL-QOL) (McHorney, Robbins, 
Lomax, & Rosenbek, et al., 2002). Whilst both tools are affordable, non 
invasive, quick to administer and reportedly indicate any dysphagic 
symptoms before in depth formal assessment, there are two main 
differences which differentiate the tools in terms of suitability for the study 
detailed in this thesis. The MDADI was designed to assess swallowing 
related quality of life secondary to head and neck cancer, whilst the SWAL-
QOL was developed using a general dysphagic population (including COPD 
subjects). Secondly, The SWAL-QOL contains more in depth questioning on 
quality of life as well as including symptom related domain; useful for the 
objectives set out within the study detailed in this thesis. Therefore the 
SWAL-QOL questionnaire was selected for use in this study as it was 
developed with a heterogeneous population; including COPD subjects. It 
also incorporates psychosocial sections seen in HRQOL tools and disease 
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specific QOL tools. Therefore the SWAL-QOL will now be discussed in detail, 
and its relevance to this study.   
Development of SWAL-QOL Tool 
The SWAL-QOL; or Swallowing Quality of Life is a disease specific 
(dysphagia) quality of life measure that integrates clinical dysphagia-specific 
physiological outcomes and psychosocial issues as perceived by the patient. 
It was published by McHorney and Robbins et al (2002) to be used as a 
research tool in clinical practice, and also to investigate effectiveness of 
intervention strategies. The tool was developed over three phases; focus 
groups with service users and carers; pretesting and item revision; and field 
testing to assess validity and reliability.  For the purposes of this thesis, only 
the last phase will be discussed in detail.  
The SWAL-QOL questionnaire is a 44 item self report questionnaire. The 
items are  divided  into ten quality of life sections  (‘Burden’, ‘Food Selection’, 
Eating Duration’, Eating Desire’, ‘Fear’, ‘Sleep’, ‘Communication’, Mental 
Health’, ‘Fatigue’, ‘Social Functioning’) and one pathophysiological section 
(‘Symptoms’). Each item answer is in the form of a Likert scale which is 
equally weighted. In order to assess validity, relevant questions were 
compared to the Medical Outcomes Study (MOS). 
Sampling included both historical and prospective design. Inclusion criteria 
was a diagnosis of oropharyngeal dysphagia as seen in videofluoroscopy, 
was in ‘stable’ dysphagia status according to the Speech and Language 
Pathologist and the service user, and was within three months of being 
assessed by videofluoroscopy.  Dysphagia ‘stability’ was determined by a 
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‘three item Diet Assessment Form’ conducted by the Speech and Language 
Pathologist (food texture, liquid consistency and percentage of oral nutrition).  
Exclusion criteria were no informed consent, non English speaking, 
inadequate reading or writing for the task, or had an active oesophageal 
dysphagia. A mail out/mail back technique was enrolled for people 
diagnosed with oropharyngeal dysphagia. There was a 70% return rate 
(n=386), with a majority of white male (approx 80%) of average age of 66 
years (+/- 13 years). The majority of ‘first diagnosis’ was Head and Neck 
Cancer (28.2%), with COPD being 6% of sample. A healthy control group 
was recruited which consisted of 40 males and females with an average age 
of 72 years. The healthy control group completed only six sections; ‘Food 
Selection’, ‘Eating Desire’, ‘Fear’, ‘Communication’, ‘Fatigue’ and ‘Sleep’. 
They were not given ‘Mental Health’, ‘Social Functioning’, ‘Burden’ or ‘Eating 
Duration’; as the phrase ‘swallowing problem’ was part of the item stem 
which was deemed unsuitable for ‘non-dysphagics’ to answer.  
Responses to the questionnaire from the normal and dysphagia group were 
analysed for validity and reliability.  Reliability measures tested scale, test- 
retest and intraclass reliability. Cronbach α coefficient to test internal 
consistency of scale reliability showed seven scales had an α>0.90. Only the 
‘Fear’ section had an α=0.79, lower than the standard of α>0.80 expected. 
Intraclass correlation was reported between 0.59- 0.91, with three sections 
under the standard of 0.75 expected. Validity measures tested convergent, 
Factor structure and clinical validity. Convergent validity was tested using 
scale to scale correlations (r= 0.19-0.74) and against MOS scale (r=0.50- 
0.56). The ‘Symptoms’ section was analysed for internal consistency. ‘Known 
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groups validity’ was used for clinical validity to distinguish between groups 
(disease and healthy) and severity. Results from ‘between groups’ showed 
statistically significant differences (p<0.01) for all items.  
 
Use of SWAL-QOL in other studies 
The SWAL-QOL has been used in eight independent articles. Three articles 
validated the tool in a language other than English (Mandarin, French and 
Dutch) either in multiple disease states compared with the EuroQOL 
(Bogaart, 2009), or a specific disease state (Khaldoun, Woisard, & Verin, 
2009) compared against UW-QOL (Lam and Lai, 2010).  Four articles used 
the SWAL-QOL as an outcome measure to assess dysphagia related quality 
of life pre and post cancer related treatment/care (Genden, Okay, Stepp, & 
Rezaee, 2003; Roe, Leslie, & Drinnan, 2007; Banderira, Axevedo, Vartanian, 
& Nishimoto, et al., 2008; Greenblatt, Sippel, Leverson, & Frydman, et al., 
2009). Lastly, McKinstry and Tranter et al (2009) used the SWAL-QOL to 
measure outcomes after dysphagia assessment and education within a 
Pulmonary Rehabilitaion setting as discussed in chapter two.  
The use of a disease specific QOL tool (rather than a generic QOL tool) 
increases the internal validity of the research. Although the SWAL-QOL is 
still in its infancy, it has evidence to support its validity and reliability to be 
used as a research tool for dysphagia specific assessment.  As well as 
providing information on the perception of QOL for patients with COPD, the 
research within this thesis may also provide evidence for using the SWAL-
QOL within a British COPD population.  
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The SWAL-QOL does not have a summary or total score at the end of the 
questionnaire. McHorney and Robbins et al (2002) noted interpretation 
problems used on other quality of life questionnaires and therefore scores 
are calculated at the end of each section. This also allows for the 
researcher/clinician to use sections as required. Multiple questions per 
section also increases validity and improves reliability to be used in small 
sample research projects. 
 
Use of SWAL-QOL in this study 
Minor modifications were made to the SWAL-QOL secondary to results from 
field testing the SWAL-QOL on a COPD population, as will be discussed 
later in section 4.4.  
 
4.3.3iv) Justification for Biomechanical swallow analysis tool 
‘Bedside assessment’ is the most common assessment used in outpatients 
and inpatients to assess swallowing difficulties. However bedside 
assessment has been reported to fail to identify up to 50% of pharyngeal 
stage dysphagia; even with the most experienced clinician (Splaingard, 
Hutchins, & Chaudhuri, 1988). Instrumental examination has been 
documented as providing more information than bedside evaluation 
(Langmore, 2003). For the purposes of this study, instrumental measures 
were required to record and simultaneously measure oral and pharyngeal 
swallow, alongside respiratory-swallow pattern analysis. Therefore bedside 
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assessment did not suit the requirements of this study. Instrumental 
assessments of the swallow found within the literature were the Swallow 
Provocation Test, SEMG, Fibreoptic Endoscopic Evaluation of Swallowing 
(FEES) and videofluoroscopy which are now discussed. 
 
Swallowing Provocation Test (SPT) 
In a series of letters to the editors of differing journal articles and within a fully 
published study, Teramoto and colleagues describe an evaluation designed 
to detect aspiration at bedside for elderly patients (Teramoto, Matsuse, & 
Fukuchi, 1999; Teramoto & Fukuchi, 2000; Teramoto, Kume, & Ouchi, 2002; 
Teramoto, Yamamoto, Yamaguchi, & Ouchi, 2004; Teramoto, Ishii, 
Yamamoto, & Yamaguchi, et al., 2005). The Swallowing Provocation Test 
(SPT) and Simple SPT (S-SPT) were evaluated on stroke subjects and 
report having a high specificity and sensitivity rating (above 80%). Teramoto 
and Fukuchi (2000) and Terada and Muro et al (2010) are the only known 
studies that provide a detailed methodological design of performing the SPT. 
The procedure requires the subject to be supine whilst a small bolus is 
injected directly into the pharynx via a nasal catheter; either as two stages 
(SPT) as employed by Teramoto and Fukuchi (2000) and Terada and Muro 
et al (2010) (0.4ml and 2.0ml injections) or one stage (S-SPT) seen in 
Kobayashi and Kubo et al (2007) (bolus volume not reported) and Matsuda 
and Teramoto et al (2004) (1ml). The injection is timed to occur at end 
expiration with the subject blind to the timing of the bolus arrival. Whilst this 
ensures accurate bolus measurement entering the pharynx, it excludes the 
oral preparatory and oral stage as discussed in chapter two; increasing the 
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difficultly for the subject to successfully prepare the bolus before entering the 
pharynx (Langmore, Terpenning, Schok, & Chen, et al., 1998; Harding, 
2002). The position of the catheter was not clearly detailed in any of the 
studies, however, positioning may result in the ‘trigger’ position also being 
missed out. Teramoto and Fukuchi et al (2000) reports that the injection is 
timed to correspond with end exhalation phase. However as discussed in 
chapter three, this places the subject at increased risk of aspiration as they 
would need to inhale immediately after the bolus was injected; increasing the 
potential for the bolus to be inhaled.  
The research teams classified a normal swallow reflex response as ‘less 
than three seconds’. It is widely acknowledged swallow initiation as almost 
instantaneous (Logemann, 1988), with a normal pharyngeal stage of 
approximately 750msec-1sec (Logemann, Kahrilas, Cheng, & Pauloski, et 
al., 1992; Love & Webb, 1996). Teramoto and Ishii et al highlight their 
misunderstandings of the nature of oropharyngeal dysphagia further in their 
letter to the editor in 2005. They define findings of gastro-oesophageal reflux 
as a pharyngeal swallowing disorder, quoting figures of oropharyngeal 
dysphagia which also include incidence of gastro- oesophageal reflux; thus 
making it difficult to draw conclusions on swallowing difficulties exclusively 
due to true oropharyngeal dysphagia. 
In my opinion, and those expressed as responses to Teramoto and Kume et 
al’s 2002 letter to the editor (Mokhlesi, 2002; Morice, 2005), the use of The 
Swallow Provocation Test to detect aspiration, and the evidence which 
supports it should be viewed with caution. Furthermore, it is acknowledged 
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that visual analysis of the swallow provides the most valid method of 
assessing aspiration (Langmore, Terpenning, Schork, & Chen, et al., 1998).  
 
Surface Electromyography (SEMG)  
Surface electromyography (SEMG) uses basic electrodes attached to the 
surface of the skin to identify muscle activity. When placed submentally, the 
electrodes show activation of the anterior belly of the digastric, mylohyoid 
and geniohyoid muscles; with electrodes placed above the thyroid cartilage 
showing activity from the thyrohyoid muscles (Reimers-Neils, Logemann, & 
Larson, 1994). SEMG then gauges the vertical excursion of the submental 
and infrahyoid muscles to indicate a swallow has occured. In a study of five 
healthy adults using this technique, Reimers-Neils and Logemann et al 
(1994) found submental muscle activity initiated 85% of swallows observed; 
whilst infrahyoid muscle activity terminated 72% of swallows.  
This technique has been acknowledged to be a potentially useful adjunct to 
traditional bedside evaluations (Gupta, Reddy, & Canilang, 1996). It is cost 
effective, less invasive and easier to administer at bedside. However SEMG 
assessment excludes the oral preparatory and oral stages of the swallow, 
and is difficult to differentiate between true swallow activity and mastication 
movements or laryngeal bobbing. Furthermore, the assessor is must assume 
pharyngeal dysfunction without visual confirmation; and unable to comment 
on the physiology of the nature of the dysphagia (Martin-Harris, Brodsky, 
Price, & Michel, et al., 2003). As with SPT discussed earlier, the study in this 
thesis requires objective measures to visually confirm the oral and 
pharyngeal stage of the swallow and the nature of the respiratory-swallow 
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pattern. Therefore SPT and SEMG were discounted as potential 
methodolgies for this study. 
 
Fibreoptic Endoscopic Evaluation of Swallow (FEES) 
Fibreoptic endoscopic evaluation of swallow (FEES) uses a nasendoscope to 
view the nasopharyngeal and laryngeal anatomical structures (Langmore, 
2003). It shows the anatomy and swallow events pre and post the 
pharyngeal stage, however it is unable to assess the oral stage of the 
swallow, and creates a ‘white out’ phase during swallow apnoea; thereby not 
visualising function during the swallow (Logemann, Rademaker, Pauloski, & 
Ohmae, et al., 1998). This technique is considered a valid tool for assessing 
saliva management, and detecting any penetration and aspiration of a bolus 
or pharyngeal residue; with the latter reported as greater severity during 
FEES when compared with videofluoroscopic assessment (Kelly, Leslie, 
Beale, Payten, & Drinnan, 2006). The FEES equipment is portable and able 
to be conducted at bedside, and should include a multidisciplinary team. This 
includes a Speech and Language Therapist competent in conducting the 
evaluation (Kelly, Hydes, McLaughlin, & Wallace, 2007). As discussed in the 
previous sections, the research objectives of the study detailed in this thesis 
require visual assessment of the oral and pharyngeal stages during the 
swallow simultaneously with respiratory-pattern assessment and recording to 
later analyse inhalation/exhalation patterns surrounding the swallow. 
Additionally, FEES equipment was not available to the research team at the 
time of data collection, nor was any of the research team trained in using this 
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technique. Therefore FEES was considered unsuitable for the study in this 
thesis. 
Videofluoroscopy 
Videofluoroscopy (VF) is currently the predominate method for assessing 
oropharyngeal dysphagia, and visualise and analyse swallows  (Martin-
Harris, Brodsky, Michel, & Ford, Walters, et al., 2005; Swigert, 2007; Frowen, 
Cotton, & Perry, 2008). Videofluoroscopy is conducted in the radiology suite, 
and provides visualisation of oral and pharyngeal stages of the swallow; 
identifying any underlying abnormality in the biomechanics of the swallow as 
well as visualising any penetration and/or aspiration of the bolus. It takes 
approximately 15 minutes, with an estimated total x-ray dose 1.22 mSv per 
session (Crawley, Savage, & Oakley, 2004). This is equivalent to 
approximately 14 months natural background radiation. The Health 
Protection Agency Radiation Protection Division describe a ‘few year’s 
natural background radiation’ as ‘Low Risk’, with 1:10,000 to 1:1,000 lifetime 
additional risk of cancer (Health Protection Agency, accessed online 2006). 
Patients are unlikely to identify any health detriment from their participation in 
the study. The potential radiation detriment resulting from this study was 
therefore deemed appropriate for the purposes of the study detailed in this 
thesis.  
The use of videofluoroscopy allows the professional (researcher or clinician) 
to assess the biomechanical swallow process. The disadvantage is that the 
radiology suite does not provide a ‘natural environment’. For example, 
videofluoroscopy assesses each swallow in ‘a moment in time’ within the 
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confines of a radiological suite. Videofluoroscopy is able to provide 
information on the anatomical structures and physiology, but unable to 
identify any sensory changes. There is little research in exploring the impact 
that the technology has on changing the performance of the patient, or 
interfering with the overall process. For example the patient may not like the 
taste of a trial bolus and therefore alters the movement and duration of the 
oral stage. Additionally, there is little evidence on the degree of error of 
recordings. Furthermore, videofluoroscopes vary in age and clarity, but no 
known studies have explored the relationship between clarity of the image 
and missed penetration/aspiration. 
Both FEES and VF aim to identify the nature of biomechanical dysphagia, 
however videofluoroscopy allows visualisation of the oral stage and 
pharyngeal stage physiology, and therefore was chosen as the ‘best 
available’ tool to assess the biomechanical swallow in this study, with its 
limitations being recognised. 
 
4.3.3v) Justification for Respiratory-Swallow Pattern analysis tool 
This study required unobtrusive measurements of the respiratory phase 
surrounding the swallow to investigate the impact of an altered respiratory-
swallow pattern on swallowing ability during stable and exacerbation phases 
of COPD adults; concurrently with videofluoroscopy assessment. The two 
main techniques to assess respiration are via direct airflow (oral or nasal) or 
indirectly called respiratory effort, which measures lung inflation (chest wall 
or abdomen excursion). A review of techniques to record respiration during 
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swallowing found measuring the respiratory-swallow pattern by indirect 
methods alone inadequate due to artefactual movement in the readings. 
(Tarrant, Ellis, Flack, & Selley, 1997). This review concluded nasal airflow 
combined with chest excursion provides the most accurate readings for 
swallowing related research.  Intranasal pressure measurement combined 
with plethysmography has been used in other respiratory-swallow pattern 
studies, as outlined in chapter three (Dozier, Harris, Brodsky, & Michel, et al., 
2006; Kelly, Huckabee, Jones, & Carroll, 2007; Cvejic, Harding, Churchward, 
& Turton, et al., 2011). The nasal transducer measures exhalation by 
increased pressure due to flowing air, and inhalation by decreased pressure. 
Chest excursion is measured through two bands worn across the chest  
where combined signals give measures of tidal volume. The use of both 
nasal and chest plethysmography decreases the possibility of lost data due 
to mouth breathing, and also corroborates the direct and indirect measures.  
The equipment recording the respiration phase data needed to be portable, 
compact and non invasive for the subject and to the radiology equipment. 
The Limited Polysomnogram (LPSG) was selected as it is non invasive and 
portable. For the purposes of this study, the LPSG was used to record 
respiratory traces before, during and after each swallow. The event marker 
on the LPSG was used to ensure the LPSG and videofluoroscopy were 
synchronised when recording the onset of the oral and pharyngeal stage of 
the swallow; for later anaylsis.  
Whilst the LPSG is a acknowledged as ‘gold standard’ practice in the 
assessment of sleep apnoea, there are no known publications documenting 
the LPSG machine to be used concurrently with videofluoroscopy. However 
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the principles of what it measures have been widely measured in 
combination with swallow in patients with COPD (Shaker, Ren, Townsend, & 
Dodds, et al., 1992; Gross, Atwood, Ross, & Olszewski, et al., 2009; Gross, 
Atwood Jnr, Grayhack, & Shaiman, 2003; Cvejic, Harding, Churchward, & 
Turton, et al., 2011). 
 
4.4 Feasibility and Piloting 
Feasibility and piloting was originally part of the modelling phase in the MRC 
(2000) framework, and was revised in 2010 to become a separate stage. 
This stage includes preparatory work on areas such as testing procedures 
for their acceptability and validity; and may be paper based or qualitative 
testing, such as the use of preliminary surveys. Each of the key components 
are now discussed within this stage. 
 
4.4.1 Self report dysphagia symptoms and quality of life (QOL) 
Feasibility testing of the SWAL-QOL was conducted in order to evaluate the 
suitability of using the questionnaire on a British COPD population; not 
previously diagnosed with oropharyngeal dysphagia, as this does not appear 
to be previously researched; by the author of the SWAL-QOL, or within 
independent studies in the literature. Feasibility testing also allowed for a non 
intrusive prevalence estimate before embarking on the larger study; as 
sample size estimations were not available from the literature. Permission 
was gained from the author of the SWAL-QOL to use in this study (see 
Appendix 1). 
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4.4.1i) Aims of Feasibility Testing 
1. To evaluate ‘proof of principle’ before combining with more in-depth 
study. 
2. To test suitability of SWAL-QOL in a British COPD population, not 
previously diagnosed with oropharyngeal dysphagia 
 
4.4.1ii) Sample size 
Information was not available from the literature on the likely sample size 
required to estimate prevalence of swallowing difficulties in COPD. Therefore 
an estimate of expected proportion using a sample size of 35 was trialled 
(Julious, 2005), and this allowed an assumed prevalence of 10%. Initial 
sample size also allowed for a predicted return rate of questionnaires. 
 
4.4.1iii) Ethics and Clinical Governance 
Ethics and Clinical Governance approval was gained from the North 
Sheffield Research and Ethics Committee and Sheffield Research and 
Development in February 2005 (REC Reference number 05/Q2308/7) and 
April 2005 (STH Reference number STH13949) respectively (Appendix 2). 
As the population studied were not known to the researcher, ethics and 
clinical governance approval was granted on the stipulation I became 
involved only after written consent from participants was granted.  
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4.4.1iv) Method 
Mail out/Mail in cross sectional study. 
 
4.4.1v) Recruitment 
Sheffield Teaching Hospital (STH) Information Technology Department 
randomly selected 200 names from the 1 389 patients who were discharged 
from STH with a diagnosis of COPD in 2004. Cross matching was deemed 
necessary to ensure accurate identification of potential participants before 
initial contact, thus a COPD Specialist Nurse cross matched names with the 
COPD Supported Early Discharge Scheme computerised database to 
confirm a diagnosis of COPD. 
The respiratory consultants (in charge of the potential participant’s care) 
agreed to approach their clients via letter, inviting them to participate in the 
research project. The respiratory consultant mailed a participant pack 
(Appendix 3) to each of the selected COPD candidates, which contained: 
 A personalised letter signed by the respiratory consultant to invite the 
person to participate in a research project. 
 A client information letter describing the research project and what 
participating will involve 
 Self report questionnaire, the SWAL-QOL. Participants were encouraged 
to complete the comments section with the SWAL-QOL. 
 Contact numbers attached if they need assistance with completing or 
sending the pack, or for requesting further information.  
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 A consent form to sign for the questionnaire; use of their professional 
notes and informing their GP 
 A franked self-addressed envelope for returning the completed survey 
and consent form to the respiratory secretary. 
 
A second posting of the participant packs occurred after 14 days if there was 
no response. On confirmation of returned questionnaires and written 
consent, medical notes and questionnaires were reviewed against the 
inclusion/exclusion criteria and for missing data. 
Each returned pack was allocated a code and identifying information was 
removed and filed separately. The database of names was kept separate 
from the survey and consent forms, and filed in a lockable cabinet at the 
researcher’s workplace. Identifying information was destroyed on completion 
of the field test.  
 
4.4.1vi) Inclusion/Exclusion criteria 
Inclusion criteria were a primary diagnosis of COPD, admitted to STH under 
a Respiratory Consultant in 2004, and known to the COPD Supported Early 
Discharge scheme. 
Exclusion criteria were co-morbidities known to cause oropharyngeal 
dysphagia (neurological or oncological), not known to the STH Respiratory 
Consultant or the COPD Supported Early Discharge Scheme, or failure to 
consent. 
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4.4.1vii) Results 
Although 200 names were requested from the STH database, 299 names 
were supplied with 41 names being repeated. The COPD Supported Early 
Discharge Scheme Specialist Nurse matched 139 names that had accessed 
the Supported Early Discharge Scheme in 2004 and therefore had a 
confirmed diagnosis of COPD. Two respiratory consultants were unavailable 
to sign letters of invitation and send participant packs, resulting in 16 names 
being excluded. Participant packs were mailed to 123 people by seven 
respiratory consultants, with 46 (37%) surveys returned via the respiratory 
medicine secretary. From the returned surveys, 16 were excluded due to non 
consent (n=14), incomplete data (n=1) or co-morbidities (obtained from the 
medical notes) causing dysphagic symptoms (n=1). Information on the 
characteristics of the respondents was not available for all 30 participants 
included in the research group due to missing data in the questionnaire and 
medical notes. None of the research participants had a dysphagia 
assessment previously. Figure 6 shows a flowchart, illustrating the steps of 
the selection process and reasons for exclusion.  
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Figure 6: Flowchart of selection of SWAL-QOL field test research group. 
 
 
 
Characteristics of Respondents 
Biographical information of respondents; as summarised in table 9, revealed 
a median age of 75 years (35-90 years), and 42% respondents were male. 
Median BMI (n=23) was 23.4 (14- 37). A BMI of 20 or less was found in 22% 
of the sample. 
Of the COPD respondents classified into severity by their respiratory 
consultant (n=10), 40% were coded as mild and 60% coded as moderate 
COPD, with none of the respondents were classified as severe COPD. 
Names crosschecked by COPD 
Supported Early Discharge 
Scheme (SEDS). 
(n= 139) 
Excluded: 
Not known to COPD 
SEDS 
(n= 119) 
 
Letter of invitation and 
Participant Packs sent 
(n= 123) 
Excluded:  
Two Consultants 
unavailable to sign 
letter of invitation   
(n= 16) 
Returned SWAL-QOL 
Questionnaire 
(n=46) 
Excluded: 
SWAL-QOL not 
returned 
(n=77) 
 
Included into Field Testing 
Group: 
(n=30) 
Excluded: 
No consent (n=14) 
Incomplete (n=1) 
Comorbidities (n=1) 
 
 
Randomised names provided by STH PAS 
(n= 258) 
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Median hospital admissions due to chest related illness was one admission 
within the last six months (0-6 admissions).  
Self imposed modification of food was reported by seven (24%) respondents, 
in which they excluded harder to eat textures such as fried foods, toast and 
boiled rice. All respondents continued with normal drinks, and did not self 
impose thicker drinks such as tomato juice, yoghurt drinks to aid safety of the 
swallow (see section 2.6). 
Table 9: Summary of biodemographics of field test research group.  
Biographical 
Information 
 
N 
 
Descriptives 
Range 
(min-max) 
  
Age (Median) 
 
30 75 years        
 
35 - 90 
 
  
Gender Ratio 
Male:Female 
 
 
30 
  13:17  
 COPD Severity  
 
10 
 40% Mild 
 60% Moderate 
 
 Hospital Admissions  
 in last 6 months 
(Median) 
  
 
28 
 1.0 
 
0 - 6 
 
 Description of current 
intake 
                           Food  
 
                           Drinks  
 
 
30 
      
 24% self imposed  
 modified diet 
100% Normal fluids  
  
 
 Body Mass Index (BMI)  
(Median)  
 (normal range 20-25) 
 
 
23 
23.4 
 
14.6- 37.1 
 
 Ethnic Origin  
 
30 
 97% White British 
 3% Black   
 Caribbean 
 
 Marital Status 
 
30 
 47% Married 
 10% Single 
 37% Widowed 
 6% Divorced 
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4.4.1viii) Analysis of SWAL-QOL 
Analysis of the SWAL-QOL was divided in order to answer the aims of the 
field test. Firstly, proof of principle was explored by analysing each section 
against normative data provided in the development of the questionnaire. 
Secondly, qualitative responses were gathered to further explore the 
suitability of using the SWAL-QOL within a British COPD population. 
 
Proof of Principle 
The first aim of the field test was to determine whether people with COPD 
perceive symptoms of dysphagia which negatively impacts on their quality of 
life. Descriptives of the 30 questionnaires included in the study are 
summarised in table 10.  
Table 10: Descriptives of COPD SWAL-QOL field test scores by domain  
SWAL QOL Domain             
(Score range) 
N Median Range 
(min-max) 
Symptom (14-70) 26 61 28-70 
Burden (2-10) 30 10 2-10 
Food Selection (2-10) 30 9 2-10 
Eating Duration and 
Desire (5-25) 
29 23 5-25 
Fear (4-20) 29 18 7-20 
Fatigue (5-25) 26 13 5-25 
Mental Health (5-25) 30 25 7-25 
Social (5-25) 28 25 5-25 
Communication (2-10) 30 10 8-10 
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In order to investigate variation from a normal SWAL-QOL response and 
compare with answers from a dysphagic population, COPD results were 
compared with the reported historical normals and historical known 
dysphagics used for the development of the SWAL-QOL (McHorney, 
Robbins, Lomax, & Rosenbek, et al., 2002). This was achieved by converting 
each SWAL-QOL section Likert scale into a total scale score and then 
linearly converting into a percentage; as conducted in McHorney and 
Robbins et al’s (2002) study and shown in figure 7. A score of 100% 
indicates no perceived difficulty, and the lower the score the more perceived 
difficulty. Not all of the historical data was reported; therefore the sections 
Burden, Mental Health and Social have no comparative data. All COPD data 
(except the domains Communication and Food Selection) fell between the 
historical normal and historical dysphagia data. 
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Figure 7: COPD SWAL-QOL field test domains compared with historical controls (McHorney 
and Robbins et al, 2002). 
 
 
Suitability 
The second aim of the feasibility test was to explore the suitability of using 
the SWAL-QOL within a British population, not previously diagnosed with 
dysphagia. Invitation letters included a general request to add any comments 
throughout the questionnaire, or in the space provided at the back. All of the 
30 respondents included in the study made at least one comment about the 
study. Comments could be divided into two main themes; style of questioning 
and time taken to complete. 
45
50
55
60
65
70
75
80
85
90
95
100
S
c
o
re
 %
SWAL-QOL Sections
Historic Normals (Mean) (n=40) Historic Dysphagics (Mean) (n=386)
COPD (Median) from field testing
 151 
 
 Style of questioning:  The highest number of comments from included 
respondents (n=27) regarded the item stem. At the beginning of each 
section, the question asked ‘how often………as a result of your 
swallowing problem’. Some respondents (n=17) wrote at the top of the 
questionnaire that they did not have a swallowing problem. Of these 
respondents, five discontinued scoring some sections. However this was 
contradicted later in the questionnaire within the additional comments 
section, where statements were written such as ‘I don’t have a swallowing 
problem but… 
- ‘I choke on my saliva….’ (n=7) 
- ‘I can’t eat hard foods’ (n=5) 
- ‘I can’t swallow dry foods.....I chew and then.... spit them out’ (n=7) 
- ‘I cough on drinks’ (n=11).  
 
 Time taken to complete: The second highest number of comments (n=22) 
pertained to length of the questionnaire. McHorney and Robbins et al 
(2002) suggested the questionnaire should take approximately 14 
minutes to complete. Of the 22 comments, only one reported the time, 
stating it took 30 minutes to complete, whilst another reported ‘being 
bored half way through’.  
 
Rather than reduce the number of questions in each domain; which would 
affect the validity of scale, whole domains were omitted that were deemed as 
either not addressing the aim and objectives of the study detailed in this 
thesis, or difficult for patients with COPD to answer. The Fatigue domain was 
 152 
 
omitted from the final questionnaire, as eighteen subjects in field testing 
commented it was difficult to distinguish questions as a result of swallowing 
as opposed to their normal COPD symptoms. The Communication domain 
was also omitted, as this was not an aim for the study detailed in this thesis. 
This left six QOL domains and one symptom domain within the final 
questionnaire to be used in the study detailed in this thesis.  
 
4.4.1ix) Limitations of the field testing 
The most notable limitation of the field testing of the SWAL-QOL was the 
method of selecting the sample. Due to ethics and clinical governance 
stipulations, I was unable to access databases or medical notes before 
written consent from the participant was granted. Therefore I was required to 
access names via a Specialist COPD Nurse volunteering her time for the 
project, and a database that had confirmed diagnoses of COPD. The 
Supported Early Discharge Scheme used specific criteria for inclusion into 
the scheme which were; no medical complications, no radiological 
consolidation, and oxygen saturations greater than 90% on air. These criteria 
excluded clients who needed to stay in hospital for longer due to medical 
complications and severe pneumonia, and therefore would be classified as 
‘too unwell’ for the scheme. By using this database, 119 names provided 
from the original STH database were excluded from this feasibility testing; 
which would have included the more severe COPD client group.  Therefore 
the finding of the feasibility testing is likely to underestimate the prevalence 
of the burden of dysphagia in the hospital population of COPD patients 
overall. 
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The design of the research included personalised letters of invitation to the 
client by the known respiratory consultant, and franked, self addressed 
envelopes to enhance the response rate. However, the response rate still 
only achieved 37%. This was further reduced to 24% when questionnaires 
were excluded for non consent, missing data and co-morbidities. Low 
response rate may have been influenced by a number of factors. It may be 
due to general difficulties recruiting participants using a questionnaire, as 
patients who are unwell are less likely to participate. As this is an older 
population with mobility and respiratory difficulties, they may have had 
difficulties in completing or sending the survey. However the potential to 
assist the participants was hindered by the ethics stipulation of only 
becoming involved when signed consent was received via the respiratory 
department.  
 
4.4.1x) Conclusions of field testing 
The SWAL-QOL proved to be a useful tool to use for a British COPD 
population and produced coherent answers. Field Testing revealed 82% of 
respondents perceived some symptoms of oropharyngeal dysphagia, 
indicating further testing in this population was warranted.  
Comments from the respondents led to two modifications to the SWAL-QOL. 
Firstly, as the sample population had not been previously diagnosed with 
dysphagia, the stem item question for each section was changed from ‘how 
often………as a result of your swallowing problem’, to ‘as a result of your 
swallowing’. Secondly, to reduce time spent on completing the questionnaire, 
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only sections considered relevant to the study were retained to use in the 
larger study. 
 
4.4.2 Biomechanical swallow analysis 
The second key component requiring analysis is the biomechanical swallow. 
The Speech and Language Therapy Department in Sheffield Teaching 
Hospitals operates a weekly videofluoroscopy clinic to examine the 
biomechanics of swallowing in referred patients. Feasibility of using this as a 
tool for research purposes has already been established within the literature 
(discussed in chapters two and three) and in current clinical practice. I am 
one of the Speech and Language Therapists currently providing this service 
in the hospital, and therefore further feasibility testing for videofluoroscopy to 
be used as a tool for this study was not required. However, as the 
participants have not been referred for the service and are attending solely 
for the purposes of the research, feasibility testing was required to document 
patient flow through the research process, and issues such as cost 
implications and staffing issues as shown in figures 8 and 9.  
Agreement was granted from the STH Radiology and Speech and Language 
Therapy Departments to allocate two sessions per week for the sole purpose 
of this research. Each videofluoroscopy assessment was charged at £250 
per session, paid with grants received (see Appendix 13). The subject’s GP 
and relevant Staff at STH were consulted and agreed to the research 
pathway. Staff members consulted were from Speech and Language 
Therapy Department (such as Therapists, Assistants and Secretaries), 
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Emergency Admissions Unit (EAU) and acute wards (such as admitting 
Consultants, Nurses), Radiological Department (such as expert 
Radiographer, Receptionists and Nurses), Respiratory Outpatient 
Department (such as Respiratory Function Unit (RFU) Specialists, Nurses, 
Receptionists, Consultant), and other hospital staff (such as Porters, front 
desk Receptionists, taxi desk Receptionist, kitchen staff and the Hospital 
Volunteer Manager).  
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Figure 8: Pathway for research subject and corresponding researcher process  
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Figure 9: Pathway for control subjects and corresponding researcher process.  
 
 
4.4.3 Respiratory-Swallow Pattern analysis 
The final key component for feasibility and modelling was assessment and 
analysis of the respiratory-swallow pattern. The preparatory work required for 
this component consisted of testing the Limited Polysomnogram (LPSG) for 
its acceptability and validity within the design of the study detailed in this 
thesis. This was achieved by evaluating the accuracy of the respiratory 
traces on four volunteer staff members before ethics approval and 
recruitment phase of the study. These ‘practise sessions’ within the 
Respiratory Functions Unit at the Royal Hallamshire Hospital given by two 
respiratory physiologists also provided training on how to place the straps on 
the subject, ensuring battery checking and calibration occurs before starting 
SUBJECT PATHWAY RESEARCHER PROCESS 
 Meeting with Hospital Volunteer 
Manager 
 Provided 50 ‘volunteer envelopes’ 
Hospital Volunteer Manager 
invited Volunteers to participate 
 
No Consent 
Anonymous completed forms 
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 Hospital Volunteer 
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 Ensure volunteer data meets 
control group inclusion criteria 
 Analyse data 
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‘Volunteer Envelopes’ 
containing: 
1. Information Leaflet and 
contact details of researcher 
2. SWAL-QOL 
3. Biographical questions 
4. Stamped self addressed 
envelope (SAE) 
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the assessment, pressing the event marker for each oral and pharyngeal 
stage of the swallow, and downloading the information from the hand held 
machine onto the computer programme for later analysis. Data from the 
resting respiration, saliva swallows and bolus swallows from the four 
volunteer staff members were then interpreted for clinical validity. The 
respiratory traces for twenty swallows were analysed; with the duration of 
each swallow’s respiratory trace elongated to visualise when inhalation or 
exhalation occurred more easily. Each respiratory-swallow pattern showed a 
clear rise when inhalation occurred and decline for exhalation for the ‘effort’ 
of chest excursion (chest straps); and a clear decline when inhalation 
occurred and rise when exhalation occurred for airflow measures (nasal 
cannulae).  These respiratory traces surrounding a clear swallow apnoea, 
represented as a plateau on the respiratory trace; showing no detected chest 
excursion or airflow. Event markers successfully indicated the initiation of 
either the oral of pharyngeal stage of the swallow, providing further 
confirmation of when the phase of the swallow occurred with reference to the 
respiratory trace. The LPSG was therefore deemed suitable for the purposes 
of the study detailed in this thesis. 
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4.5 Evaluation 
The revised MRC (2010) guidelines emphasize the importance of choosing 
the right study design to suit the aims and objectives of the research. 
However it also stresses the importance of randomisation and clinical trials.  
In the case of this research, a full- scale randomised study is unjustified as 
proof of principle evidence is still required, as shown previously in the 
theoretical stage. Chapter five details the methods undertaken to 
demonstrate the prevalence of key components within patients with COPD; 
with chapter six reporting the results and chapter seven discussing outcomes 
of the evaluation stage alongside other stages of the MRC framework. 
 
Summary of use of MRC Framework in this thesis 
The revised MRC Framework for Development and Evaluation of Complex 
Interventions (2010) allows for a general model for the study detailed in this 
thesis to follow. Although the framework tends to focus on randomised 
controlled clinical trials, it has recently highlighted the importance of proof of 
principle studies requiring alternative study designs. This research thesis 
focuses the development, feasibility and evaluation stages to gain evidence 
to support the aim of the study. 
The limited research exploring dysphagia in COPD has been documented 
between grades B and D (discussed in section 2.8.1) (O'Kane & Groher, 
2009). Identification of the nature of a disorder within a disease (such as 
oropharyngeal dysphagia with COPD) has been shown more appropriately 
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with cross sectional study methodology (Sackett, Rosenberg, Gray, & 
Haynes, et al., 1996).  
 
4.6 Ethical considerations 
Assessing the same research subject during the stable and exacerbation 
phase reduced confounding variables to determine the effect of different 
phases of the disease. The study detailed in this thesis would have benefited 
from using a case control research design; including controls for each 
objective as seen in Cvejic and Harding et al (2011). However ethical 
stipulations for the study in this thesis required the control group to complete 
only objective one of the study (SWAL-QOL). 
Interventions were not withheld for this study, as, generally speaking, COPD 
patients are not recognised at being at risk of aspiration and hence not 
assessed. It is more likely therefore that participation in the study will 
increase recognition of problems and lead to additional treatment rather than 
the converse. One purpose of this study was to obtain true prevalence, 
therefore raising awareness and providing appropriate referral criteria. 
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4.7 Limitations  
The study detailed in this thesis was limited by the ability of the subject to be 
adequately mobile to attend the videofluoroscopy clinic session. If subjects 
were deemed medically too unwell to be able to attend videofluoroscopy, this 
automatically excluded the severe end of the COPD population. Follow-up 
during the stable phase was reduced due to subjects not reaching a ‘stable’ 
state of their disease during the data collection period of time. Four 
participants required multiple hospitalisations during this time and were 
considered too unwell to continue, and are discussed in more detail in 
chapter seven.  
Recruitment was required to be within 48 hours before the allocated 
videofluoroscopy timeslots to ensure maximum exacerbative phase 
assessment. Although this arrangement was reviewed, it reduced potential 
recruitment to fall within two days per week; and within the hospital 
containing the videofluoroscopy unit. Whilst potentially limiting total 
recruitment this strategy allows maximum sensitivity for the detection of 
differences between exacerbation and stable phases of COPD. 
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4.8 Summary of chapter 
The three key components identified as active ingredients in this study; 
patient perception of swallowing impairment and swallowing related quality of 
life, biomechanical swallow and respiratory-swallow pattern, have been 
discussed within the stages of the MRC framework. Although the content of 
the study is new and innovative, the measures justified in this chapter to be 
used for obtaining the research aim and objectives have long been 
acknowledged as suitable means for research; with videofluoroscopy 
considered to be a ‘gold standard’ technique.  Measures were considered 
‘best available that would yield useful results’ (Medical Research Council, 
2010).   
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Chapter Five 
 
Methods 
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Chapter Five: Methods 
5.1  Introduction 
The ‘Evaluation stage’ of the MRC Framework; as discussed in chapter five, 
describes choosing a research design to suit the research question. This 
chapter details the relevant methods employed to explore the objectives of 
this study. 
 
5.2  Ethics and Clinical Governance 
Ethical approval was gained from the North Sheffield Local Research Ethics 
Committee (REC Reference number 07/Q2308/32), and Sheffield Teaching 
Hospitals NHS Foundation Trust Research and Development Department 
(Reference Number STH14598) in May 2007 (Appendix 4).  
The application to the Ethics Committee originally included identical 
assessments for the normal healthy control group and the research group. 
However the Ethics Committee did not approve inclusion of the normal 
healthy control subjects in the videofluoroscopy and respiratory analysis for 
this study, but allowed them to complete the questionnaire. The Ethics 
Committee further stipulated that I was required to recruit normal healthy 
controls indirectly. As the control group was intended to be recruited from 
hospital volunteers, their line manager agreed to provide the invitation letter 
and participation pack once consented.  As potential research subjects were 
also not known to Speech and Language Therapy prior to the study, the 
Ethics Committee also stipulated consent must be taken by the respiratory 
consultant before I approached the research subject with further information 
on the study.  
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5.3 Study Design 
This study used a prospective, repeated measures observational design; 
with a cross sectional control stage. Table 11 summarises the key elements 
of the research design by study objective, including measures used within 
each objective. 
Table 11:  Study design by research objective.  
 
Objective 
 
Objective 1 
 
 
Objective 2 
 
Objective 3 
 
 
Measure 
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Normal Healthy Control Group √ X X 
COPD 
 
Exacerbation 
Phase  
√ √ √ 
Stable Phase √ √ √ 
SWAL-QOL(ab)= abridged version of SWAL-QOL  
 
5.4 Sample Size  
There was no previously published research at the time of protocol 
development to base a power calculation to estimate sample size in order to 
gain statistical significance. Feasibility testing discussed in chapter four 
revealed 82% (n=30) of COPD subjects perceived some level of dysphagic 
symptoms. Therefore the sample size determined for this study of 12 per 
group was justified on feasibility and precision around the estimates (Julious, 
2005). It was judged that this should be sufficient to have reasonable 
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estimates of means and confidence intervals, and allow estimates to be used 
in future larger studies.  
 
5.5 Recruitment and Consent 
5.5.1  Research Group 
Recruitment into the research group was conducted during admission to the 
Royal Hallamshire Hospital, Sheffield Teaching Hospitals (STH), Sheffield 
U.K., and presenting with acute exacerbation of COPD. Potential subjects 
were identified by a respiratory consultant (Dr R.L) in the Emergency 
Admissions Unit (EAU) or on the ward within 24 hours of admission. Once 
each subject met the inclusion criteria (detailed later) and consented for the 
study, I approached the subject and provided a detailed explanation of what 
the study involved. A letter of invitation and information leaflets were 
provided (see Appendix 5), and the potential subject was given time to read 
the leaflets and discuss with family. I returned within 24 hours to gain written 
consent and ensure they were medically appropriate for the assessment. 
Consent was gained at the start of the investigation for the entire 
assessment procedure; however confirmation of consent was gained before 
each videofluoroscopy. The subject remained under the active care of Dr 
R.L. throughout the study. Once consented, the subject’s General 
Practitioner (GP) was notified of the subject’s inclusion and details of the 
study; and requested the GP confirm the subject’ s suitability for 
videofluoroscopy, and provide current medication lists and number of 
antibiotic treatments within the last six months (see Appendix 6).  
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5.5.2 Control Group 
Volunteers from the Sheffield Teaching Hospital Volunteers organisation 
were invited to participate as part of the control group of this study. Due to 
Ethic Committee requirements, recruitment was conducted via the Volunteer 
Hospital Manager, and information packs (Appendix 7) were distributed 
during an unrelated social event. Potential subjects were asked to complete 
the questionnaire ‘if they did not have a past medical history of smoking, 
neurological condition, and/or head and neck surgery’. 
 
5.6 Inclusion Criteria 
Inclusion and exclusion criteria are discussed by research and control group. 
The research group is further divided by exacerbation and stable phase. 
Criteria used for this study is summarised in table 12. 
 
5.6.1 Research Group 
General inclusion criteria for research group subjects were a confirmed 
primary diagnosis of COPD and under an STH Respiratory Consultant’s 
active care (Dr R.L.).  
5.6.1i) Exacerbation Phase 
Potential COPD subjects were included in the exacerbation phase of the 
study if their condition met with the general inclusion criteria as judged by Dr 
R. L., and had two out of three of:  
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 increased sputum,  
 increased breathlessness and fever,  
 required treatment with oral steroids and/or antibiotics following 
assessment in hospital. 
 
5.6.1ii) Stable Phase 
COPD subjects were included in the stable phase of the study if their 
condition was deemed ‘clinically stale’; that is no change in daily symptoms 
or medication use for six weeks. This was assessed by Dr R.L. before 
commencement of the second assessment phase of the study. 
 
5.6.2 Control Group 
Subjects were included into the normal healthy control group if considered fit 
and healthy with no co-morbidities causing dysphagia. Consent was implicit 
with returning a completed SWAL-QOL questionnaire. At the time of handing 
out the questionnaires, they were asked to complete the questionnaire if they 
did not have a history of neurological conditions such as stroke or had a 
history of smoking. The questionnaire also included a section on background 
information with specific questions on past medical history and smoking 
status to ensure control subjects met the inclusion criteria (see Appendix 8). 
5.7 Exclusion criteria 
5.7.1 Research Group 
Subjects were excluded if they were: 
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 non consenting  
 cognitively impaired (acute or chronic) 
 deemed to have a co-morbidity causing dysphagia (e.g. stroke, 
neurodegenerative conditions such as multiple sclerosis, motor 
neuron disease, Parkinson’s disease), or previous head and neck 
cancers incorporating the oral cavity or pharynx.  
 not known to Respiratory Consultant (Dr R.L.) 
 unable to tolerate videofluoroscopy procedure 
Subjects were also excluded during the study if their condition became 
immediately life threatening; required ventilatory support or supplemental 
oxygen that could not be adequately delivered by nasal cannulae.  
 
5.7.2 Control Group 
Subjects were excluded if consent was not gained, questionnaires not 
returned, or if biographical information included co-morbidities that may 
cause dysphagia, a history of smoking, or they documented any relevant co-
morbidity in the ‘other’ section in the biographical section.  
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Table 12: Summary of inclusion and exclusion criteria.  
 
INCLUSION CRITERIA EXCLUSION CRITERIA 
COPD 
Subjects 
 Consent given 
 Confirmed diagnosis of COPD 
 Under care of Respiratory 
Consultant Dr R.L. 
 Meets Exacerbation/Stable 
criteria 
 
 
 No consent  
 Decreased cognitive ability 
 Co-morbidities causing 
oropharyngeal dysphagia 
 Unable to tolerate 
Videofluoroscopy procedure 
 Deteriorated medical status 
Normal 
Healthy 
Control 
Subjects 
 Consent given 
 Considered fit and healthy 
 
 No consent 
 Questionnaire not returned 
 History of smoking 
 Co-morbidities causing 
oropharyngeal dysphagia 
 
5.8 Assessment Procedure 
This section details the assessments conducted for the research and control 
group and is summarised in figure 10. 
Figure 10: Subject flowchart through assessment procedure.  
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Control Subjects 
Exacerbation 
Phase 
SWAL-QOL(ab) 
Videofluoroscopy 
LPSG 
Biographical  
 
Stable Phase 
 
SWAL-QOL(ab) 
Videofluoroscopy 
LPSG 
Biographical  
 
 
SWAL-QOL(ab) 
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5.8.1  Research Group 
The assessment procedure for both the exacerbative and stable phase 
assessments was identical for the research group.  During each session, 
subjects completed the abridged SWAL-QOL (Appendix 9). Severity of 
COPD was further described by level of dyspnoea via the Dyspnoea Visual 
Analogue Scale (VAS) and Modified Borg Scale (see Appendix 10) in the 
radiology waiting area before entering the videofluoroscopy suite. Once in 
the radiology suite, the Limited Polysomnogram (LPSG) was positioned; 
respiratory strap around the chest, above the subject’s shirt/dress (for chest 
excursion) and nasal prongs (for respiratory flow)  
The subject was positioned in a sitting position, lateral to the radiology cone.  
I stood alongside the volunteer (using a lead apron and thyroid shield) for 
reassurance, to pass the volunteer each trial bolus, and to press the event 
marker button to record each oral and pharyngeal stage on the LPSG output 
for later analysis (as discussed in section 4.4.3). Figure 11a) and b) show an 
example set up (not actual subject) in the radiology suite. In these photos, 
the LPSG machine is attached to the front of the chest excursion strap, 
however, during actual assessment, I held the LPSG machine in order to 
press the event marker button to coincide with oral and pharyngeal stages of 
the swallow on videofluoroscopy. The LPSG machine was calibrated before 
each session to ensure accurate readings, and the respiration traces were 
continuous throughout the videofluoroscopy period. 
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Figure 11: Example set up of a) Speech therapist positioning and b) subject ready for 
videofluoroscopy and LPSG trial.  
   a)          b)  
Videofluoroscopy conformed to standard procedures as set out by 
Logemann (1993) and Ionising Radiation (Medical Exposure) Regulations 
(IRMER) (Department of Health, 2007). The radiological image was 
consistently set to include a lateral view of the subject’s lips, tongue and 
alveolar ridge anteriorly; cervical spine posteriorly; nasopharynx and the 
upper one third of the trachea, to the level of C6-C7. E-Z-HDTM Barium 
Sulphate was used for all procedures and was mixed with water to form a 
liquid suspension, before adding to water for drink trials, or thick puree 
consistency to add on bread for solid trials.  The videofluoroscopy started 
recording when the bolus reached the lips, and continued to observe any 
follow-up swallows. The image was recorded at 30 frames per second on a 
Maxwell DVD for later analysis. The recordings were labelled with subject 
identification numbers to ensure anonymity.   
Each subject was required to swallow six 10 ml barium water units (three 
units before and after the bread trials), considered equivalent to the 
consistency of ‘thin fluids’, and three 1/8 barium coated white sliced bread 
units. Ten ml bolus size was chosen to discourage piecemeal deglutition 
(Perlman & He, 2006) and ensure wider upper oesophageal sphincter 
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opening (Logemann, Pauloski, Rademaker, & Kahrilas, 2002). The fluids 
were presented via a small medicine cup per bolus trial and 1/8 sliced white 
bread with barium coating per trial. Subjects were instructed to drink or eat 
normally when ready to reduce effects of command on the swallow (Daniels, 
Schroeder, DeGeorge, & Rosenbek, 2006). 
Sessions occurred at the same time of day (midday) for each assessment to 
increase sensitivity of the results. This aimed to reduce any diurnal 
complications such as fatigue or changes in thirst or hunger. Subjects were 
seated during assessment, to relax and assess in a ‘normal’ posture for 
mealtime. 
Each session lasted approximately 30 minutes to complete the SWAL-
QOL(ab) questionnaire, videofluoroscopy and respiratory assessment. 
Biographical and medical history were documented from each subjects’ 
medical notes. Current medication and number of antibiotic treatments were 
gathered from their General Practitioner.  
 
5.8.2 Control Group 
The control group was recruited from the Sheffield Teaching Hospitals 
volunteer service by their Line Manager using the inclusion and exclusion 
criteria described previously. Each potential subject was given a pack which 
included a letter of invitation, information sheets on the study, SWAL-QOL(ab) 
questionnaire and a self addressed envelope. Completed SWAL-QOL(ab) 
questionnaires were returned anonymously through internal hospital post, 
franked self addressed envelope or via the Volunteer Manager.  
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Due to Ethics Committee restrictions, the control group were not approached 
by anyone related to the study; nor underwent videofluoroscopic, respiratory 
or medical note investigations.   
 
5.9 Data Collection  
5.9.1 Research Group 
Data was collected from three main sources to meet the aim and objectives 
for this study during exacerbation and stable phase of COPD from the 
research group:  
 self report answers from abridged SWAL QOL questionnaire 
 videofluoroscopy assessment for objective biomechanical analysis of 
swallow 
 respiratory assessment (LPSG) for respiratory-swallow pattern 
analysis 
General information to describe the research subjects’ respiratory status 
;dyspnoea visual analogue scale and Modified Borg scale was completed 
before each videofluoroscopy assessment. All data was coded to ensure 
anonymity and destroyed once data analysis was completed. 
 
5.9.2 Control Group 
Data was collected from answers from completed and returned SWAL-
QOL(ab) questionnaires. 
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5.10  Data Analysis 
All data was analysed using descriptive and quantitative methods, using a 
statistical package (SPSS for Windows, version 14). The data was duplicated 
onto the package to highlight any inputting errors, to be corrected before 
analysis was initiated. I completed all of the analysis with supervision and 
advice provided by the University of Sheffield, School of Health and Related 
Research (ScHARR) statistical support (Prof M.C. and Dr G.Y.). 
As the data was not normally distributed, non parametric tested was used. 
Mann Whitney U Tests were used to investigate the difference between two 
independent data sets (Normal Healthy Controls versus Stable COPD), and 
Wilcoxon Signed Rank Tests were used to investigate two related sets of 
data (Stable versus Exacerbation COPD). 
 
5.10.1  Swallowing related Quality of Life (QOL) 
Each SWAL-QOL(ab) total scale score was converted into a percentage, and 
compared between subjects; against normal healthy scores, and within 
subjects; by phase of COPD. The results in this section provided information 
for objective one of the study. Two important questions to be answered in 
this section are:  
 Is there a perceived difference of dysphagia symptoms and 
swallowing related quality of life between ‘normal healthy’ and 
by phase of COPD?  
 Is there a perceived difference of dysphagia symptoms and 
swallowing related quality of life between stable and 
exacerbation phases of COPD?  
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If normal healthy swallows differ from stable phase swallows, and stable 
phase swallows differ from exacerbation phase swallows, then logic leads to 
believe exacerbation phase swallows differ from normal healthy swallows. 
 
5.10.2 Biomechanical Analysis 
Videofluoroscopy recordings scored for one primary event (overall 
dysphagia) and three secondary events (penetration, aspiration, 
spontaneous compensatory strategies), to meet objectives two and 2a of the 
study. Videofluoroscopies were scored using an analysis sheet, with 
penetration and aspiration also rated using Rosenbek and Robbins et al’s 
(1996) scale (see Appendix 11). Videofluoroscopy data was scored 
dichotomously. Whilst it is acknowledged that this approach reduces the 
richness of data, information in this preliminary stage of investigation was 
required to be condensed for the purposes of addressing the main objectives 
set out in the study detailed in this thesis and provide information on 
prevalence. Thus, three important questions to be answered by this section 
are: 
 Are people with COPD dysphagic, compared with  normative data 
found within the literature? 
 If so, what is the nature of the dysphagia? 
 If so, is there a difference found between stable and exacerbation 
phases of COPD? 
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5.10.2i)  Overall Dysphagic 
A swallow was considered overall dysphagic if either of the oral or 
pharyngeal stages were shown to be disordered on videofluoroscopy for food 
and/or drink. Types of dysphagic characteristics were documented in chapter 
two. 
 
5.10.2ii) Penetration 
A swallow was scored as penetrated if a food or drink bolus entered the 
airway above or to the level of the vocal cords; before, during or after the 
swallow was initiated, as discussed in chapter two. Evidence of penetration 
was scored using the Rosenbek and Robbins et al (1996) penetration- 
aspiration scale; where a score of three to five (indicating increased depth 
and amount of penetrated bolus) would indicate a dysphagic characteristic 
as discussed previously in section 2.3.3.   
 
5.10.2iii) Aspiration 
A swallow was scored as aspirated if a food or drink bolus entered the 
airway, and continued past the true vocal cords towards the lungs with or 
without the presence of a reflexive cough; before, during or after the swallow 
was initiated, as discussed in chapter two. This would score between six and 
eight using the Rosenbek and Robbins et al (1996) penetration- aspiration 
scale, and either score would be considered dysphagic as discussed 
previously in section 2.4.3. 
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5.10.2iv) Spontaneous Compensatory Strategies 
The swallow was coded as using spontaneous compensatory strategies if 
the swallow physiology contained movements or postural changes; 
considered as additional or altered from the known normal swallow 
physiology. A swallow was coded as using a spontaneous compensatory 
strategy if: 
 more than three swallows was used to clear a 10ml water bolus or 1/8 
slice of bread from the oral cavity 
 Chin tuck during the swallow 
 Head tilt to either side to aid flow of bolus in oral cavity 
 Head turn to either side to direct bolus flow towards opposite side of 
pharynx 
 Early laryngeal elevation and closure, before initiation of pharyngeal 
stage 
 Extended breath holding pre or post swallow 
 Multiple swallows during breath hold 
5.10.3 Respiration-Swallow Pattern Analysis 
Respiratory-Swallow patterns were recorded simultaneously with 
videofluoroscopy using a Limited Polysomnogram (LPSG). Recordings were 
later transferred to the Respiratory Functions Unit computer, coded using 
identification numbers, and analysed using the Stardust program. Relevant 
data was then transferred onto SPSS and analysed to meet objectives three 
of the study. Two important questions answered in section are: 
 What is the most common respiratory-swallow pattern used in COPD? 
 Does the respiratory-swallow pattern alter during exacerbative phase 
COPD? 
 Is there a difference between food and drink swallows? 
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5.10.3i)  Swallow Apnoea  
Swallow apnoea duration was measured by the length in time of zero effort in 
chest excursion, and zero flow from nasal cannulae LPSG readings during 
the swallow.  
 
5.10.3ii) Respiration-Swallow Pattern 
The LPSG recorded resting respiration, and changes in respiration before, 
during and after the swallow. Airflow was measured by identifying the 
direction of the respiratory/effort traces before and after each swallow 
apnoea as discussed in section 4.4.3. The event markers recorded on the 
readings delineated the onset of the oral and pharyngeal stage of each 
swallow, allowing analysis of respiratory status and oxygen saturation before, 
during and after the swallow, and recorded on a respiratory phase scoring 
sheet (see Appendix 12). This allowed for cross checking videofluoroscopy 
and respiratory data to ensure accurate timing of readings. 
5.10.4 Correlational data analysis 
Data from the primary event ‘Overall Dysphagic’ from biomechanical analysis 
was compared to the SWAL-QOL(ab) symptom section and inhalation post 
swallow respiratory-swallow pattern to meet objectives 2b and 3a 
respectively. Two important questions answered in these sections are: 
 Are perceptions of swallow symptoms more likely occur with 
biomechanical objective ratings of ‘overall dysphagic’?  
 Are ‘overall dysphagic’ characteristics more likely to occur as a result 
of using inhalation post swallow? 
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5.11  Reliability 
5.11.1 SWAL-QOL(ab) 
Scores for the SWAL-QOL(ab) were inputted twice into the SPSS package to 
highlight any inputting errors, which were corrected before statistical analysis 
was carried out. 
 
5.11.2 Biomechanical analysis 
All of the videofluoroscopy data was analysed by the researcher (SLT 1). 
Five videofluoroscopy recordings were viewed by three independent 
experienced Speech and Language Therapists (SLT 2- 4) with an average of 
five years experience; who were blinded to the study.   
 
5.11.3  Respiratory-swallow pattern analysis 
Training was provided by two respiratory function unit physiologists (C.B. and 
A.P.) in using the LPSG machine, and downloading and interpreting data. 
The first ten swallows were analysed by me and the two physiologists, until 
100% agreement was obtained. Thereafter, at least one of the physiologists 
reviewed a further 30% of swallows, ensuring 100% agreement with my 
analysis. 
5.12 Analysis ‘Per Subject’ versus ‘Percentage of Swallows 
Per Subject’ 
Videofluoroscopy and respiration-swallow pattern data was analysed per 
subject, and by percentage of swallows per subject. Reporting results per 
subject provided an estimate of prevalence within the research group; 
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however it reports only the majority of events, as only dysphagic events and 
respiratory-swallow patterns occurring 50% or more of the time are included 
by this technique. Therefore clinically relevant information from each subject 
who showed greater variability; resulting in dysphagic events or respiratory-
swallow pattern occurring less than 49% of the time, was not being reported. 
This is overcome by recording by percentage of swallows per subject. This 
provides clinically relevant information on the variability utilised by each 
subject, and allows for more clinically significant information when 
investigating swallowing and respiratory-swallow pattern.  
 
5.13  Summary  
The study detailed in this thesis used a prospective, repeated measures 
observational design; incorporating a cross sectional control phase. 
Measures were analysed using descriptive and quantitative methods, 
suitable to meet the aim and objectives of the study. Findings from the study 
are reported in the next chapter. 
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Chapter Six 
 
Results 
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Chapter Six: Results 
6.1 Introduction  
This chapter presents the results from the study detailed in this thesis. 
General descriptives and demographical information of the sample 
population are provided initially, followed by further statistical analysis 
reported by study objective.   
 
6.2 General Descriptives  
6.2.1 Research pathway  
Recruitment for the study occurred between May 2007 and March 2008. 
COPD subjects were considered as potential candidates for the study if they 
were admitted to the Royal Hallamshire Hospital (RHH), Sheffield on 
Wednesdays and Thursdays each week. This time period was used to 
ensure subjects were within 48 hours of exacerbation phase before 
videofluoroscopy assessment was conducted as allocated sessions were on 
Fridays. Allocated videofluoroscopy times were increased in September 
2007 to include Thursday sessions, thereby allowing recruitment to extend to 
Tuesdays to Thursdays.  
During the recruitment period, 4 764 people with COPD were discharged 
from any of the Sheffield Teaching Hospitals, with 1 165 people being 
discharged from The Royal Hallamshire Hospital (RHH). Of those who were 
discharged from RHH, 138 patients were coded as ‘acute exacerbation of 
COPD’, ranging between three and 13 discharges a month during the data 
collection phase. Of the 138 patients admitted to RHH presenting with an 
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acute exacerbation of known COPD, 39 patients were admitted into hospital 
within the allocated timeframe; with 23 potential subjects meeting the 
inclusion criteria. Of the 23 patients, five potential subjects did not consent at 
the first stage, and three agreed to discuss the research further, however did 
not consent to the research. Therefore fifteen subjects were initially 
consented; with one subject withdrawing consent midway through the 
exacerbation phase assessment and therefore was not included within the 
final analysis. Thus 14 subjects completed ‘Assessment One’ of the study, 
with ten subjects meeting the criteria to be followed up in stable phase to 
complete ‘Assessment Two’.  
 
Fifty participant packs were handed to Hospital Volunteers, and 49 (98%) 
were returned. Of those returned, 13 did not meet the inclusion criteria; 
therefore 36 normal healthy volunteers were included in the study as the 
control group. The flow diagram (figure 12) summarises the steps of the 
research pathway for COPD and normal control subjects recruited. Each 
step shows the number of subjects included (or excluded).  
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Figure 12: Flow diagram of number of subjects considered at each stage of the research 
process. 
 
 
The SWAL-QOL(ab) questionnaire was given to normal subjects (control 
group) (n=50) by their  manager (Sheffield Teaching Hospitals NHS Trust 
Volunteers Manager) and requested to return completed questionnaires 
anonymously via a stamped, self addressed envelope provided. A total of 49 
questionnaires were returned, however 13 were excluded as they did not 
meet the inclusion criteria (Stroke n= 4, Smoker n= 8, Parkinson’s disease 
n= 1). Therefore a total of 36 questionnaires (10 males) for the normal 
healthy age match controls were analysed.  
Potential subject identified by 
Respiratory Consultant (Dr RL).  
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Once consent procedures were completed, COPD subjects (research group) 
were given the SWAL-QOL(ab) questionnaire to complete immediately before 
each videofluoroscopy assessment. The SWAL-QOL(ab) was either given to 
them to complete on their own, or help was given with reading/scribing if 
requested. 
A total of fifteen COPD subjects were recruited during exacerbation phase. 
One subject consented to the study and completed the SWAL-QOL(ab) 
questionnaire during an exacerbative phase, however withdrew consent 
before completing videofluoroscopy and respiratory analysis. Therefore the 
completed SWAL-QOL(ab) was not included in the results. Four (4/14) of the 
COPD subjects were not considered medically stable within the allocated 
research period, therefore could not be followed up for the stable phase 
stage for the purposes of this study. Thus ten subjects (10/14) met the 
criteria to be followed up during a stable phase. 
 
6.2.2 Demographics 
General biographical information as summarised in table13, show median 
ages for the normal control group approximates the median age of COPD 
subjects. Information was gathered from all recruited subjects unless 
otherwise stated; the sample size indicated in each box, or the diagonal line 
showing information for that event was not applicable.  
Table 13 also details diagnostic information on COPD in subjects including 
severity of COPD, and median FEV1/FVC % ratio, dyspnoea visual analogue 
(VAS) (Wewers & Lowe, 1990) and the Modified Borg Scale (MBS) (Burdon, 
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Jumiper, Killian, Hargrave, & Campbell, 1982). Recruited COPD subjects 
were classified as moderate and severe for both phases of the condition. The 
four COPD subjects not included in stable phase data were classified as 
moderate (n=1) and severe (n=3). Taking FEV1 and FEV1/FVC % ratings is 
not considered reliable during exacerbation phase (National Clinical 
Guideline Centre, 2010), therefore this was not included as part of the 
demographic information. 
Information of the number of hospital admissions for each subject was taken 
from medical notes at the Royal Hallamshire Hospital before the 
exacerbation phase assessment. None of the subjects included in the follow-
up stable phase assessment were admitted to hospital between 
assessments. The four COPD subjects not included in the stable phase data 
were admitted to hospital before exacerbation phase assessments  between 
one and three times within the previous six months, and had multiple 
admissions between assessments (Md= 3).  
The number of courses of antibiotics for chest related illness was provided 
either by self report for the normal control group, or by General Practitioner 
for the COPD group (n=9). Antibiotic use was documented for the six months 
previous to exacerbation phase assessment.  
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Table 13: General biodemographic information of research subjects.  
 Normal Healthy 
Control  
Stable Phase 
COPD 
Exacerbation 
Phase  
COPD 
Total number of subjects 
(Male: Female ratio) 
36 
(11:25) 
10 
(4:6) 
14 
(6:8) 
Age Median (min-max) 68.5 (58-87) 
 
71 (65-91) 
 
71 (62-91) 
 
BMI Median (min-max) 23.97 (21-30) 
(n=34) 
24 (18-29) 
 
21 (17-28) 
 
Severity of COPD subjects 
ratio Mild: Moderate: Severe 
 0:8:2 0:9:5 
FEV1 
median (min-max) 
 0.87 
(0.48- 1.14) 
 
 
FEV1/FVC % 
median (min-max) 
 37.22 
(29- 45) 
  
 
Modified Borg Scale (MBS) 
median (min-max) 
 
 
2.0 
(0.5- 5.0) 
 
 
6.0 
(1.0- 9.0) 
Visual Analogue Scale (VAS) 
median (min-max) 
 2.41 
(1.30- 3.90) 
 
6.32 
(2.00- 9.50) 
 
Number of hospital 
admissions in last 6 months  
Median (min-max)  
0 
(n=30) 
 
0  
(n=10) 
1.43 (0-3) 
(n=13) 
Number of courses of 
antibiotics for chest related 
illness in last 6 months 
Median (min-max)  
0 (0-2) 
(n=25) 
 4 (1-6) 
(n=9) 
Self Imposed Modified Diet 0% Food 
0% Drink 
29% Food 
0% Drink 
71% Food 
0% Drink 
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6.3 Rater reliability 
Inter or intra rater reliability was conducted on the three measures of 
assessment. The SWAL-QOL(ab) used intrarater reliability as discussed 
earlier to gain 100% accuracy. Interrater reliability was used for LPSG 
recording to ensure 100% between myself and at least one respiratory 
physiologist. Videofluoroscopy used interrater reliability and the results are 
now discussed.  
 
6.3.1 Videofluoroscopy 
Reliability testing of interpretation of videofluoroscopy recordings was 
conducted on 20% of data (5/24). Table 14 shows interrater reliability from 
three experienced speech and language therapists (SLT 2-4) rating five 
videofluoroscopies (VF) during four events, and compared to my ratings 
(SLT 1). A score of yes relates to a subject scoring more than 50% within in 
each event for six drink trials and three food trials. There was a 75% and 
100% agreement for objective one (PHAG) for food and drink respectively, 
and 50-100% agreement for secondary objectives: penetration (PEN), 
aspiration (ASP) and use of spontaneous compensatory manoeuvres (MAN).  
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Table 14: Percentages of 'total agreement' for interrater reliability of swallow events observed 
during videofluoroscopy.  
  
SLT1 
 
SLT2 
 
SLT3 
 
SLT4 
TOTAL 
AGREEMENT 
% 
 EVENT DRINK FOOD DRINK FOOD DRINK FOOD DRINK FOOD DRINK FOOD 
VF1 PHAG YES YES YES NO YES NO YES NO 100 75 
 PEN NO NO NO NO NO NO NO NO 100 100 
 ASP NO NO NO NO NO NO NO NO 100 100 
 MAN YES NO YES NO YES NO NO NO 75 100 
VF2 PHAG YES YES YES YES YES YES YES NO 100 75 
 PEN NO NO NO NO NO NO NO NO 100 100 
 ASP NO NO NO NO NO NO NO NO 100 100 
 MAN YES YES YES YES YES YES YES NO 100 75 
VF3 PHAG YES YES YES YES YES YES YES YES 100 100 
 PEN YES NO YES NO YES NO YES NO 100 100 
 ASP NO NO NO NO NO NO NO NO 100 100 
 MAN YES NO YES NO YES NO YES NO 100 100 
VF4 PHAG YES YES YES YES YES YES NO NO 75 75 
 PEN NO NO NO NO NO NO NO NO 100 100 
 ASP NO NO NO NO NO NO NO NO 100 100 
 MAN NO NO YES YES YES YES NO NO 50 50 
VF5 PHAG YES NO YES NO YES NO YES YES 100 75 
 PEN YES NO YES NO YES NO NO NO 75 75 
 ASP NO NO NO NO NO NO NO NO 100 100 
 MAN NO NO YES YES YES NO NO YES 50 50 
PHAG= Overall Dysphagic 
PEN= Penetration observed 
ASP= Aspiration observed 
MAN= Spontaneous compensatory manoeuvres observed 
 
 
6.4 Objective One 
Objective one of this study aimed to:  
Compare perception of dysphagic symptoms and swallowing 
related quality of life between Normal Controls, and by phase of 
COPD  
 
This was achieved using the abridged SWAL-QOL (SWAL-QOL(ab)). To 
compare the mean scores of the SWAL-QOL(ab) domains between and within 
research groups, the total median scores of each SWAL-QOL(ab)domain were 
converted into a percentage to allow an overview of the data, as shown in 
figure 13.  The normal healthy control group (black bar) indicated having the 
highest scores and reported no dysphagic symptoms or impact on quality of 
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life for all domains assessed; further confirmation that the SWAL-QOL is 
appropriate for the local population. 
All domains for COPD subjects in stable phase (diamond) showed lowered 
scores (compared to normal controls), except for the ‘Social’ domain which 
equalled the normal healthy control scores. All domains for the COPD 
subjects in exacerbation phase (asterisk) showed the lowest scores; hence 
the most dysphagic symptoms and greatest impact on swallowing related 
quality of life. 
Figure 13: Median percentage scores for SWAL-QOL (ab) domains  
 
 
The SWAL-QOL(ab) can be divided into two sections; perception of 
physiologic dysphagic symptoms as assessed by the ‘symptoms’ domain, 
and the associated impact on quality of life as assessed by the remaining six 
domains. The results for the two sections are now discussed. 
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6.4.1 Perception of oropharyngeal symptoms 
This section explores issues relating to perceived oral and pharyngeal 
function of the swallow by phase of COPD; measured using the ‘Symptoms’ 
domain of the SWAL-QOL(ab). Results were compared with the normal 
control group and by phase of COPD. Table 15 reports descriptive statistics 
for scores on the Symptom domain of the SWAL-QOL(ab) for each group.  
The SWAL-QOL(ab) Likert scale is inversely related to symptoms of 
dysphagia. Fourteen questions in the Symptom domain investigate physical 
difficulties with swallowing. A maximum score of 70 relates to no dysphagic 
symptoms perceived by the scorer, a score of 56 and above indicates 
infrequent or no signs of dysphagia and a score lower than 56 would show 
evidence of perceived difficulties with swallowing. The minimum score for 
this domain is 14, which indicates the most severe symptoms of dysphagia.  
There were 30% (n=3) of COPD subjects during stable phase, and 71% 
(n=10) during exacerbation phase who scored 56 or lower in this domain, 
with no normal healthy control group subject scoring lower than 56. The 
normal control group (n=36) showed a median score of 70 with a very small 
range (3), therefore rating their swallow as having no dysphagic symptoms. 
The median score for COPD subjects during stable phase indicated no 
dysphagic symptoms; however there was a larger variation when compared 
to normal controls. COPD subjects during exacerbation phase reported more 
frequent physiological swallowing difficulties; again there was a further 
increase in the range of scores. 
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Table 15: Descriptive statistics for SWAL-QOL (ab) 'Symptom' domain.  
Total score for 
Symptoms section 
N 
 
Median
† 
Range 
(min-max) 
Normal Healthy 36 70 67-70 
Stable COPD 10 60.50 50-69 
Exac COPD 14 44.00 25-63 
 Total 
 
60 
  
†
 Scores within normal limits = 56-70 
 
 
Further analysis using a box and whisker plot (figure 14), show the 
distribution of the scores in more detail. The interquartile range (box) shows 
the middle 50% of the total scores, with the median represented as a black 
bar within the interquartile range. The whiskers (line above and below each 
interquartile range) show the remaining data within 1.5 box-lengths from the 
edge of the box, and extreme outliers (more than three box-lengths from the 
edge of the box) represented as an asterisk with the subject identification 
number (Pallant, 2007). The normal control group show three close outliers 
(asterisks). The phases of COPD show a relatively large interquartile range 
relative to the outliers (whiskers), and they are slightly skewed; Stable COPD 
positively and Exacerbation COPD negatively skewed.  The skewness 
reveals that the data is not normally distributed.  
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Figure 14: Box and whisker plot summary of SWAL-QOL(ab) 'Symptoms' domain.  
 
COPD subjects generally scored ‘symptoms’ of dysphagia differently within 
each phase of their condition and from the normal control group which 
required further exploration. Non parametric testing was used as the box and 
whisker plots show that ratio between the upper and lower quartile was 
greater than two, revealing that the data is not normally distributed (Machin, 
Campbell, & Walters, 2010). Furthermore, as advised by a statistician (Prof 
M.C.), calculations of the mean and median revealed a difference of greater 
than 1% for the majority of data points; providing further evidence of 
asymmetry. Mann Whitney U tests were used for testing the two independent 
sets of data (Normal control group versus Stable COPD), and Wilcoxon 
Signed Rank Tests were used to the test the two related sets; Stable COPD 
versus Exacerbation COPD (as this was the repeated measures design 
discussed in chapter five). The results of non parametric testing are now 
discussed. 
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6.4.1i) Normal Healthy Control vs. Stable COPD 
Quantitative analysis on the Symptom section of the SWAL-QOL(ab) using the 
Mann Whitney U Test investigated the difference between the normal healthy 
control group and the stable COPD group, as shown in table 16.  
Table 16: Mann Whitney U Test: Normal- Stable COPD for SWAL-QOL(ab) 'Symptoms' domain.  
Total score for 
Symptoms 
Normal Control - 
Stable COPD 
Mann-Whitney U 3.00 
  
Z -5.935 
Asymp. Sig. (2-tailed) .000* 
  
* Significant at p<0.05 
A statistically significant difference was found between Normal Controls (Md= 
70, n=36) and Stable COPDs (Md= 60.50, n=10) subjects, U= 3.00,             
z= -5.935, p=0.00. The Stable COPD subjects in this study were statistically 
more likely to perceive more physiologic dysphagic symptoms than normal 
healthy controls.  
6.4.1ii)  Exacerbation COPD vs. Stable COPD 
Quantitative analysis using the Wilcoxon Signed Rank Test investigated the 
difference between Stable and Exacerbation phase COPD, as shown in table 
17.  
Table 17: Wilcoxon Signed Rank Test: Stable COPD-Exac COPD for SWAL-QOL(ab) 'Symptom' 
domain  
Total score for 
Symptoms 
Stable COPD-
Exac COPD 
Median Difference 
Z 
Asymp. Sig. (2-tailed) 
 
-2.501
a
 
 
0.012* 
a. based on positive ranks 
* Significant at p<0.05 
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A statistically significant difference was found between scores of Stable 
COPD and Exacerbation COPD for the Symptoms domain, z= -2.501, 
(p<0.05). The COPD group in this study were statistically more likely to 
report more physiologic dysphagic symptoms in exacerbation phase than 
during stable phase. 
 
6.4.2 Perception of swallowing related quality of life 
This section in objective one explored the impact that any physiological 
dysphagic symptoms may have on quality of life (QOL). Six domains of 
quality of life were assessed; Burden, Eating duration and desire, Food 
selection, Fear, Mental Health and Social in normal controls and by phase of 
COPD. Table 18 shows descriptive statistics for the six QOL domains; 
including the minimum and maximum achievable score, and median and 
range for each of the groups. Sample size is the same for each domain and 
is therefore documented in the Burden category only. Scores within normal 
limits (WNL) indicate no swallowing related quality of life changes within 
each domain. The median for the normal control group resulted in the 
maximum achievable score for each category, with minimal variation. Both 
phases of COPD scored lower than the normal control group, with 
exacerbation phase scoring the lowest in each domain, also with the largest 
range.  
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Table 18: Descriptive analysis of six SWAL-QOL(ab) domains.   
Total score for SWAL-QOL(ab) Domains Median Range 
(min-max) 
Burden Normal Control (n= 36) 10 8-10 
(Min score= 2, Max score= 10) Stable COPD (n=10) 8.5 4-10 
(WNL= 9-10) Exac COPD (n=14) 7 2-10 
Eating duration and desire Normal Control 25 24-25 
(Min score=5, Max score=25) Stable COPD 19.5 16-23 
(WNL= 23-25) Exac COPD 12 5-25 
Food selection Normal Control 10 8-10 
(Min score=2, Max score=10) Stable COPD 8 6-10 
(WNL= 8-10) Exac COPD 7 2-10 
Fear Normal Control 20 20-20 
(Min score=4, Max score=20) Stable COPD 19 13-20 
(WNL= 18-20) Exac COPD 14 8-20 
Mental Health Normal Control 25 25-25 
(Min score=5, Max score=25) Stable COPD 23 13-25 
(WNL= 23-25) Exac COPD 20 9-25 
Social Normal Control 25 25-25 
(Min score=5, Max score=25) Stable COPD 25 17-25 
(WNL= 20-25) Exac COPD 20 5-25 
WNL= Within Normal Limits for each domain 
 
Figure 15 also shows the differences between the groups, quantitatively 
highlighting the variability of the data between the normal control group and 
the phases of COPD using box and whisker plots for each of the six 
domains. 
The COPD data show a large interquartile range with symmetry shown only 
with Burden (Stable phase) and Fear (Exacerbation phase COPD). Eating 
duration and desire (Exacerbation phase COPD) is positively skewed, and 
the remaining domains are negatively skewed. The level of skewness 
reveals the data is not normally distributed.  
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Figure 15: Box and Whisker Plot by SWAL-QOL(ab) domains  
a) Burden     b) Eating duration and desire 
   
c)  Food Selection    d) Fear 
    
 
e) Mental Health    f) Social 
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As with the physiologic dysphagia symptom measures discussed previously, 
the data required further analysis, and therefore non parametric tests were 
used. Results are now discussed. 
 
6.4.2i) Normal Healthy Control vs. Stable COPD 
A Mann Whitney U test was used to test if any significant differences 
occurred between the Normal Control group and Stable COPD in ratings of 
swallowing related quality of life, as shown in table 19.  
Table 19: Mann Whitney U Test: Normal-Stable COPD SWAL-QOL(ab) QOL domains.  
Test Statistics(b) 
Total Score SWAL-QOL(ab) for Healthy Control-Stable COPD 
 Burden Eating 
duration 
and desire 
Food 
selection 
Fear Mental 
Health 
Social 
Mann Whitney U 58.50 0.00 77.50 108.00 36.00 112.00 
Z -4.90 -6.41 -4.135 -3.276 -5.807 -3.353 
Asymp. Sig (2-
tailed) 
p<0.0001* p<0.001* p<0.001* p<0.001* p<0.001* p<0.001* 
* Significant at p<0.05 
 
A statistically significant difference was found in all domains of swallowing 
related quality of life (p<0.05). Stable COPD subjects in this study were more 
likely to rate their swallowing as negatively impacting their quality of life, 
more than the normal control group. 
  
 200 
 
6.4.2ii) Exacerbation COPD vs. Stable COPD 
A Wilcoxon Signed Rank Test was used to investigate any difference 
between COPD subjects during stable and exacerbation phase scores for 
ratings of swallowing related quality of life, as shown in table 20.  
 Table 20: Wilcoxon Signed Rank Test: Exac COPD-Stable COPD SWAL-QOL(ab) QOL domains.  
Total Score SWAL-QOL(ab) for Exac COPD-Stable COPD 
 Burden Eating 
duration 
and desire 
Food 
selection 
Fear Mental 
Health 
Social 
Z -1.725
a 
-2.312 -1.841
a 
-2.023
a 
-0.957
a 
-1.225
a 
Asymp. Sig (2-
tailed) 
0.084 0.021* 0.066 0.043* 0.339 0.221 
a Based on positive ranks 
* Significant at p<0.05 
 
A statistically significant difference was found between Stable and 
Exacerbation phase of COPD for two domains; Eating duration and desire 
(p= 0.021), and Fear (p=0.043). The COPD group in this study were more 
likely to rate their quality of life lower in exacerbation phase than during 
stable phase of their condition for questions relating to Eating duration and 
desire and Fear. 
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6.5 Objective Two 
Objective two of this study contained one primary and two secondary 
objectives. This objective aimed to: 
Investigate the prevalence of oropharyngeal biomechanical   
dysphagia by phase of COPD. 
a) Explore the nature of the oropharyngeal dysphagia by 
phase of COPD. 
b)  Compare the perception of dysphagia symptoms with 
the biomechanical analysis by phase of COPD. 
 
This was achieved using videofluoroscopic analysis. Videofluoroscopy 
measures were assessed within the same subjects during stable phase and 
exacerbation phase of their condition. Fourteen COPD subjects were 
assessed during exacerbation phase with ten subjects being suitable for 
follow-up in stable phase. Table 21 indicates the median times and exposure 
for videofluoroscopy. 
Table 21: Median Videofluoroscopy durations and radiation exposure  
 Stable COPD Exacerbation 
COPD 
Number of subjects 10 14 
VF Time in minutes  
median (min-max) 
 
3.18 
(1.80-4.00) 
 
4.26 
(2.70-7.00) 
VF Exposure in mGy/cm
2   
median (min-max) 
 
3476.33 
(2034- 4979) 
 
4373.29 
(2520- 7321) 
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Number of Swallows Analysed  
Subjects were given six water trials and three food trials. A total of 131 drink 
swallows (56 in stable and 75 in exacerbation phase) and 72 food swallows 
(30 in stable and 42 in exacerbation phase) were able to be analysed from 
videofluoroscopy.  
Data was lost due to not meeting stable criteria (n= 4), withdrawal of consent 
(n=1), recording equipment not working correctly (13 drink swallows). Most 
volunteers used the required number of swallows for drink (93% stable and 
89% exacerbation phase) and food (100% for both stable and exacerbation).  
Videofluoroscopic measures were analysed per subject in order to provide a 
descriptive overview of the results, and as a percentage of swallows per 
subject for further quantitative analysis as discussed previously in chapter 
five. 
 
6.5.1 Prevalence of dysphagia 
The primary aim of objective two was to estimate prevalence of 
oropharyngeal biomechanical dysphagia in subjects with COPD. Subjects 
were coded as ‘overall’ dysphagic if either of the oral or pharyngeal stages of 
the swallow were shown to be disordered on videofluoroscopy for food 
and/or drink; with definitions of dysphagia discussed in chapters two and five. 
Types of dysphagic characteristics observed for one or more swallows by 
COPD subjects were: 
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 reduced oral control of bolus (including reduced anterior-posterior 
movement, reduced bolus cohesiveness, reduced chewing, reduced 
tongue strength) during stable phase food (n=5) and drink trials (n=4), 
and during exacerbation phase food (n= 9) and drink trials (n=4). 
 reduced ‘base of tongue’ strength during stable phase food (n= 4) and 
drink trials (n= 6), and during exacerbation phase food (n= 7) and drink 
trials (n=11). 
 delayed initiation of swallow during stable phase food (n= 2) and drink 
trials (n=7), and during exacerbation phase food (n= 3) and drink trials 
(n=10).  
 reduced laryngeal elevation and closure during stable phase food (n= 0) 
and drink trials (n= 6), and during exacerbation food (n= 3) and drink trials 
(n=7).  
 reduced pharyngeal constriction during stable phase food (n= 0) and 
drink trials (n=1), and during exacerbation phase food (n= 2) and drink 
trials (n=1). 
 
These dysphagic characteristics precipitate events coded within the 
secondary objectives (penetration, aspiration and spontaneous 
manoeuvres). Table 22 highlights the difference in reporting objectives as 
50% or more of trials versus one or more trials for each objective, and the 
implications discussed further in section 7.3.2i. From table 22, there is a 
clear increase in number of subjects considered dysphagic during 
exacerbation phase. 
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Table 22: Number of subjects dysphagic by phase of COPD. 
 Primary Objective Secondary Objectives 
Overall Dysphagic Penetration (Mode 
Rosenbek score) 
Aspiration 
(Mode Rosenbek 
score) 
Spontaneous 
Manoeuvres 
For 50% 
or more 
of trials 
For one 
or more 
of trials 
For 50% 
or more 
of trials 
For one 
or more 
of trials 
For 50% 
or more 
of trials 
For one 
or more 
of trials 
For 50% 
or more 
of trials 
For one 
or more 
of trials 
Stable COPD 
(n=10) 
FOOD 20% 50% 0% 10% 
(2) 
0% 0% 20% 40% 
 DRINK 70% 70% 10%  
(2) 
40% 
(2) 
0% 20% 
(8) 
50% 80% 
Exacerbation 
COPD (n=14) 
FOOD 64% 86% 14%  
(3) 
29% 
(3) 
0% 7% 
(7) 
43% 86% 
 DRINK 100% 100% 50% 
 (3) 
86% 
(4) 
21%  
(8) 
57% 
(8) 
79% 100% 
 
6.5.1i) Percentage of swallows 
Further analysis using quantitative measures was explored using 
‘percentage of swallows’ per subject. Table 23 summarises relevant 
descriptive statistics for the percentage of drink and food swallows 
considered dysphagic in either stable or exacerbation phase COPD. Median 
scores reveal a higher percentage of swallows are classified as dysphagic in 
exacerbation phase for food and drink trials. All trials showed a large range 
of scores. 
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Table 23: Percentage of swallows considered dysphagic.  
Percentage of Swallows 
Considered ‘Overall’ Dysphagic 
 
N 
 
 
 
 
Number 
of 
swallows 
analysed 
 
Median 
% 
 
Range 
%  
(Min-Max) 
 
 
DRINK 
 
Stable Phase 10 
 
56 
 
83.00 
 
0-100 
   
Exacerbation Phase 
 
14 
 
75 
 
93.00 
 
67-100 
   
Total 
 
24 
 
131 
  
 
FOOD 
 
Stable Phase 10 
 
30 
 
16.50 
 
0-100 
 
   
Exacerbation Phase 
 
14 
 
42 
 
67.00 
 
0-100 
   
Total 
 
24 
 
72 
  
 
A Wilcoxon Signed Rank Test revealed a statistically significant difference 
between stable and exacerbation phase of COPD for percentage of swallows 
considered dysphagic for drinks, Z= -2.103, (p=0.035) and food, Z= -1.995 
(p=0.046) as shown in table 24.  
Table 24: Wilcoxon Signed Rank Test: Exac COPD-Stable COPD for percentage of swallows 
considered dysphagic.  
Percentage of Swallows Considered Dysphagic 
 
Exacerbation- Stable 
DRINK 
 
FOOD 
 
Z -2.103(a) -1.995(a) 
Asymp. Sig. (2-tailed) 0.035* 0.046* 
a  Wilcoxon Signed Ranks Test 
* Significant at p<0.05 
 
 
COPD subjects in this study had significantly more swallows rated as 
dysphagic during exacerbation phase of their condition; compared to stable 
phase, for food and drink trials. 
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6.5.2 Nature of dysphagia 
Biomechanical analysis of the swallow using videofluoroscopy enables a 
detailed investigation of dysphagic events. For the purposes of this thesis, 
three clinically significant events (penetration of the bolus, aspiration of the 
bolus, and spontaneous manoeuvres) were recorded and analysed as 
secondary objectives in objective two. 
 
6.5.2i)  Penetration of bolus 
Penetration was defined as the bolus entering the airway to the level of the 
vocal cords, as discussed in chapter two. Descriptive statistics for food and 
drink swallows shown to penetrate in COPD subjects during stable and 
exacerbation phase for food and drink trials are summarised in table 25. A 
median ‘percentage of swallows’ penetrated revealed little or no penetration 
of a bolus during food or drink trials, with an increase in penetration seen 
during exacerbation phase for drink trials.  
Table 25: Percentage of swallows penetrated by phase of COPD.  
Percentage of Swallows Penetrated 
 
N 
 
 
 
Number 
of 
swallows 
analysed 
 
Median 
(%) 
 
Range 
(Min-Max) 
(%) 
DRINK  Stable Phase 10 56 0.00 0-50 
  Exacerbation Phase 14 75 41.50 0-83 
   
Total 
 
24 131 
  
FOOD 
Stable Phase 10 30 0.00 0-33 
  Exacerbation Phase 14 42 0.00 0-67 
   
Total 24 72 
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Further analysis on penetration scores using a Wilcoxon Signed Rank Test 
revealed a statistically significant difference between stable and exacerbation 
phase of COPD for penetration during drink swallows, Z= -2.15, (p=0.031), 
but not for food swallows, Z= -1.30, (p>0.05) as shown in table 26. COPD 
subjects in this study were more likely to penetrate on drink trials during 
Exacerbation phase; compared to Stable phase of their condition. 
Table 26: Wilcoxon Signed Rank Test: Exac COPD-Stable COPD Percentage of swallows 
penetrated  
Percentage of Swallows Penetrated 
 
Exacerbation-Stable 
DRINK 
 
 
FOOD 
 
 
Z -2.153(a) -1.300(a) 
Asymp. Sig. (2-tailed) 0.031* 0.194 
(a)  Based on negative ranks. 
* Significant at p<0.05 
 
 
6.5.2ii) Aspiration of the bolus 
Aspiration of the bolus was defined as entering the airway and passing 
through the vocal cords, as discussed in chapter two. Descriptive statistics 
for swallows shown to aspirate food or drink trials during stable or 
exacerbation phase of COPD are shown in table 27. As seen with analysis of 
penetration of trials, a median ‘percentage of swallows’ aspirated revealed 
little or no aspiration of a bolus during food or drink trials, with an increase in 
aspiration seen during exacerbation phase for drink trials. All of the aspirated 
swallows were rated as trace aspiration, or equivalent to less than or equal to 
1% of bolus total. Of the swallows coded as aspirated, all were scored as 
silent (i.e. no cough reflex was elicited). 
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Table 27: Descriptives of percentage of swallows aspirated by phase of COPD.  
 
Percentage of Swallows Aspirated 
 
N 
 
 
Number 
of 
swallows 
 
Median 
% 
 
Range 
(Min-Max) 
(%) 
 
DRINK 
 
Stable Phase 
 
10 
 
56 
 
0.00 
 
0-17 
  Exacerbation Phase 14 75 17.00 0-83 
   
Total 
 
24 
 
131 
  
 
FOOD 
 
Stable Phase 
 
10 
 
30 
 
0.00 
 
0-0 
  Exacerbation Phase 14 42 0.00 0-33 
   
Total 
 
24 
 
72 
  
 
 
 
Further analysis of aspiration scores using a Wilcoxon Signed Rank Test 
revealed no statistically significant difference between stable or exacerbation 
phase COPD for aspiration on drink swallows, Z= -1.70, (p>0.05) or food 
swallows, Z= -1.00 (p>0.05), as shown in table 28.  
Table 28: Wilcoxon Signed Ranks Test: Exac COPD-Stable COPD: Percentage of swallows 
aspirated  
Percentage of Swallows Aspirated 
 
Exacerbation-Stable 
DRINK 
 
FOOD 
 
Z -1.703(a) -1.000(a) 
Asymp. Sig. (2-tailed) 0.089 0.317 
(a) Based on negative ranks. 
 
A COPD subject in this study was statistically no more likely to aspirate on 
food or drinks during either phase of their condition. However it is notable 
that all aspirations seen during the study took place with drinks in 
exacerbation phase and this may be a type 2 statistical error due to the 
modest sample size. This will be discussed further in section 7.3.2ii.  
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6.5.2iii) Spontaneous Manoeuvres  
The third event scored for this study was the subject’s use of spontaneous 
manoeuvres during videofluoroscopy.  Descriptive statistics for the 
percentage of spontaneous manoeuvres used during food and drink 
swallows in either stable or exacerbation phase COPD are shown in table 
29. Types of spontaneous manoeuvres observed in COPD subjects were:  
 breath holding pre swallow during stable phase food (n=2) and drink trials 
(n=3) and exacerbation phase food (n=3) and drink (n=7) trials  
 laryngeal elevation holding post swallow during stable phase drink trials 
(n= 2) and during exacerbation phase food (n=3) and drink trials (n=3)  
 more than three clearing swallows during stable phase food (n=3) and 
drink trials (n=7) and during exacerbation food (n= 10) and drink trials 
(n=12)  
 head tilt during exacerbation phase food (n=1) and drink trials (n=1)  
 chin tuck during exacerbation drink trials (n=1) 
 
Table 29: Descriptives of percentage of swallows using spontaneous manoeuvres by phase of 
COPD.  
Percentage of Swallows using Spontaneous 
Manoeuvres 
 
N 
 
 
 
Number 
of 
swallows 
 
Median 
(%) 
 
Range 
(Min-Max) 
(%) 
 
DRINK 
 
Stable Phase 
 
10 
 
56 
 
50.00 
 
0-100  
  Exacerbation phase 14 75 58.50 17-100 
   
Total 
 
24 
 
131 
  
 
FOOD 
 
Stable Phase 
 
10 
 
30 
 
0.00 
 
0-100 
  Exacerbation Phase 14 42 41.50 0-100 
   
Total 
 
24 
 
72 
  
 
Further analysis on spontaneous manoeuvres using a Wilcoxon Signed Rank 
Test revealed no statistically significant difference between stable or 
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exacerbation phase for using spontaneous manoeuvres  with drink swallows, 
Z= -1.404, (p>0.05). However food swallows did reach statistical 
significance, Z= -2.013 (p=0.044) as shown in table 30. 
Table 30: Wilcoxon Signed Rank Test: Exac COPD-Stable COPD: Percentage of swallows using 
spontaneous manoeuvres.  
Percentage of Swallows 
Using Spontaneous 
Manoeuvres  
 
Exacerbation-Stable 
DRINK 
 
 
FOOD 
 
 
Z -1.404(a) -2.013(a) 
Asymp. Sig. (2-tailed) .160 0.044* 
a  Based on negative ranks. 
* Statistically significant at P>0.05 
A COPD subject in this study was more likely to use spontaneous 
manoeuvres during exacerbation phase for food swallows than in stable 
phase of the condition. 
  
6.5.3 Perception reports vs. biomechanical analysis 
The event coded as ‘considered dysphagic’ from videofluoroscopy and the 
SWAL-QOL(ab) ‘Symptom’ domain from objective one analysis can be further 
divided to show symptoms for oral stage and pharyngeal stage dysphagia. 
This enables a general overview comparing the number of subjects 
perceiving swallowing difficulty with objective detection of dysphagia as 
shown in figure16a) oral stage symptoms and 16b) pharyngeal stage 
symptoms. Oral stage food scores for stable phase COPD appear to be the 
only rating similar in SWAL-QOL(ab) and videofluoroscopy analysis. 
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Figure 16: Perception vs Biomechanical analysis: Percentage of subjects considered 
dysphagic  
a) oral stage     b) pharyngeal stage 
   
To analyse this theory further, scatterplots and non parametric testing was 
used to quantify the strength of the relationship (Pallant, 2007). Food and 
drink were separated and rated by phase of COPD. A negative Spearman’s 
Rho correlation coefficient was expected, due to the inverse scores on the 
SWAL-QOL(ab). Figure 17 shows four scatterplots for Percentage of swallows 
considered dysphagic and SWAL-QOL Symptoms domain in either stable or 
exacerbation phase of COPD during drink and food trials.  
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Figure 17: Scatterplots Symptoms domain vs overall dysphagic score by phase of COPD for 
food and drink swallows.  
a) Drink swallows Stable COPD   b) Food swallows Stable COPD 
    
c) Drink swallows EXAC COPD   d) Food swallows EXAC COPD 
      
The scatterplots and Spearman’s Rho coefficients in table 31 reveal scores 
for stable phase food and drink swallows produced the expected negative 
relationship.  
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Table 31: Spearman's Rho coefficient for percentage of swallows considered dysphagic v 
SWAL-QOL Symptom domain score by phase of COPD.  
Phase of COPD 
  
Spearman’s Rho 
 
Total score 
for  
SWAL-QOL 
SYMPTOMS 
Stable Phase DRINK Percentage of drink 
swallows considered 
dysphagic 
Correlation 
Coefficient -.145 
      Sig. (2-tailed) .689 
      Number of swallows 48 
       
 FOOD Percentage of food 
swallows considered 
dysphagic 
Correlation 
Coefficient -.480 
      Sig. (2-tailed) .160 
      Number of swallows 26 
Exacerbation 
Phase 
DRINK Percentage of drink 
swallows considered 
dysphagic 
Correlation 
Coefficient .317 
 
   Sig. (2-tailed) 
.270 
    Number of swallows 62 
     
 FOOD Percentage of food 
swallows considered 
dysphagic 
Correlation 
Coefficient .357 
     Sig. (2-tailed) .210 
     Number of swallows 31 
 
Drink trials during stable phase COPD suggested a small relationship 
between ratings on ‘considered dysphagic’ and the SWAL-QOL Symptoms 
domain; with scores on the Symptom domain helping to explain 20% of the 
variance on scores for ‘overall dysphagic’ using videofluoroscopy. However 
the significance level shows that this relationship is highly uncertain            
(r= -0.145, p>0.05). Food swallows in stable phase suggested a medium 
strength relationship; with the Symptom domain helping to explain 23% of 
the variance on scores for ‘overall dysphagic’ using videofluoroscopy. 
However this did not reach statistical significance and therefore shows this 
relationship is also highly uncertain (r= -0.480, p>0.05).  Statistical 
significance may not have been reached due to the modest sample size. 
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Spearman’s Rho correlational coefficient scores in exacerbation phase for 
food and drink did not produce the expected negative relationship, but 
indicated a medium strength relationship for drink (r= 0.317) and food (r= 
0.357). Neither drink nor food trials reached statistical significance showing 
this relationship is highly uncertain.  
 
6.6 Objective Three 
The final objective for this study explored the respiratory-swallow pattern in 
COPD. It aimed to: 
Investigate the nature of the respiratory-swallow pattern by phase 
of COPD. 
a)  Compare the respiratory-swallow pattern with the 
biomechanical analysis by phase of COPD. 
 
The respiratory-swallow pattern was measured simultaneously with 
videofluoroscopy to record respiratory status throughout the swallowing 
process, using a Limited Polysomnogram (LPSG). Readings from chest 
excursions provided the most accurate information regarding respiratory 
status before; at the time of; and after a swallow. Airflow readings provided 
by the nasal cannulae proved inconsistent (possible reasons explored in 
chapter seven). This information, synchronised with videofluoroscopic events 
enabled measurements to be taken for swallow apnoea duration and the 
respiratory-swallow patterns; inhalation-swallow apnoea-inhalation 
(INH/INH); exhalation-swallow apnoea-inhalation (EXH/INH); or inhalation-
swallow apnoea- exhalation (INH/EXH); and exhalation-swallow apnoea- 
exhalation (EXH/EXH) (Martin-Harris, 2008). 
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Descriptive analysis of swallow apnoea durations; as shown in table 32, 
show exacerbation phase had the largest range of duration for food 
(3.17sec) and drink (1.95) swallows than during stable phase. 
 Table 32: Descriptives of swallow apnoea duration by phase of COPD. 
Swallow Apnoea Duration 
 
N 
 
 
Number 
of 
swallows 
 
Median  
Sec 
 
Range 
(Min-Max) 
Sec 
 
DRINK 
 
Stable Phase 
 
9 
 
 
48 
 
1.630 
 
0.960-2.000 
  Exacerbation Phase 14 
 
62 1.585 0.850- 2.800 
   
Total 
 
24 
 
110 
 
 
FOOD 
 
Stable Phase 
 
9 
 
26 
 
 
1.170 
 
1.000- 2.700 
  Exacerbation Phase 14 
 
31 1.500  0.830- 4.000 
   
Total 
 
24 
 
57 
 
 
Results of the respiratory-swallow pattern are presented descriptively per 
subject, and further quantitative analysis was completed using percentage 
swallows per subject; as described in the methodology chapter and 
conducted for objective two, which are now discussed.  
 
6.6.1 Nature of respiratory-swallow pattern 
The predominate respiratory-swallow pattern used by the COPD subjects in 
this study was Exhalation-(swallow apnoea)-Inhalation (EXH/INH) for food 
and drink trials in Stable phase; whereas Inhalation-(swallow apnoea)- 
Inhalation (INH/INH) equalled the EXH/INH pattern during drink trials in 
Exacerbation phase when reporting COPD subjects using a respiratory-
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swallow pattern for 50% or more of trials. Table 33 summarises subjects 
using respiratory-swallow patterns for 50% or more of trials and also for one 
or more of trials; where greater variation in the use of respiratory-swallow 
patterns within subjects can be seen, as discussed previously for prevalence 
of dysphagia.  
Table 33: Number of subjects using a Respiratory-Swallow pattern by phase of COPD. 
 INH/INH EXH/INH INH/EXH EXH/EXH 
For 50% 
or more 
of trials 
For one 
or more 
of trials 
For 50% 
or more 
of trials 
For one 
or more 
of trials 
For 50% 
or more 
of trials 
For one 
or more 
of trials 
For 50% 
or more 
of trials 
For one 
or more 
of trials 
Stable COPD 
(n=10) 
FOOD 10% 30% 40% 90% 10% 50% 0% 20% 
 DRINK 0% 50% 70% 90% 30% 80% 0% 20% 
Exacerbation 
COPD (n=14) 
FOOD 29% 43% 57% 79% 7% 71% 0% 0% 
 DRINK 43% 64% 43% 64% 21% 100% 0% 14% 
 
6.6.1i)  Percentage of swallows 
To analyse the variability within subjects; and therefore include all clinically 
relevant data, respiratory-swallow pattern was further analysed using 
percentage of swallows per subject.  Table 34 summarises descriptive 
statistics for the median percentage of swallows used by subjects for each of 
the four respiratory-swallow patterns by phase of COPD for food and drink 
trials. This table highlights the variability of respiratory-swallow patterns used 
within this COPD sample, more specifically the increased use of INH/INH 
pattern during Exacerbation phase for food and drink swallows, not seen 
when assessing per subject.  
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Table 34: Percentage of swallows using respiratory-swallow patterns by phase of COPD.  
Phase of COPD DRINK 
MEDIAN% 
FOOD 
MEDIAN% 
Stable Phase INH/INH  
(mid INH) 
14.8 13.30 
 EXH/INH 
(end EXH) 
50.80 60.20 
 EXH/EXH 
(mid EXH) 
3.4 6.60 
 INH/EXH 
(end INH) 
31.00 19.90 
 TOTAL 100% 100% 
Exacerbation Phase  INH/INH  
(mid INH) 
30.43 23.86 
 EXH/INH 
(end EXH) 
29.86 49.57 
 EXH/EXH 
(mid EXH) 
3.36 0.00 
 INH/EXH 
(end INH) 
36.36 26.57 
 TOTAL 100% 100% 
 
The two respiratory-swallow patterns using inhalation post swallow (INH/INH 
and EXH/INH) were further analysed as these were reported to be the least 
likely respiratory phases to be observed within normal and normal age 
swallows; as reported within the literature (see chapter three). A Wilcoxon 
Signed Rank Test revealed no statistically significant difference in use of 
inhalation post swallow when a subject was in either stable or exacerbation 
phase of COPD with drink swallows, Z= -0.654, (p>0.05) or food swallows, 
Z= -0.137 (p>0.05) as shown in table 35.  
Table 35: Wilcoxon Signed Rank Test: Exac COPD-Stable COPD: Percentage of inhalation post 
swallow.  
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Percentage of swallows using Inhalation 
post swallow  
 
Exacerbation-Stable 
DRINK 
 
 
FOOD 
 
 
Z -0.654(b) -0.137(a) 
Asymp. Sig. (2-tailed) 0.513 0.891 
(a)  Based on negative ranks. 
(b)  Based on positive ranks. 
 
 
A COPD subject in this study was no more likely to use inhalation post 
swallow for food or drink swallows during stable or exacerbation phase of 
their condition. 
 
6.6.2 Respiratory swallow pattern analysis vs. biomechanical analysis 
The secondary objective aimed to compare the respiratory-swallow pattern 
and biomechanical swallow analysis from objective two. A Spearman’s Rho 
correlational coefficient was used to analyse the relationship between 
percentage of swallows considered dysphagic and percentage of swallows 
using inhalation post swallow; for food and drink trials by phase of COPD, as 
shown in table 36. A positive correlation was expected, indicating the higher 
the use of inhalation post swallow, the higher percentage of swallows 
considered dysphagic. 
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Table 36: Spearman’s Rho Correlation of percentage swallows considered dysphagic 
vs. Percentage of swallows using inhalation post swallow by phase of COPD. 
Phase of COPD 
  
 Spearman’s Rho 
 
Total score 
for  
INHALATION 
POST 
SWALLOW 
Stable Phase DRINK Percentage of drink 
swallows considered 
dysphagic 
Correlation 
Coefficient 0.268 
      Sig. (2-tailed) 0.454 
      Number of swallows 48 
       
 FOOD Percentage of food 
swallows considered 
dysphagic 
Correlation 
Coefficient 0.165 
      Sig. (2-tailed) 0.649 
      Number of swallows 26 
     
Exacerbation 
Phase 
DRINK Percentage of drink 
swallows considered 
dysphagic 
Correlation 
Coefficient -0.590* 
    Sig. (2-tailed) 0.026 
    Number of swallows 62 
     
 FOOD Percentage of food 
swallows considered 
dysphagic 
Correlation 
Coefficient -0.008 
     Sig. (2-tailed) 0.978 
     Number of swallows 31 
* Significant at 0.05 level (2 tailed) 
 
A small strength relationship was indicated for stable phase drink and food 
swallows; with inhalation post swallow helping to explain only 7% of 
dysphagia in drink swallows and 3% in food swallows. However both  
significance levels show that the relationships are highly uncertain; (r= 0.268, 
p>0.05) and (r= 0.165, p>0.05) respectively. 
Analysis of the respiratory-swallow pattern during exacerbation phase 
revealed unexpected results. There was a large, negative correlation for 
drink swallows during exacerbation phase, which also reached statistical 
significance (r= - 0.590, p=0.026). This is explored further in chapter seven. 
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6.7 Summary of Results 
This study aimed to investigate the nature and extent of oropharyngeal 
dysphagia in COPD. Clinically appropriate measures were chosen to 
investigate the perception of swallowing difficulties and associated impact on 
quality of life, prevalence of biomechanical dysphagia and nature of 
respiratory-swallow pattern. Secondary objectives explored the nature of the 
biomechanical dysphagia findings, and the relationship between perception 
of swallowing skills with biomechanical measures and biomechanical 
measures with respiratory-swallow pattern analysis. Results using this 
method do not appear to have been documented in the literature previously 
by phase of COPD, and are summarised in table 37. 
Findings revealed COPD subjects in this study have statistically lower 
perceived swallowing skills than normal healthy age matched peers; 
negatively impacting on their quality of life. Findings also revealed a 
statistically significant deterioration in perception and objectively measured 
swallowing ability during exacerbation phase when compared with stable 
phase. Although not all findings reached statistical significance, the results of 
the study detailed in this thesis may provide clinically important information; 
as highlighted by interest generated through awards and conference 
presentations (see Appendix 13), and is explored further in the next chapter. 
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Table 37: Summary of findings by objective. 
OBJECTIVE OUTCOME 
ONE COPD subjects in this study were statistically more likely to: 
 Perceive their swallowing ability lower than normal healthy 
controls (p<0.01). 
 Perceive their swallowing ability lower during exacerbation 
phase than stable phase of their condition (p=0.012). 
 Perceive their swallowing related quality of life lower than 
normal healthy controls (p<0.01 for all domains) 
 Perceive their swallowing related quality of life lower during 
exacerbation phase than stable phase of their condition  
(Eating duration and desire, p=0.021, Fear, p=0.043). 
 
TWO For 50% or more of trials: 
 70% of COPD subjects during stable phase were considered 
dysphagic on drink swallows, increasing to 100% during 
exacerbation phase. 
 20% of COPD subjects during stable phase were considered 
dysphagic on food swallows, increasing to 64% during 
exacerbation phase. 
 No subject aspirated drink or food trials for more than 50% 
of trials during stable phase; however 21% of subjects 
aspirated drink trials during exacerbation phase. 
COPD subjects in this study showed statistically more 
swallows during exacerbation phase: 
 As ‘overall’ dysphagic for food (p=0.046) and drink (p=0.035) 
 As penetrated for drink swallows (p=0.031) 
 As using spontaneous manoeuvres for food swallows 
(p=0.044) 
 
THREE A non statistically significant difference, but clinically relevant 
finding was seen as COPD subjects in this study used inhalation 
post swallow for 50% or more of trials during stable phase: 
 For 74% of food and 66% of drink swallows 
And during exacerbation phase: 
 For 74% of food and 61% of drink swallows. 
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Chapter Seven 
 
Discussion 
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Chapter Seven: Discussion 
7.1 Introduction 
People with Chronic Obstructive Pulmonary Disease (COPD) frequently 
report difficulty with eating and drinking. However there has been a dearth of 
previous research interest which has resulted in a limited evidence base 
regarding true prevalence or the nature of oropharyngeal dysphagia in this 
population; and how oropharyngeal dysphagia contributes to the onset, 
frequency or severity of exacerbations. Furthermore, the impact of 
swallowing related quality of life as experienced by people with COPD is also 
under researched. The study detailed in this thesis aimed to address this 
lack of evidence and inform statistical power required for future longitudinal 
studies in patients with COPD. This was achieved by using an innovative 
research design, incorporating triangulation methodology to assess the 
extent and nature of oropharyngeal dysphagia by phase of COPD.  
This chapter discusses the statistically and clinically significant findings 
within the study detailed in this thesis (reported in chapter six), and 
compares this new information with current knowledge within the literature. 
Additionally, this chapter considers the clinical implications of the findings, 
the limitations of this study and highlights areas requiring further exploration. 
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7.2 Literature 
The literature review provided in chapters two and three revealed the normal 
and normal age swallow has been previously well documented (Logemann, 
1988; Martin-Harris, Brodsky, Michel, & Lee, et al., 2007). Similarly, 
aberrations to the swallow pattern have also been well documented in 
neurological and non neurological aetiologies such as stroke and head and 
neck cancer (Leslie, 2010). However, a review revealed paucity in the 
evidence base regarding the prevalence and nature of oropharyngeal 
characteristics in patients with COPD; a progressive pulmonary disease. 
Nevertheless, the strong evidence base for normal swallow patterns 
combined with the limited literature investigating COPD swallows was used 
to inform the methodological design of this study and compared to findings 
within this study.  
Subsequent to protocol development and data collection within this study, 
four studies (Gross, Atwood, Ross, & Olszewski, et al., 2009; McKinstry, 
Tranter, & Sweeney, 2009; Terada, Muro, Ohara, & Kudo, et al., 2010; 
Cvejic, Harding, Churchward, & Turton, et al., 2011), one systematic review 
(O'Kane & Groher, 2009)  and editorial (Singh, 2011) were published, 
pertinent to this study’s design and findings. Although these articles were not 
published in time to inform research design, they were reviewed in the 
relevant chapters of this thesis and are included within the discussion 
alongside this study’s findings. 
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7.3  Research Findings 
The study detailed in this thesis added new information regarding the extent 
and nature of oropharyngeal dysphagia in patients with COPD to the body of 
knowledge, using an innovative and highly replicable research design. A 
repeated measures design was enlisted to assess COPD subjects in 
exacerbation phase and followed up in stable phase which focused on three 
main objectives; perception of swallow and swallow related quality of life, 
biomechanical swallow and respiratory-swallow pattern. Secondary 
objectives explored the interaction between these three assessment 
measures. Findings are now discussed alongside evidence within the 
literature. 
 
7.3.1 Objective one: Perception of swallow and swallow related quality 
of life. 
Objective one aimed to compare perception of physiological dysphagic 
symptoms and swallowing related quality of life between normal healthy 
controls and by phase of COPD. This was measured using the pre validated 
SWAL-QOL(ab) (McHorney, Robbins, Lomax, & Rosenbek, et al., 2002). 
  
7.3.1i) Perceived oropharyngeal dysphagia symptoms 
The ‘symptom’ domain in the SWAL-QOL(ab) measured common 
physiological signs and symptoms related to oropharyngeal dysphagia; such 
as ‘coughing on food/drink’, ‘food getting stuck in the throat’ or ‘problems 
chewing’. This domain was inversely related to symptoms; the lower the 
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score the higher the perceived difficulty, with a score of 56 or lower indicating 
a frequent occurrence of perceived difficulty. There were 30% of COPD 
subjects in this study during stable phase (n=3), and 71% during 
exacerbation phase (n=10) who scored 56 or lower in this domain, with none 
of the normal healthy control group subjects scoring lower than 56 (n= 36). 
Non parametric testing revealed COPD subjects in this study perceived their 
physiological swallowing ability as significantly lower than the normal healthy 
control group (p<0.001); with a significant deterioration during exacerbation 
when compared to stable phase (p=0.012).  
To date, there is no known published study that has used the SWAL-QOL 
with COPD subjects to estimate true prevalence (as reported by patient 
experience) or evaluate changes by phase of COPD. McHorney and Robbins 
et al (2002) developed the SWAL-QOL using populations previously 
diagnosed as dysphagic, and reported the questionnaire was not considered 
a screening tool. However in a study by Ding and Logemann (2008), 
correlations between videofluoroscopy ratings and patient self perceptions of 
swallowing difficulties were high for patients with respiratory diseases 
(Cramer’s V= 0.864, p<0.001). Furthermore, the SWAL-QOL has been used 
in other studies with populations not previously diagnosed (or documented) 
as dysphagic (Genden, Okay, Stepp, & Rezaee, 2003; Lovell, Wong, Low, & 
Ngo, et al., 2005; Roe, Leslie, & Drinnan, 2007; Bandeira, Azevedo, 
Vartanian, & Nishimoto, et al., 2008; Greenblatt, Sippel, Leverson, & 
Frydman, et al., 2009; Leow, Huckabee, Anderson, & Beckert, 2010); as 
used in this study and discussed in chapter three. Of these studies only Roe 
and Leslie et al (2007) documented an estimated prevalence (64%, n=11) 
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from their ‘non head and neck cancer’ research group receiving palliative 
care; which is lower than the estimated prevalence found for COPD subjects 
in the study detailed in this thesis during exacerbation phase, as assessed 
by the SWAL-QOL ‘symptom’ domain (71%, n=14).  
The majority of studies using the SWAL-QOL documented significant 
differences in group scores when compared against a normal control group 
or post intervention within a disease group. Leow et al (2010) and McHorney 
and Robbins et al (2002) (during development of the SWAL-QOL) are the 
only known studies to compare disease groups against normal healthy 
controls. Both studies reported normal control mean scores on the ‘symptom’ 
domain of 63/70 (mean age= 73 years) and 62/70 (mean age= 73 years) 
respectively. Suprisingly, the normal healthy control group in this study 
recorded a median score of 70/70 for the ‘symptom’ domain, with three close 
outliers (see section 6.4.1). Evidence within the literature investigating 
normal swallowing patterns (discussed in chapter two) may highlight reasons 
for the differences seen between the study detailed in this thesis and control 
groups reported by Leow and Huckabee et al (2010) and McHorney and 
Robbins et al (2002). As Logemann (1990) suggests, age is a factor in 
changes in swallowing pattern; with the median age of 69 years within the 
study in this thesis which is younger than Leow and Huckabee et al (2010) 
and McHorney and Robbins et al’s (2002) control groups. Gender differences 
have also been shown in Logemann and Pauloski et al (2002); with the study 
in this thesis recruiting 69% of women, compared to Leow and Huckabee et 
al (2010) and McHorney and Robbins et al (2002) recruiting equal numbers 
of men and women. The study detailed in this thesis used a more rigorous 
 228 
 
criteria for the control group to exclude any previous history of smoking; 
compared to Leow and Huckabee et al (2010) who included subjects who 
had stopped smoking for five or more years prior to data gathering. A history 
of ‘never smoked’ was important within this study’s recruitment criteria, to 
ensure the normal control group did not contain any potentially undiagnosed 
cases of COPD. Additionally, McHorney and Robbins et al (2002) included 
recruitment within residential homes with an undisclosed medical history, and 
therefore may have not have been as ‘healthy’ as controls recruited for the 
study in this thesis. Nevertheless, scores over 56/70 were considered within 
normal limits for this study, thereby categorising all control groups (for this 
study and within the literature) within the normal range. 
Results from COPD subjects in this study also reflect similar findings found in 
the literature who also used the SWAL-QOL to investigate a specific disease 
group. Most studies evaluating symptoms of oropharyngeal dysphagia using 
the SWAL-QOL were with oncological related diseases (Genden, Okay, 
Stepp, & Rezaee, 2003; Lovell, Wong, Low, & Ngo, et al., 2005; Roe, Leslie, 
& Drinnan, 2007; Bandeira, Azevedo, Vartanian, & Nishimoto, et al., 2008; 
Greenblatt, Sippel, Leverson, & Frydman, et al., 2009; Khaldoun, Woisard, & 
Verin, 2009). Only three of these studies documented ‘symptom’ domain 
mean scores for their subjects post surgery; with Banderia and Azevedo et al 
(2008) and Greenblatt and Sippel et al (2009) reporting scores above 56/70 
and Khaldoun and Woisard et al (2009) who reported a mean score of 39/70. 
Interestingly, the Greenblatt and Sippel et al (2009) study also recorded a 
pre-surgical symptom mean score which was above 56/70, thereby placing 
pre-surgical patients within the normal range for this domain. Lower scores in 
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the Khaldoun and Woisard et al (2009) study may reflect subjects recruited 
with pharyngeal cancer, as the SWAL-QOL symptom domain is 
predominated with pharyngeal symptom questions compared to oral 
symptoms. However this study’s findings of COPD subjects during stable 
phase were similar to Banderia and Azevedo et al (2008) and Greenblatt and 
Sippel et al’s (2009) (pre and post surgery) findings within oral and thyroid 
cancer surgical subjects respectively, and also findings during feasibility 
testing for the study in this thesis (Md score 58/70); discussed in section 
4.4.1. As the feasibility testing was a mailout/mail in design, respondents 
came from the community setting (respondents’ homes) and therefore more 
likely to be stable during completion of the questionnaire. 
In studies using the SWAL-QOL with disease states other than oncology and 
with a previous diagnosis of oropharyngeal dysphagia, Leow and Huckabee 
et al (2010) investigated perceived symptoms in Parkinson’s disease (PD), 
and found a mean score of 49/70 for the ‘symptom’ domain within the later 
stage PD group. Similiarly, Khaldoun and Woisard et al (2009) reported a 
mean score of 48/70 for stroke patients with long term oropharyngeal 
dysphagia. Another finding published after this study’s data gathering phase 
was in McKinstry and Tranter et al (2009), who explored rehabilitation 
outcomes in chronic respiratory disease subjects previously diagnosed with 
oropharyngeal dysphagia. Subjects recorded a ‘pre intervention symptom 
domain’ mean score of 49/70. However as discussed in section 2.8.5iii, 
COPD was a majority subgroup of the research sample with 78% of 
McKinstry  and Tranter et al’s (2009) subjects diagnosed with COPD. They 
also do not state inclusion/exclusion criteria or comorbidities, nor do they 
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state the COPD subject’s phase of COPD at the time of assessing pre 
intervention scores. Nevertheless, all previous studies evaluating known 
dysphagic populations report scores on the ‘symptoms’ domain of the SWAL-
QOL similar to findings for COPD subjects in the study detailed in this thesis 
during exacerbation phase; who have not been previously diagnosed with 
oropharyngeal dysphagia.  
 
7.3.1ii) Perceived swallowing related quality of life 
Six domains of the SWAL-QOL(ab) measured swallowing related quality of 
life; Burden, Eating duration and desire, Food selection, Fear, Mental Health 
and Social. Non parametric testing revealed COPD subjects in this study 
perceived their swallowing related quality of life as significantly lower in all six 
domains when compared with the normal healthy control group (all domains 
p> 0.001), and showed a significant deterioration in two domains during 
exacerbation phase when compared to stable phase; Eating duration and 
desire (p= 0.021) and Fear (p= 0.043). These results suggest COPD 
subjects in this study take longer to eat a meal, have a reduced appetite, and 
have increased fear regarding choking on food/drink; significantly more than 
the normal control group, and significantly more during exacerbations. The 
remaining quality of life domains evaluated using the SWAL-QOL(ab) revealed 
COPD subjects rated swallowing as being a greater burden in life, had 
greater difficulty choosing food and drink they feel they could swallow safely, 
showed greater levels of frustration and anxiety around mealtimes, and 
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reported a negative impact on social situations significantly more than the 
normal control group in this study.  
Of other studies using the SWAL-QOL, only three documented scores for the 
quality of life domains (Bandeira, Azevedo, Vartanian, & Nishimoto, et al., 
2008; Greenblatt, Sippel, Leverson, & Frydman, et al., 2009; McKinstry, 
Tranter, & Sweeney, 2009). As with the symptom domain analysis described 
earlier, swallowing related quality of life mean scores within the literature, 
and during feasibility testing showed similar findings to median scores during 
stable phase COPD in the study detailed in this thesis. However McKinstry 
and Tranter et al’s (2009) findings for ‘pre intervention’ COPD subjects 
varied; with two scores similar to this study’s stable phase COPD findings 
(Food selection and Eating duration and desire), two scores similar to this 
study’s exacerbation phase COPD findings (Burden and Social), and two 
scores not matching either phase within the study detailed in this thesis (Fear 
and Mental Health). This may be due to mixed medical aetiologies, co-
morbidities and/or phase of COPD. However, as discussed previously, 
McKinstry et al’s lack of detail regarding recruitment criteria and phase of 
disease during testing makes it difficult to compare findings. Nevertheless, 
findings from this study show perceived swallowing difficulties impact 
patients with COPD. Interestingly, these findings were also captured in 
patient reports described during case history and clinical suspicion; 
discussed in chapter one and during feasibility testing (chapter four). 
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7.3.1iii) Further considerations 
The SWAL-QOL is still a relatively new tool, and disease specific clinical 
validity and clinical significance of scores have yet to be explored. The 
SWAL-QOL has been validated to be used as a research tool for small 
samples to evaluate outcomes of intervention, therefore assessing changes 
in domain scores within subjects. However what has not been established is 
the threshold of a clinically meaningful change- is a difference of one point 
meaningful within a clinical situation? Differences in scores between phases 
of COPD were found to be statistically significant in the findings detailed in 
this thesis; however further research is also required to ascertain the clinical 
significance of these differences; which are also addressed in subsequent 
objectives in this study. 
McHorney and Robbins et al (2002) developed the SWAL-QOL using 
multiple medical conditions; which included 6% of subjects with a primary 
condition coded as ‘obstructive respiratory disease’ (n= 23). However results 
were reported as a group mean and therefore unable to quantify the number 
of COPD subjects and mean scores that were included within this subgroup. 
COPD specific SWAL-QOL findings within McKinstry and Tranter et al’s 
(2009) study are inconsistent with findings within the study in this thesis as 
discussed earlier. This variability of findings may be due to phase of the 
condition, as addressed within this study; however severity may also effect 
outcome. In the study detailed in this thesis, recruits were rated as moderate 
to severe COPD. Whereas during feasibility testing for this thesis, and 
documented within the McKinstry and Tranter et al (2009) study, recruits 
were coded as mild to moderate COPD; reflecting the higher scores (and 
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therefore less dysphagic and swallowing related quality of life issues) shown 
for the symptom and associated quality of life domains. Additionally, three of 
the four subjects that did not complete the stable phase of the study in this 
thesis were coded as severe COPD and rated within the most dysphagic 
symptoms and associated quality of life. These results highlight the need for 
further research to ascertain the impact of severity of COPD on 
oropharyngeal dysphagia. 
Feedback during feasibility testing for this thesis revealed responders had 
difficulty differentiating general COPD symptoms and those caused by 
swallowing difficulties (n=18). As a result, the domain evaluating fatigue was 
removed as all questions in this domain proved difficult to differentiate and 
had the most negative comments; reporting the greatest confusion. However 
the ‘Fear’ domain had only one potentially confusing question and was 
therefore retained due to the potential relevance to the research aim. 
However subjects may still have had difficulty differentiating general ‘COPD 
symptoms’ from ‘swallowing symptoms’ when answering the question ‘I 
worry about getting pneumonia’ within this domain. Similarly, subjects with 
(understandably) limited knowledge into their swallowing skills may have 
found questions in the ‘symptoms’ domain; such as ‘frequency of coughing’, 
or ‘Having to clear your throat’, difficult to separate from general COPD 
symptoms. Small, mostly non significant changes between pre and post 
intervention scores in McKinstry and Tranter et al’s (2009) study may also 
illustrate this point, as once educated on swallowing symptoms, COPD 
subjects may have increased their awareness and therefore had been better 
equipped to answer the questions more accurately. Further research may be 
 234 
 
required to investigate the sensitivity of the SWAL-QOL within a COPD 
population. 
COPD subjects in this study who self modified their diet may also have had a 
positive impact on SWAL-QOL scores. Subjects who excluded harder to eat 
consistencies from their diet (29% in stable phase and 71% during 
exacerbation phase of COPD) may have reported fewer symptoms resulting 
in a perceived higher quality of life than those who continued with eating all 
consistencies, but with increased difficulty during exacerbations. Similarly, 
levels of personal control and self efficacy (as discussed in section 1.4.2iv) 
may also have contributed to how subjects perceived their swallowing related 
quality of life, as diagnosis and severity does not explain the variance in 
quality of life ratings. However this was beyond the scope of the study 
detailed in this thesis. 
 
7.3.2 Objective Two: Biomechanical swallow characteristics 
The second objective for this study investigated prevalence of biomechanical 
dysphagia by phase of COPD. Additional secondary objectives explored the 
nature of the oropharyngeal dysphagia observed, and also compared 
perception of dysphagic symptoms discussed in section 7.2.1i) with objective 
biomechanical analysis.  This was achieved using the videofluoroscopy 
assessment, and the ‘symptoms’ domain scores from the SWAL-QOL. The 
normal healthy control group did not complete this part of the study as it did 
not receive Ethic Committee’s approval, discussed previously in section 5.2.  
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7.3.2i) Prevalence of oropharyngeal dysphagia in COPD 
Data from videofluoroscopy recordings was translated into four main 
outcomes for food and drink trials; overall dysphagia diagnosis, penetration 
of the bolus, aspiration of the bolus and use of spontaneous compensatory 
manoeuvres. More COPD subjects in this study were considered dysphagic 
on 50% or more of trials during an exacerbation phase (n=14) for food (64%) 
and drink (100%) trials, than for food (20%) and drink trials (70%) during 
stable phase (n=10) as shown in table 22 in chapter six. Non parametric 
testing was completed using percentage of swallows per subject. This 
allowed documentation of all swallows assessed and highlighted the 
variability within subjects in order to gain a greater clinical understanding of 
the nature of oropharyngeal dysphagia in COPD. This study found COPD 
subjects exhibited a significant deterioration in their swallowing ability, with 
more dysphagic swallows during exacerbation phase than during stable 
phase for food (p= 0.046) and drink (p= 0.035) trials.  
These findings broadly concur with Coelho (1987) and Good-Fratturelli and 
Curlee et al (2000) who estimated prevalence of dysphagia in COPD as 71% 
and 85% respectively; with both noting increased dysphagic characteristics 
with drink swallows more than solid trials. However as discussed in chapter 
two, both samples were selected from a pre-existing dysphagia caseload 
with co-morbidities that may account for dysphagia.  When comparing with a 
well documented disease group, findings in the study detailed in this thesis 
during stable phase COPD were similar to estimated prevalence of between 
30% and 65% for assessment within seven days of acute stroke (Smithard, 
O’Neill, Park, & Morris, et al., 1996; Wade & Langton Hewer, 1997; Mann, 
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Hankey, & Cameron, 2000; Pownall, 2009). It is noteworthy that estimated 
prevalence for drink trials for either phase of COPD in the study detailed in 
this thesis exceeded estimates of prevalence during the most acute stage of 
stroke. 
 
7.3.2ii) Secondary Objectives 
Swallows may be considered dysphagic if they differ from the acknowledged 
normal patterns, yet they can still be considered functional, or predict no 
medical sequelae (such as aspiration pneumonia) from assessment. This 
next sections endeavoured to explore dysphagic characteristics within the 
COPD research group further by analysing three key elements of the 
biomechanical swallow process; penetration, aspiration and use of 
spontaneous compensatory manoeuvres. Additionally, this objective 
compared perception of swallow using the ‘symptoms’ domain of the SWAL-
QOL with objective biomechanical measures.  
 
Penetration 
COPD subjects in this study were found to penetrate on one or more 
swallows for 10% of food and 40% of drink trials during stable phase (n=10), 
and 29% of food and 86% of drink trials during exacerbation (n=14). This 
concurs with previous findings within the COPD literature (Good-Fratturelli, 
Curlee, & Holle, 2000; Mahoney, Foo, Goudge, & Scott, et al., 2004; Carney, 
Sheppard, & Laframboise, 2005). However the findings within the literature 
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vary by bolus number, type and size, and phase of COPD proving difficult to 
compare findings with substantial rigor.  Current evidence suggests the 
occurrence of laryngeal penetration increases with age within normal healthy 
populations (Daniels, Corey, & Hadskey, 2004; McCullough, Rosenbek, 
Wertz, & Suiter, et al., 2007; Allen, White, Leonard, & Belafsky, 2010). This 
suggests penetration documented within the study detailed in this thesis, and 
shown within the literature for COPD is considered within normal limits. 
However, the study detailed in this thesis is the first known study to explore 
differences between phases in COPD subjects not previously diagnosed with 
dysphagia, and revealed a significant increase in rates of penetration of drink 
trials during exacerbation phase (p=0.031). Furthermore, subjects observed 
to penetrate food and drink reported within the study in this thesis were 
coded as three (enters the laryngeal vestibule with visible residue remaining) 
with increased frequency during exacerbation phase. These findings 
highlight an increased risk of dysphagia when COPD patients become 
medically unstable, as predicted within other disease states previously 
diagnosed with dysphagia (Logemann, Pauloski, Rademaker, & Kahrilas, 
2002). However a larger sample is required to confirm these preliminary 
findings. 
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Aspiration 
This is the first known study to compare oropharyngeal aspiration by phase 
of COPD subjects not previously diagnosed with dysphagia in order to 
estimate prevalence. Although findings did not reach statistical significance, 
trace aspiration was noted more during exacerbation phase for drinks and 
food trials. Rates of aspiration for COPD subjects in this study during one or 
more swallows for food (7%) and drink (57%) trials during exacerbation 
(n=14); when compared to food (0%) and drink (20%) trials during stable 
phase (n=10), may provide clinically significant information. Additionally, 
findings within this study were also similar to the literature for COPD subjects 
with known dysphagia exploring rates of aspiration. COPD subjects in this 
study generally concurred with the prevalence of aspiration occurring more 
during liquid than solids trials (Good-Fratturelli, Curlee, & Holle, 2000; 
Mokhlesi, Logemann, Rademaker, & Stangl, et al., 2002). Good-Fratturelli 
and Curlee et al (2000) reported a large proportion of their sample (42%) 
aspirated. Whereas Carney and Sheppard et al (2005) was the only study to 
overtly recruit exacerbation phase subjects, and revealed aspiration during 
drink trials (10/21) on videofluoroscopy. Both Good-Fraturelli and Curlee et 
al’s (2000) and Carney and Sheppard et al’s (2005) study revealed lower 
rates of aspiration in a known dysphagic population than findings in the study 
detailed in this thesis for drink trials during exacerbation phase. 
Consequently, findings within the study detailed in this thesis may provide 
clinically significant information regarding the importance of strong 
pulmonary defences but the findings require further exploration given the 
modest number of subjects included.  
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Whether oropharyngeal aspiration within a normal healthy population is 
considered normal (Beal, Chesson, Garcia, & Caldito, et al., 2004; Butler, 
Stuart, & Kemp, 2009) or abnormal (Robbins, Hamilton, & Lof, 1992; Allen, 
White, Leonard, & Belafsky, 2010), the normal healthy population are 
considered to be more mobile and exhibit strong pulmonary defences to 
combat aspiration should it occur (Gleeson, Eggli, & Maxwell, 1997; 
Langmore, 1991; Langmore, Terpenning, Schork, & Chen, et al., 1998). This 
is in direct contrast to patients with COPD who, by the very nature of their 
disease, have deteriorating lung function alongside reduced mobility and 
lowered pulmonary defence mechanisms (Donaldson & Wedzicha, 2006). 
Perhaps trace aspiration; considered insignificant and a normal occurrence 
in some studies alongside normal lungs defences and mobility, may need to 
be viewed as more detrimental within a population with reduced lung 
function. To understand the importance of aspiration for patients with COPD, 
further longitudinal research should endeavour to explore the health 
outcomes of unmanaged dysphagia; comparing groups of COPD patients 
with and without oropharyngeal aspiration (trace or otherwise), rather than 
exclusively comparing with findings from normal healthy controls. 
 
Spontaneous Compensatory Manoeuvres 
Spontaneous manoeuvres for one or more swallows were used by COPD 
subjects in this study during 40% of food and 80% of drink trials during stable 
phase (n=10), and 86% of food and 100% of drink trials during exacerbation 
phase (n=14). Furthermore, non parametric testing revealed COPD subjects 
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in this study used significantly more spontaneous compensatory manoeuvres 
for food trials during exacerbation phase than during stable phase (p=0.044). 
Yet findings for both consistencies (regardless of phase of COPD) may 
provide clinically significant information when compared with normative 
information documented within the literature. Descriptive analysis revealed 
COPD subjects in this study provided additional airway protection by 
spontaneously using compensatory manoeuvres. As discussed in chapter 
two, normal healthy adults irrespective of age do not appear to use 
spontaneous compensatory manoeuvres during swallowing (Leslie, Drinnan, 
Ford, & Wilson, 2005; Perlman & He, 2006). Therefore the use of 
spontaneous manoeuvres as seen in this study may reflect an underlying 
oropharyngeal dysphagia and a subconscious effort to compensate for 
difficulties; more so (with or without success) during exacerbation phase 
within this study.  
Teaching compensatory manoeuvres can be part of a Speech and Language 
Therapy intervention plan when a patient has oropharyngeal dysphagia, as 
discussed in section 2.6. However none of the COPD subjects in this study 
had received swallowing advice or were taught compensatory manoeuvres 
prior to recruitment. Therefore they all spontaneously developed strategies in 
order to feel safer when eating and drinking. Interestingly, some of the 
techniques observed are recognised manoeuvres taught by Speech and 
Language Therapists to improve the efficiency and safety of the swallow 
(Logemann, 1998). Previous studies in the literature have also revealed that 
patients with progressive and degenerative diseases naturally develop 
functional compensations or tolerances to swallowing difficulties (Logemann, 
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1999; Hadjikoutis, Pickersgill, Dawson, & Wiles, 2000). With this in mind, the 
use of spontaneous manoeuvres may have positively influenced the amount 
of penetration and aspiration observed in the study detailed in this thesis as 
discussed earlier. By spontaneously using compensatory manoeuvres, 
COPD subjects in the study detailed in this thesis may have successfully 
avoided aspirating a bolus, and/or produced a swallow that was coded as 
dysphagic ( by using a manoeuvre) but functional. This may be further 
highlighted by the relatively high proportion of subjects considered dysphagic 
compared with a lower proportion observed to penetrate or aspirate. 
Additionally, the increased proportion of penetration and aspiration seen 
during exacerbation phase may indicate that spontaneous manoeuvres may 
not be as effective during exacerbations for COPD subjects in this study. The 
findings emerging from this preliminary study confirm that larger scale 
studies on the use and effectiveness of spontaneous compensatory 
manoeuvres by phase of COPD is merited. 
 
Perception of swallow verses videofluoroscopy 
The ‘symptom’ domain on the SWAL-QOL was compared with the ‘overall 
dysphagic’ score from videofluoroscopy (both discussed earlier) to 
investigate whether patient perception of physiological swallow correlated 
with objective biomechanical measurement. A negative relationship was 
expected; the lower the score on the symptom domain, the higher the 
percentage for the ‘overall dysphagia’ section. Findings revealed a small to 
moderate relationship which was not statistically significant between stable 
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food (r= -0.480, p>0.05) and drink swallows (r= -0.145, p>0.05), however 
exacerbation phase trials did not produce the expected negative relationship.  
McHorney and Martin-Harris et al (2006) suggest the SWAL-QOL provides a 
relative independence of dysphagia specific QOL and biomechanical function 
and results should provide ‘varied but complimentary information about the 
patient’. This is certainly true regarding the QOL domains as these areas 
explore the perceived impact of swallowing on the patient; acknowledged 
within the literature to differ from objective measures (Wilson & Cleary, 
1995).  However, information on the ‘symptoms’ domain clearly state 
questions pertaining to oral and pharyngeal physiological dysphagic 
symptoms, questions also found in dysphagia specific functioning 
questionnaires for head and neck cancer (Chen, Frankowski, Bishop-Leone, 
& Herbert, et al., 2001) and therefore should correspond to more objective 
measures. Interestingly, McHorney and Martin-Harris et al (2006) explored 
the relationship between the SWAL-QOL and videofluoroscopic assessment 
with known dysphagics, but excluded correlational analysis from the findings 
between the symptom domain and videofluoroscopy results without 
explanation. Furthermore, videofluoroscopies were historical measurements 
from outpatient clinics and SWAL-QOL was completed up to three months 
post videofluoroscopy using a mail out/mail in system; hence 
videofluoroscopy may have been completed during an acute phase, and 
SWAL-QOL completed during stable dysphagia. It is noted that McHorney 
and Martin-Harris et al (2006) used penetration/aspiration rates to correlate 
with the quality of life domain. As discussed earlier, symptoms of swallowing 
difficulties are not always associated with pathophysiological markers of 
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dysphagia, therefore using a true representation of the swallow; such as an 
‘overall dysphagic’ rating as used in this study which includes more 
dysphagic characteristics than just penetration/aspiration rates, may provide 
more relevant information. However the study detailed in this thesis recruited 
a small sample and larger longitudinal studies are required to confirm these 
preliminary findings. 
 
7.3.3 Objective Three: Respiratory-swallow pattern  
The final objective of this study aimed to investigate the respiratory-swallow 
pattern used in stable and exacerbation phases of COPD, and to explore the 
relationship between the respiratory-swallow pattern and biomechanical 
assessment. This was achieved by simultaneously assessing respiration 
surrounding the swallow during videofluoroscopy analysis using a Limited 
Polysomnogram (LPSG), and the ‘overall dysphagic’ score obtained in 
objective two. The normal healthy control group did not complete this part of 
the study as it did not receive Ethic Committee’s approval, as discussed 
previously. 
 
7.3.3i) Respiratory-swallow pattern 
Data from LPSG readings were translated into four main respiratory-swallow 
patterns; inhalation-swallow-inhalation (INH/INH), exhalation-swallow-
inhalation (EXH/INH), inhalation-swallow-exhalation (INH/EXH) or 
exhalation-swallow-exhalation (EXH/EXH). This study was interested in the 
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variation of pattern within subjects and the use of inhalation post swallow 
(either INH/INH or EXH/INH patterns) increasing the risk of aspiration; as 
predicted by Martin-Harris and Brodsky et al (2003). Descriptive analysis 
revealed the COPD subjects in this study used inhalation post swallow for 
one or more swallows for 100% of food and drink trials during stable phase, 
and 93% and 100% for food and drink trials respectively during exacerbation 
phase. Non parametric testing revealed a non-statistically significant 
difference for COPD subjects in this study, suggesting they were no more 
likely to use inhalation post swallow during stable or exacerbation phase.   
Although findings did not reach statistical significance, descriptive analysis 
may provide clinically significant information. COPD subjects in this study 
revealed an altered respiratory-swallow pattern from the well documented 
normal pattern within the literature discussed in chapter three; which 
acknowledges exhalation post swallow as the predominant pattern used by 
normal healthy adults (Selley, Flack, Ellis, & Brooks, 1989; Smith, Wolcove, 
Colacone, & Kreisman, 1989; Shaker, Ren, Townsend, & Dodds, et al., 
1992; Martin, Shaker, & Dodds, 1994; Paydarfar, Gilbert, Poppel, & Nassab, 
1995; Preiksaitis, Mayrand, Robins, & Diamant, 1992; Klahn & Perlman, 
1999; Gross, Atwood Jnr, Grayhack, & Shaiman, 2003; Martin-Harris, 
Brodsky, Michel, & Ford, et al., 2005). The (non statistically significant) 
altered respiratory-swallow pattern found in the study detailed in this thesis 
cannot be accounted for by increasing age, as the majority of studies 
suggest age does not alter this pattern (Zamir, Ren, Hogan, & Shaker, 1996; 
Hiss, Treole, & Stuart, 2001; Hirst, Ford, Gibson, & Wilson, 2002; 
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Charbonneau, Lund, & McFarland, 2005; Leslie, Drinnan, Ford, & Wilson, 
2005; Kelly, Huckabee, Jones, & Carroll, 2007).  
The high proportion of the preferred aberrant respiratory-swallow pattern for 
drink trials found in the study in this thesis also cannot be accounted for by 
bolus volume or delivery. This study used a bolus volume of 10ml self 
delivered by small cup; instructed to swallow ‘in their own time’ which has 
been shown in the literature not to influence respiratory-swallow pattern 
(Nishino & Hiraga, 1991; Dozier, Harris, Brodsky, & Michel, et al, 2006; 
Martin-Harris, 2008). Food trials that require chewing; as used in this study, 
have been shown in the literature to vary the use of respiratory-swallow 
patterns in normal populations (Matsuo, Palmer, & Hiiemae, 2006; Gross, 
Atwood, Ross, & Olszewski, et al., 2009). However if this was the case, 
findings in the study in this thesis would have expected to show a difference 
in pattern between food and drink trials, yet the proportion of inhalation post 
swallow for food and drink trials were relatively equal. Therefore this may not 
be the only factor to influence the respiratory-swallow pattern for food trials. 
Deviation to the normal respiratory-swallow coupling has been 
acknowledged in the literature to be due to disease or disorder, as discussed 
in chapter three.  Additionally, two studies investigating the respiratory-
swallow pattern in COPD subjects also suggest disease is a factor in altering 
this pattern (Shaker, Ren, Townsend, & Dodds, et al., 1992; Gross, Atwood, 
Ross, & Olszewski, et al., 2009). The use of strict inclusion criteria, bolus 
volume and delivery, alongside historical normative and COPD findings in 
the literature, enables findings in this study to conclude that disease is most 
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likely a contributing factor in altering respiratory-swallow pattern in COPD in 
this study.  
Swallow Apnoea 
Swallow apnoea duration during the respiratory-swallow pattern was 
measured from videofluoroscopy recordings matched with LPSG readings. 
Descriptive analysis revealed median scores for apnoea duration in stable 
phase was 1.6 seconds (0.960-2.00 sec) for drink trials and 1.2 seconds 
(1.00-2.70 sec) for food trials; and 1.6 seconds (0.850-2.80 sec) and 1.5 
seconds (0.830-4.00 sec) for drink and food trials respectively during 
exacerbation phase. Earlier work within the literature suggests swallow 
apnoea duration is shorter than the pharyngeal stage duration of 
(approximately) 750 milliseconds (Love & Webb, 1996). However findings in 
this study tend to concur with more recent studies that suggest swallow 
apnoea can be initiated within the oral preparatory and oral stages of the 
swallow, or continue after the pharyngeal stage has completed (discussed in 
chapter two) (Martin-Harris, Brodsky, Price, & Michel, et al., 2003; Martin-
Harris, Brodsky, Michel, & Ford, et al., 2005), thereby observing longer 
apnoea durations than previously known. This finding may also confirm the 
use of spontaneous compensatory manoeuvres seen in objective two (see 
section 6.5.2iii); the majority of which employed by subjects require increase 
airway protection; subsequently increasing apnoeic durations. The observed 
longer swallow apnoea durations may also account for the low rates of 
aspiration found in this study. This concurs with a study by Nilsson and 
Ekberg et al (1997) who suggested shorter swallow apnoea and longer 
pharyngeal transit times increased the incidence of aspiration and 
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penetration. However Martin-Harris and Brodsky et al (2005) found healthy 
patients over the age of 81 exhibited longer swallow apnoeas (mean=1.69 
seconds) when compared to a younger group (21-40years, mean=1.04 
seconds). Age may have been a factor contributing to the increased duration 
of swallow apnoea within the findings in the study detailed in this thesis; 
however it is most likely that the significant use of spontaneous 
compensatory manoeuvres (that require longer airway closure) is also a 
major contributing factor. The impact of eliciting spontaneous manoeuvres on 
swallow apnoea duration requires further larger scale research to confirm 
this potentially clinically significant finding. 
 
7.3.3ii) Respiratory-swallow pattern verses biomechanical 
analysis. 
The final objective explored the relationship between the predominant 
respiratory phase used post swallow by COPD subjects in this study 
(inhalation) with ‘overall dysphagic’ ratings documented in objective two to 
investigate if the use of inhalation post swallow was a contributing factor to 
dysphagic characteristics. However there was no significant relationship in 
either phase of COPD for food or drink trials found. A likely factor 
contributing to this result may have been the lack of variability within the 
sample, with scores clustered in the higher observations for both inhalation 
post swallow and swallows considered dysphagic.  
Methodology and data analysis within this objective was unique, as it 
investigated the relationship using a range of dysphagic characteristics, such 
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as impaired chewing, premature loss of the bolus, oral and pharyngeal 
residue, delay pharyngeal initiation, as well as aspiration scores by phase of 
COPD. Other studies that have explored the respiratory-swallow pattern 
have either not commented on observed simultaneous swallow function 
(Martin-Harris, Brodsky, Price, & Michel, et al., 2003; Gross, Atwood, Ross, 
& Olszewski, et al., 2009) or correlated the respiratory pattern with rates of 
penetration and/or aspiration only (Nilsson, Ekberg, Bulow, & Hindfelt, 1997; 
Martin-Harris, Brodsky, Michel, & Ford, et al., 2005; Dozier, Harris, Brodsky, 
& Michel, et al., 2006; Cvejic, Harding, Churchward, & Turton, et al., 2011). 
Of these, Nilsson and Ekberg et al (1997) used dysphagic stroke patients, 
whilst Martin-Harris and Brodsky et al (2005) and Dozier and Harris et al 
(2006) aimed to explore normal patterns. Unsurprisingly the latter two studies 
found no aspiration or penetration among normal subjects and subsequently 
no significant respiratory-swallow pattern correlation. However Nilsson and 
Ekberg et al (1997) did not comment on respiratory phases surrounding the 
swallow, therefore cannot be compared with findings in this study. 
Interestingly, Cvejic and Harding et al (2011) found aspiration occurred in 
more stable COPD subjects (4/16) than normal controls (1/15) (p=0.07), with 
a preferred respiratory-swallow pattern in COPD subjects of INH/EXH than 
normal controls (p=0.02) during 100ml drink trials. However the relationship 
between respiratory-swallow pattern and rates of aspiration was not 
documented. 
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7.4 Overall considerations 
This study aimed to estimate true prevalence within a general COPD 
population. As COPD and oropharyngeal dysphagia are complex conditions, 
it would be impossible to obtain a truly homogeneous sample population. 
However we can exclude some factors in an attempt to make the sample 
population as homogeneous as possible. It is noteworthy that subjects were 
classified as moderate to severe COPD as per COPD NICE Clinical 
Guidelines 12 (National Collaborating Centre for Acute and Chronic 
Conditions., 2004); guidelines in practice at the time of protocol development 
and data collection. However subjects would have been classified as severe 
to very severe within the revised guidelines (National Clinical Guideline 
Centre, 2010).  
Subjects included in the study were not previously diagnosed with 
dysphagia, had no co-morbidities that may account for the study’s findings, 
however 11/14 met one or two of the five independent predictors of 
aspiration pneumonia (reduced locomotion and altered diet) (Langmore, 
Skarupski, Park, & Fries, 2002). 
Previous studies have reported prevalence within their findings (Coelho, 
1987; Good-Fratturelli, Curlee, & Holle, 2000) including the development of 
the SWAL-QOL (McHorney, Robbins, Lomax, & Rosenbek, et al., 2002); 
however recruitment was obtained from pre-existing or historical Speech and 
Language Therapy caseloads (see section 2.8). This would endeavour to 
provide an estimated prevalence within a subgroup of COPD patients. In my 
opinion, these studies cannot estimate true prevalence; and I concur with 
O’Kane and Groher’s (2009) systematic review of the literature, stating no 
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previous literature has provided an estimate of true prevalence of 
oropharyngeal dysphagia in the COPD population. Estimates using patient 
perception and biomechanical assessment; by phase of COPD shown in the 
study detailed in this thesis, is the first known study to provide estimates of 
true prevalence within a general COPD population. 
The study detailed in this thesis was also interested in investigating the 
detrimental effects of dysphagia on health and wellbeing in patients with 
COPD. Therefore a repeated measures design was used to follow subjects 
up during stable phase once they had been discharged from hospital. This 
allowed findings from the study to evaluate the progressive ‘decompensation’ 
of the swallow, rather than measuring just an acute episode (Langmore, 
Skarupski, Park, & Fries, 2002). Additionally, a quality of life measurement 
was included in this study to provide a holistic perspective of the impact of 
dysphagia, which is not routinely included in assessment procedures or 
management decisions (Higginson & Carr, 2001). However the literature 
acknowledges that quality of life is highly individual, and a standardised, 
‘forced choice’ questionnaire struggles to truly capture the essence of what is 
important to a particular individual. In my opinion, inclusion of both patient 
perspective and clinical judgement is crucial within research to ensure future 
holistic intervention strategies become embedded within the evidence base. 
Findings in this study were reported per subject and also as a ‘percentage of 
swallows’ per subject for objectives two and three. Most studies in the 
literature investigating oropharyngeal dysphagia report findings ‘per subject’ 
(Coelho, 1987; Logemann, Pauloski, Rademaker, & Kahrilas, 2002; 
Mokhlesi, Logemann, Rademaker, & Stangl, et al., 2002); whereas studies 
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analysing the respiratory-swallow pattern tend to report their findings as 
percentage of swallows per subject (Klahn & Perlman, 1999; Charbonneau, 
Lund, & McFarland, 2005; Kelly, Huckabee, Jones, & Carroll, 2007; Gross, 
Atwood, Ross, & Olszewski, et al., 2009). Both types of analysis provide 
valuable information and therefore were utilised in the study in this thesis 
where appropriate (see chapter five). Estimating prevalence requires 
information analysed per subject; and for this study a dysphagic 
characteristic or respiratory-swallow pattern that was observed in 50% or 
more of the swallows for food and/or drink trials was included. A figure of 
50% or more of trials was chosen to ensure the characteristic or pattern 
observed did not occur by chance; not always as rigorously administered 
within the literature. However this measure excludes characteristics or 
patterns that occur less than 49%; therefore further non parametric analysis 
on the data used percentage of swallows per subject which highlighted the 
variability within subjects. 
Non parametric testing in this study employed dependent (Wilcoxon Signed 
Rank Test) and independent analysis (Mann Whitney U Test) within subjects 
(stable verses exacerbation phase) and between subjects (COPD verses 
normal control) respectively. This method of analysis increased the statistical 
validity within this study’s small sample size (Machin, Campbell, & Walters, 
2010). However due to Wilcoxon Signed Rank Tests using related sets of 
data, four subjects who did not complete stable phase of the study were 
omitted from this part of the analysis. When these subjects are included into 
data analysis (therefore treating stable and exacerbation phases as two 
independent sets of data), then COPD subjects were shown to aspirate and 
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penetrate on drink trials significantly more during exacerbation phase than 
during stable phase of COPD. This highlights the importance of the findings 
of the study in this thesis; however a larger sample size is required to confirm 
these findings. 
 
7.5 Potential Causes of Oropharyngeal Dysphagia in COPD 
This study focused on increasing the evidence base in attributing COPD with 
oropharyngeal dysphagia, with some interesting statistically and clinically 
significant results. However with all diagnoses of dysphagia, it is important to 
not only identify symptoms, but to also understand the potential cause. 
Some studies in the literature attribute oropharyngeal dysphagia as a 
consequence of ageing (Beal, Chesson, Garcia, & Caldito, et al., 2004; 
Butler, Stuart, & Kemp, 2009). However there is more robust evidence to 
suggest normal age swallowing is not associated with aspiration of bolus, 
use of spontaneous manoeuvres, or perceived lowered swallowing related 
quality of life (Robbins, Hamilton, & Lof, 1992; Allen, White, Leonard, & 
Belafsky, 2010).  
More recently however, research interest has focused on altered lung 
volume and/or reduced subglottic pressure as contributing factors to 
oropharyngeal dysphagia. Historically swallowing and breathing mechanisms 
were considered to be independent of each other, with more current 
evidence acknowledging breathing and swallowing to be interconnected via 
central pattern generators found in the medulla, with sensory receptors found 
in the pharynx and larynx as previously discussed (discussed in chapter 
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two). Gross and Steinhauer et al (2006) further postulated that the larynx is 
not just an organ for vocalisation, but contains mechanoreceptors in the 
subglottis which are important in providing sensory feedback to the medulla; 
ensuring a safe and efficient swallow. They hypothesise that these subglottic 
mechanoreceptors are dependent on lung volume; with higher lung volumes 
creating sufficient subglottic pressure to stimulate the mechanoreceptors. 
High lung volumes would place respiration post swallow in exhalation phase 
(either end inhalation or mid exhalation phases during swallow apnoea); 
confirmed by findings on the respiratory-swallow pattern in normal adults 
(Martin-Harris, Brodsky, Michel, & Ford, et al., 2005). As shown in objective 
three of this study and in the literature (Shaker, Ren, Townsend, & Dodds, et 
al., 1992; Gross, Atwood, Ross, & Olszewski, et al., 2009), patients with 
COPD tend to inhale post swallow predominately more than historic normals; 
placing their swallows in low lung volumes, thereby reducing pressure on the 
subglottic mechanoreceptors and increasing the duration of the pharyngeal 
stage. The altered respiratory-swallow pattern induced by COPD may be a 
significant contributing factor to oropharyngeal dysphagia, however further 
research is required to confirm this theory. 
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7.6 Limitations of the Study 
This study provided preliminary information to inform future studies in areas 
such as statistical power, research design, and recruitment and retention 
issues using a prescribed sample size.  A larger sample would have provided 
more statistical information however was challenging to obtain for a number 
of reasons; mostly related to ethical requirements, time and budget 
constraints. As the subjects were not originally from a Speech and Language 
Therapy caseload, ethical considerations added extra challenges to the 
recruitment procedure and payment was required for videofluoroscopy 
sessions and research team involvement. Two years of protected research 
time (two days per week) from my normal clinical duties was allocated to 
complete the study. With strict research ethics and governance protocols 
requiring a stringent application procedure completed; this allowed 10 
months for the recruitment phase. Under ethics stipulation, recruitment was 
required to be undertaken by Dr RL (Respiratory Consultant part of the 
research team), and once initial consent was gained, I was then permitted to 
approach the potential subject to finalise consent and initiate assessments. A 
more straight forward recruitment selection process would have been to use 
a pre-existing Speech and Language Therapy caseload, enabling the 
potential subjects to be approached directly. However one of the aims of the 
study was to gain true prevalence of oropharyngeal dysphagia in patients 
with COPD; therefore this recruitment selection pathway was deemed 
unsatisfactory for the needs of this study. Although the method utilised in this 
study improved on the recruitment process compared to those reported 
within the literature (dysphagic patients), it still only recruited a subgroup of 
COPD patients; that is patients admitted to hospital who were willing to 
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consent to the study. This is further highlighted by this study recruiting only 
moderate and severe COPD subjects, as mild COPD patients tended to be 
managed at home (National Clinical Guideline Centre, 2010). This weakness 
may be overcome by using a wider recruitment selection process to capture 
community and hospital based COPD patients, however this would have 
incurred larger costs and challenges with subject recruitment processes 
which were beyond the scope of this preliminary study.  
The study detailed in this thesis used strict inclusion/exclusion criteria to 
strengthen the statistical validity of the results; yet this in turn may have 
limited the clinical validity of the findings.  Approximately 15% (6/39) of 
potential subjects were excluded due to co-morbidities with known 
associations with oropharyngeal dysphagia. Such strict inclusion criteria was 
imperative in this study as any identified dysphagic characteristics within the 
research group found needed to be directly associated with a diagnosis of 
COPD. However it is acknowledged that patients with COPD are associated 
with multiple co-morbidities (Cosio & Agusti, 2010), with studies showing 
patients with COPD and co-morbidities such as stroke, further increase the 
likelihood of developing dysphagia (Ding & Logemann, 2000; Ramsey, 
Smithard, & Kalra, 2005; Sellars, Bowie, Bagg, & Sweeney, et al., 2007). 
Future research may be required to explore the effect of one or more co-
morbidities alongside a diagnosis of COPD on oropharyngeal dysphagia. 
Initial recruitment occurred during admission to hospital due to exacerbation 
of pre existing COPD. This presented an ethical dilemma as recruitment 
occurred when the subject was medically unstable; resulting in 10% (4/39) 
considered too unwell to be included. Given the unpredictable nature of 
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exacerbations, it would have been challenging to recruit during stable phase 
with the follow-up phase occurring during exacerbation phase. This was due 
to subjects being admitted into any Sheffield Teaching Hospital for their 
exacerbation (or being treated at home), and the inability to ‘flag’ admissions 
to the research team due to conflict of confidentiality. Therefore recruiting 
initially during exacerbation phase was considered the most reliable way to 
control the follow-up phase of the study, whereby subjects were given a 
follow-up appointment to attend an outpatient clinic (with Dr RL); alongside 
completion of the second element of the study once in stable phase. This 
recruitment process may also have contributed to the low retention rate.  Of 
subjects recruited during exacerbation phase, 28% (n=4) failed to meet 
criteria to undergo stable phase assessment. However this may also reflect 
the variability of medical stability and fragility within the subject group. 
The study would have also benefitted from a case control design where the 
control group completed all of the objectives. However the normal healthy 
control group was only able to complete the SWAL-QOL for objective one of 
the study due to research ethical and governance stipulations. The small 
amount of radiation was deemed appropriate for COPD subjects (not already 
referred) as it was unlikely to be identified with any health detriment from 
participation in this study (chapter four). Even though normal healthy adults 
have completed videofluoroscopy assessments under the same 
circumstances in studies found in the literature (Logemann, Rademaker, 
Pauloski, & Ohmae, et al., 1998; Logemann, Pauloski, Rademaker, & 
Colangelo, et al., 2000; Logemann, Pauloski, Rademaker, & Kahrilas, 2002; 
Cvejic, Harding, Churchward, & Turton, et al., 2011) this was not deemed 
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satisfactory and therefore declined by the research ethics and governance 
committee, and the Radiology Department at Sheffield Teaching Hospitals. 
Three videofluoroscopy sessions were initially allocated to occur on one day 
per week, thus recruitment could only take place one to two days per week in 
order to ensure exacerbation phase assessment was within the first 48 hours 
of admission (see chapter five). However successful negotiation of additional 
sessions on a separate day allowed for increased recruitment time over two 
to three days. Additional to these procedural challenges, COPD admission 
rates declined during the recruitment phase for two main reasons. Firstly, 
COPD admission rates show expected seasonal fluctuations, with an 
estimated 50% increase in exacerbations more likely to occur during the 
winter months (Donaldson & Wedzicha, 2006). However the recruitment 
phase in this study coincided mostly during the warmer months. Secondly, 
Sheffield Teaching Hospitals reported a 50% reduction in COPD admissions 
as a result of coinciding with a project piloting Telehealth within the COPD 
population during the recruitment phase of this study (Confederation of 
British Industry (CBI), 2010).  
Data collection and analysis was not blinded to the researcher or the subject. 
Videofluoroscopy and LPSG readings were subject to interpretation, and 
subjects may have attempted to ‘perform’ for the research during 
videofluoroscopy. To reduce the bias potential this may have created, and to 
increase the validity of results, inter and intra rater relability was conducted 
on all data collection. All data was entered into SPSS twice to highlight any 
inputting errors and any anomalies within the data before statstical analysis 
was performed. Interrater relaibility was conducted on both LPSG and 
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videofluoroscopy data, with a 75-100% agreement on main objectives 
achieved, as documented in chapter six. Futhermore, dichotomous outcome 
measures for LPSG and videofluoroscopy were selected for their known high 
interrater reliability. (Martin-Harris, Brodsky, Price & Michel, 2003). 
Additionally, subjects were given sufficient information to understand and 
consent to the research process, but television monitors showing ‘live 
swallows’ under x-ray were postioned out of eyesight of the patient, and 
exact measures and results were not discussed with the subject until after 
the follow-up was completed during stable phase. 
Combining the LPSG use of nasal canula with chest excursion strap 
readings to measure respiratory movements during the swallow proved vital, 
as accuracy of nasal canula readings in this study were variable. Possible 
causes for the reduced efficiency may be the high percentage of subjects 
requiring oxygen through an additional nasal canula. The flow of oxygen may 
have disrupted or masked the airflow through the nares; subsequently 
altering pressure readings within the transducer. This difficulty has not been 
documented in other studies using nasal canula readings exclusively, nor 
has the use of providing oxygen via an additional nasal canula been 
documented within previous studies to allow comparison of findings (Martin-
Harris, Brodsky, Michel, & Ford, et al., 2005; Gross, Atwood, Ross, & 
Olszewski, et al., 2009). Another possible reason may have been the 
frequency of mouth-breathing during measurement, and therefore not 
allowing airflow direction to be picked up on the nasal transducer. However, 
as the use of LPSG machine during videofluoroscopy has not been 
documented previously in the literature, it is difficult to draw conclusions. 
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Another issue regarding reliability pertains to combining respiratory and 
swallow data in order to code respiratory-swallow patterns.Readings from 
videofluoroscopy and LPSG were measured simultaneously, however data 
points from the separate recordings required to be combined manually. This 
was achieved by using the event marker on the LPSG readings (I placed for 
every start of oral and pharyngeal stage based on live videofluoroscopy 
monitor pictures), digital timer on the videofluoroscopy readings and ensuring 
trial presentation was consistent for every subject (three drink, three food, 
three drink) for ease of corresponding videofluoroscopy readings with LPSG 
output. Whilst this method proved effective, it was time consuming, as each 
swallow required individual matching. Other studies have gathered similar 
data using a ‘swallow station’. This machine automatically records and 
documents respiration alongside the swallow during videofluoroscopy. 
However this new technology is expensive and was not available within the 
clinic at Sheffield Teaching Hospitals at the time of this study. Nevertheless, 
with increased evidence, LPSG alongside videofluoroscopy may prove to be 
useful in cash strapped clinics in the future.  One possible solution to reduce 
costs of the study would have been to incorporate non-visual instrumentaton 
of the swallow such as electromyography (EMG) instead of using 
videofluoroscopy; seen within the literature (see chapter two and chapter 
four). This would have reduced costs as the radiology clinic would not have 
been required; consequently increasing recruitment potential as assessment 
could have been performed any working day and at bedside or outpatient 
clinic, and also be less invasive. However, as discussed previously, the use 
of non-visual instrumentation would not have provided the same level of 
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content validity that videofluoroscopy offers, nor would it have been able to 
provide concurrent data on the physiology of the respiratory-swallow pattern 
(Martin-Harris, Brodsky, Price, & Michel, et al., 2003) alongside physiological 
findings of the swallow. In my opinion it would have been methodologically 
flawed to use non-visual instrumentation in this study when videofluoroscopy; 
the most predominant method to measure swallowing (Martin-Harris, 
Brodsky, Michel, & Ford, et al., 2005) was available. 
 
7.7 Implications for Clinical Practice 
This study has shown emerging evidence of the potential under-diagnosis 
and therefore under-management of oropharyngeal dysphagia occurring for 
patients with COPD. Furthermore, this study provides emerging evidence for 
incorporating patient wellbeing and respiratory-swallow pattern analysis into 
the diagnostic and monitoring processes. Once confirmed by larger scale 
studies in the future, these preliminary findings may have direct implications 
on clinical practice, and subsequently COPD guidelines and national policies. 
Current intervention pathways do not acknowledge dysphagia as a risk factor 
for patients with COPD, nor do guidelines acknowledge dysphagia 
specialists as part of the core multidisciplinary team or include within 
pulmonary rehabilitation sessions (National Clinical Guideline Centre, 2010). 
Perhaps following an increased evidence base, oropharyngeal dysphagia 
diagnosis and management will be recognised within these essential 
multidisciplinary team intervention strategies. I would envisage this may 
encompass the following at a national and multiprofessional level; 
 261 
 
 Acknowledging the evidence within government guidelines and 
national policies. 
 
 Education provided to professionals, patient and carers.  
 
 Risks and symptoms of dysphagia; with referral to Speech and 
Language Therapy (or dysphagia specialists) included within patient 
care pathways. 
 
 Dysphagia education given to patients and carers, via individual 
session and group sessions, such as pulmonary rehabilitation. 
 
However improving quality of care for patients with COPD who are dysphagic 
may also occur at the level of the Speech and Language Therapist (or 
dysphagia specialist) in the following way; 
 Education in the evidence base for assessing patients with COPD 
 
 Inclusion of respiratory analysis during assessment 
 
 Intervention to include self management techniques, such as 
respiration-swallow pattern therapy or consistency modification 
 
There appears to be urgency within the NHS to provide leaner, more efficient 
packages of care with reduced waiting times (Department of Health, 2004). 
However, ‘packages of care’, or group programming alone is unlikely to 
address specific needs of this patient group. Thus, group sessions would 
need to be supported by a larger component of individualised assessment 
and intervention, which can tailor recommendations to support individual 
needs, such as intervention described in McKinstry and Tranter et al’s (2009) 
study. If future evidence supported that oropharyngeal dysphagia 
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deteriorated alongside increasing severity of COPD, early screening and 
monitoring protocols which harnesses multidisciplinary teams to maximize 
and educate early may delay, reduce or even prevent onset of potentially 
avoidable eating and/or drinking issues. This in turn may impact length or 
duration of exacerbations and hospital stay, reduce use of antibiotics, 
stabilize weight or increase quality of life. Such a package of care may turn 
statements such as ‘I stop eating for (up to) seven days’ (discussed in 
section 1.3) to ‘After my assessment and advice provided.... I know how to 
eat/drink, or I know what is safe/easy to eat/drink when I am unwell’, or ‘I 
know who to contact when I am having difficulties with my swallowing’. 
 
7.8 Implications for Future Research  
The aims and objectives of the study detailed in this thesis tested 
assumptions and methodological design using the Medical Research Council 
Health Services and Public Health Research Board’s framework for defining 
and developing complex interventions (2000). These preliminary findings 
may be furthered within the current theme and or by exploring other 
questions becoming apparent as the study in this thesis highlighted, which 
are now discussed.  
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7.8.1 Extending the current research design 
The preliminary study detailed in this thesis completed the first two stages of 
the MRC framework for development and evaluation of complex 
interventions (Medical Research Council Health Services and Public Health 
Research Board, 2000); stages of Development and Feasibility. As such, it 
explored the current evidence base and the feasibility of employing specific 
assessment measures and research design to investigate prevalence and 
the nature of oropharyngeal dysphagia in patients with COPD. Thus findings 
may inform future studies investigating the final two stages of the MRC 
Framework (2000); stages of Evaluation and Implementation, and therefore 
build on methodological design discussed within the study detailed in this 
thesis (also highlighted within section 7.6) and aid power calculations to 
estimate expected proportions. 
 
7.8.1i) Study Design 
Future studies building on preliminary findings detailed in the study within 
this thesis may benefit from using a prospective, longitudinal, repeated 
measures cohort study design. 
 
7.8.1ii) Aims and Objectives 
Using the above study design, future studies may then aim: 
 To compare swallowing related quality of life, perception and 
biomechanical swallowing and respiratory-swallow patterns in normal 
controls, dysphagic and non dysphagic COPD patients. 
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  To compare swallowing related quality of life, perception and 
biomechanical swallowing and respiratory-swallow patterns in 
dysphagic and non dysphagic COPD patients by severity. 
 
 To compare long term swallowing related quality of life and health 
changes in normal controls, dysphagic and non dysphagic COPD 
patients. 
 
 
7.8.1iii) Study Time Frame 
Due to the longitudinal time frame considered necessary to investigate the 
impact on quality of life and health, subjects recruited to the subject should 
be followed up for a minimum of two years. This would allow or seasonal 
fluctuations observed as discussed previously. 
 
7.8.1vi) Recruitment 
To meet the aims and objectives, I envisage recruitment would be within 
three main groups;  
1) COPD patients with dysphagia.  
2) COPD patients without dysphagia 
3) Normal healthy matched controls.   
This research design and longer time frame would adequately investigate the 
nature of the swallowing problems in greater depth and any sequelae as the 
condition progressed.  
The two COPD research groups may then be further analysed according to 
severity of disease (mild, moderate and severe). 
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It is essential to be able to compare data to healthy age matched peers; 
however in my opinion when investigating patients with COPD, it is equally 
important to include a second control group within the methodological 
design; such as COPD patients without signs of oropharyngeal dysphagia. 
This would allow the researcher to assess the longitudinal effects of 
unmanaged dysphagia (with or without trace aspiration), and allow 
evaluation of any longitudinal detrimental medical complications in an 
already compromised and deteriorating pulmonary system.  
 
7.8.1v) Sample Size 
A cohort study design described above would require a minimum sample 
size of 539 subjects. This overall sample size estimates 77 subjects will be 
required within each variable building in a potential 20% fallout rate. Based 
on standard power calculations (Machin, Campbell, & Walters, 2010), this 
provides an 80% power and is able to detect a 0.5SD clinically important 
change in quality of life scores. 
If mortality was included within the data analysis, using data from the 
preliminary study within this thesis would suggest a true rate of mortality 
would be less than 20%. However, this could either be accounted for by the 
estimated fallout rate, or could be added to the estimated sample size; which 
would increase the estimated sample size to be 90 subjects per variable.  
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7.8.1vi) Assessment Procedure and inclusion/exclusion criteria 
The three main measures used within the study detailed in this thesis 
(swallowing related quality of life questionnaire, videofluoroscopy and 
respiratory-swallow analysis) and inclusion/exclusion criteria revealed a valid 
approach in measuring patient and clinically relevant variables and therefore 
could be easily reproduced within a larger scale study. Each group would 
ideally complete identical assessment measures (as detailed in chapter five 
with the limitations acknowledged and potential solutions discussed in 
section 7.6) every 3 months over a two year period.  
 
7.8.1vii) Data Collection and Analysis 
Data collected to meet potential aims may measure health and quality of life 
outcomes, such as frequency of: 
 Chest infections 
 Chest related admissions to hospital or prescription of antibiotics 
 Exacerbations 
 Mortality  
 
as well as measuring: 
 Prevalence and nature of dysphagic characteristics 
 Changes in swallowing related quality of life 
 Changes in oral regime- diet and fluid consistencies 
 Use of swallowing compensatory strategies 
 
As shown by the findings within the study detailed within this thesis, 
aspiration is only one aspect of oropharyngeal dysphagia; as a patient can 
be diagnosed as dysphagic with or without aspiration being present. 
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Therefore including clinically and patient relevant measures within overall 
outcomes provides a holistic approach to the research design. 
 
7.8.1viii) Summary 
Investigations into current evidence base, justifications into methodology 
combined with preliminary findings within the study detailed in this thesis 
may be used as a base on to which further investigate dysphagia with 
patients with COPD.  
 
7.8.2 Further Research Questions 
Research tends to highlight more questions than it answers, and as this 
study progressed, areas in need for further investigation became apparent. 
Potential research questions for future investigation raised throughout this 
study have been highlighted within each relevant objective, and are 
combined in the summary table 37 with other relevant questions now 
discussed. 
Although physiological and survival measures are important outcomes for 
professionals and patients, they do not fully explore the holistic experience 
for patient and carer. This study explored patient perception of the impact of 
swallowing on their quality of life, however it did not include family and/or 
carers’ perceptions of the difficulty, the impact on their quality of life resulting 
from looking after the person with COPD, nor did it investigate any gender 
differences. The literature suggests (stereotypically) females tend to do the 
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shopping and cooking more than their male partners(Arnold, Ranchor, 
DeJongste, & Koeter, 2005), so could swallowing difficulties directly affect 
female COPD patients more than males (in the role as the carer or as the 
COPD patient)? Furthermore could patients with COPD who live alone have 
reduced swallowing related quality of life; more than patients who live with a 
spouse, family member or have carers helping with preparation of 
mealtimes?  
Throughout the assessment process subjects in this study (and occasionally 
their spouse) were interested in discussing their specific swallow 
idiosyncrasies precipitated from the questionnaire, and were keen to watch a 
replay of their own swallow assessment under x-ray. Discussion of individual 
results occurred only after the subject had completed the assessment 
process of the study (after completion of stable phase). This interest 
suggests further potential qualitative research; such as inclusion of patient 
and carer focus groups which is under explored in the literature.  
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Table 38: Summary table of potential future research questions evolving from this thesis.  
 What is the clinical significance of changes in quality of life scores between 
phases of COPD? 
 
 What is the true prevalence and impact on health and wellbeing of 
oropharyngeal dysphagia by severity of COPD? 
 
 What is the impact of oropharyngeal dysphagia on COPD carer health and 
wellbeing? 
 
 Are there gender differences in rates of oropharyngeal dysphagia and 
impact on wellbeing in patients with COPD? 
 
 What is the association between oropharyngeal dysphagia and COPD with 
or without relevant co-morbidities? 
 
 What are the longitudinal effects of unmanaged oropharyngeal dysphagia; 
with or without aspiration on health and wellbeing in COPD patients? 
 
 What is the impact of using compensatory manoeuvres on long term health 
and wellbeing in COPD patients? 
 
 What effect does teaching exhalation post swallow have on COPD health 
and wellbeing? 
 
7.9 Conclusion 
Successful intervention strategies aim to reduce the personal and social 
burden of COPD by improving patient symptoms, functional status and 
quality of life (Gupta & Kant, 2009). However prevalence; whether via the 
clinician’s or the patient’s perspective, and the nature of the problem must 
first be established in order to provide good quality, evidence based 
intervention strategies on which to be based. The theoretical phase of this 
study revealed there was still a need for research to focus on providing 
preliminary evidence, and clinical observations confirmed the potential unmet 
need within the COPD population. Findings from the study detailed in this 
thesis revealed COPD subjects in this study varied from the normal swallow, 
and respiratory-swallow pattern documented within the literature; with 
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increased signs of oropharyngeal dysphagia during exacerbation phase. 
Additionally, subjects seemed aware of their physiological vulnerability; via 
the self report swallowing symptoms and swallowing related quality of life 
questionnaire, and subconsciously enlisted airway protective mechanisms to 
avoid pulmonary complications. The holistic approach in this study using 
triangulation methodology has revealed that aspiration is only one aspect of 
dysphagia. A person with COPD may be considered to exhibit dysphagic 
characteristics clinically and perceive swallowing difficulties, yet still have a 
physiologically functional swallow. Due to the complex nature of COPD, 
multifactorial causes have been shown to contribute to the presence of 
oropharyngeal dysphagia; with psychosocial and personality traits, and social 
support system influencing how the patient views the difficulties or attempts 
to overcome them. We in the medical profession seem increasingly 
interested in ‘whether the patient has aspirated or not’, which has been 
shown to be only part of the wider picture throughout this thesis. There does 
not have to be a large clinical finding to have a significant impact on quality 
of life, and this study has shown the importance of incorporating patient 
reported perception and quality of life issues into assessment and diagnosis 
to explore dysphagia quality of care more holistically. 
This preliminary study has revealed emerging evidence suggesting 
oropharyngeal dysphagia is more prevalent than previously documented, 
however larger sample longitudinal studies are still required to confirm these 
findings. Furthermore, this study may inform future statistical power required 
and methodological design.   
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